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SUMMARY 
 
 
Articular cartilage on weight-bearing joints experiences three main forces: fluid-
induced shear across the surface, perfusion through the cartilage from the surrounding 
fluid, and compression during motion of the joint.  A new bioreactor that employs two of 
these forces was developed in this lab to study their effect on tissue-engineered cartilage 
development.  The focus of this research and overall hypothesis is that bioreactors that 
employ both perfusion and shear will improve chondrogenesis and preservation to 
produce functionally relevant cartilage by modulating shear stress and introducing 
exogenous preservation factors.  Applying both a low shear stress across the surface of 
cell-seeded scaffolds and perfusion through them in a perfusion concentric cylinder 
(PCC) bioreactor may stimulate chondrocytes to undergo chondrogenesis.  Experimental 
data showed that the PCC bioreactor stimulated cartilage growth over the course of four 
weeks, supported by the appearance of glycosaminoglycan (GAG) and collagen type II, 
which are markers for articular cartilage.  Computational fluid dynamics modeling 
showed that shear stress across the face of the construct was heterogeneous, and that only 
the center experienced a relatively uniform shear stress of 0.4 dynes/cm2 when the outer 
cup of the bioreactor rotated at 38 rpm.  When compared to a concentric cylinder (CC) 
bioreactor that employed only shear stress, the PCC bioreactor caused a significant 
increase in cellular proliferation, which resulted in a 12-fold increase in cell number per 
construct compared to 7-fold increase within the CC bioreactor.  However, the PCC 
bioreactor had a less pronounced effect on glycosaminoglycan and collagen content with 
1.3 mg of GAG and 1.8 mg of collagen per construct within the CC bioreactor and 
 xxiv 
 
0.7 mg of GAG and 0.8 mg of collagen per construct within the PCC bioreactor after 28 
days in culture (p < 0.05).  Our results led to an important observation that the PCC 
bioreactor affected cellular proliferation significantly but not extracellular matrix 
synthesis. 
The next objective of this study focused on the PCC bioreactor to evaluate the 
direct role of perfusion and shear on chondrogenesis in vitro and in vivo.  In the presence 
of perfusion+shear, cellular growth increased by 33 fold, while compared to the presence 
of shear alone, cellular growth increased by 11 fold (p < 0.05).  GAG deposition per 
construct was not affected by either bioreactors, both producing 1.2 mg/construct by 
Day 28.  Total collagen deposition, however, was significantly higher in the 
perfusion+shear bioreactor with 2.8 mg/construct, while the shear bioreactor produced 
1.2 mg/construct by Day 28.  The compressive and shear modulus measured showed no 
difference between the two bioreactors and were approximately 0.15 MPa and 0.33 MPa, 
respectively.  However, the perfusion+shear bioreactor had a significantly higher phase 
angle compared to the shear bioreactor, due to greater collagen deposition per construct 
in the perfusion+shear bioreactor.  This observation combined with the PCC versus CC 
study suggests that directional shear stress may influence the proliferation rate of 
chondrocytes, while the magnitude of shear stress may influence total collagen 
deposition.  
A rat xiphoid chondral defect model was developed to assess in vivo 
chondrogenesis supported by tissue-engineered cartilage constructs (TECCs) grown 
under perfusion+shear conditions, shear only, or static conditions for 28 days.  Implanted 
into the defect, the tissue-engineered cartilage cultured in the mechanically active 
 xxv 
 
bioreactors resulted in more mature engineered cartilage over static cultured constructs 
after 28 days in vivo.  This observation showed the necessity to consider mechanical 
forces and cell density when culturing engineered cartilage for implantation into cartilage 
defects.      
A major challenge for cartilage tissue engineering is the development of viable 
preservation methods to ensure long-term “off-the-shelf” availability.  The objective of 
the final study was to identify variables in ice-free cryopreservation by vitrification that 
affect cell viability of tissue-engineered cartilage and determine whether preservation 
could be performed in a bioreactor.  TECCs were grown in a PCC bioreactor and 
harvested for cryopreservation studies.  Traditional slow-rate freezing cryopreservation 
was carried out with 1 M DMSO introduced into TECCs.  Vitrification experiments 
consisted of treatments with different formulations of the vitrification solution: VS55, 
VS70, and VS83, which consisted of DMSO, formamide, and 1,2-propanediol.  
Vitrification experiments also consisted of different methods of introduction and elution 
of vitrification solutions into and out of TECCs: 6 or 7 (6/7) sequential discrete steps 
increasing or decreasing in concentration, respectively, 4/4 sequential discrete steps, and 
permeation of vitrification solutions using the PCC bioreactor.  The final results showed 
that VS70 preserved 2.2 times more viable cells than VS55 and VS55 preserved 2.8 times 
more viable cells than VS83.  The reduction of steps from VS70 in 6/7 sequential steps to 
VS70 in 4/4 steps did not alter cell viability, neither did the incorporation of the PCC 
bioreactor to better permeate VS70 into TECCs.  The highest cell viabilities reached were 
47.8 ± 5.6% in the PCC bioreactor treatment, which demonstrated the need to further 
tailor vitrification protocols to increase cell viability and TECCs function. 
 1
CHAPTER 1 
INTRODUCTION 
 
Articular cartilage is found at the ends of bones, providing smooth movement and 
cushioning during movement.  Cartilage degradation due to injury or disease poses a 
serious problem leading to decreased function and quality of life for patients.  Pain and 
stiffness of joints occur as cartilage wears away exposing the underlying bones.  The 
inability of cartilage to self-repair has led to a number of treatments.  By the year 2030 
the American Society of Orthopedic Surgeons estimates that 3.5 million total knee 
replacements will be needed (Pearson 2006).  Total knee replacement is ultimately a 
costly and drastic solution to cartilage dysfunction.  Alternative treatments before 
replacement of the joint have been tested (autologous grafts, chondral shaving, and anti-
inflammatory drugs).  Each has their own advantages and limitations.   
A promising and long-term solution to articular cartilage degradation is the 
implantation of tissue-engineered (TE) cartilage constructs that can repair full thickness 
defects.  Tissue engineering is the combined application of engineering principles and life 
science to develop functionally relevant tissue that can maintain and restore damaged 
areas (Langer and Vacanti 1993).  The ultimate goal of tissue engineering is to grow 
healthy functional tissue in vitro with suitable structure and properties, which can be 
implanted into damaged areas, naturally healing the affected region.  The challenge lies 
in finding the appropriate cell source, scaffold material, culture environment, and storage 
conditions to produce and maintain viable cartilage (Langer and Vacanti 1993; Nerem 
and Sambanis 1995; Hardingham, Simon et al. 2002; Ochoa and Vacanti 2002).  
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Biochemical signals, mechanical forces (such as shear stress, perfusion, and 
compression), and various other environmental cues stimulate the growth, functionality, 
and preservation of engineered cartilage (Blunk, Sieminski et al. 2002; Shieh and 
Athanasiou 2003; Saini and Wick 2004; Lee, Grad et al. 2005).  
Bioreactors can provide the necessary chemical and mechanical environment to 
affect the kinetics and material properties of chondrocytes to produce TE cartilage.  
Bioreactors are systems that provide the appropriate culture and preservation 
environment to grow three-dimensional (3-D) tissue using biologically relevant scaffolds.  
The bioreactor environment can be programmed to modulate and preserve cartilage 
growth, especially when applying mechanical stimuli such as shear and perfusion.  
Cartilage, due to its avascular structure, depends heavily on mechanical forces to 
maintain cartilage tissue function and structure; the distribution of nutrients and other 
regulatory factors also serves an important role to maintain cartilage.  Bioreactors also 
facilitate the introduction of chemical agents such as cryoprotectants for preservation to 
the fluid environment.   
This project studied some of the fundamental issues of the bioreactor environment 
that will promote the development and preservation of functional cartilage.  The main 
objective of this project was to determine whether the application of orthogonal shear 
during tissue growth would improve tissue quality.  We hypothesized that the addition of 
perfusion flow orthogonal to fluid-induced surface shear on cell-seeded polymer 
scaffolds in a perfusion concentric cylinder (PCC) bioreactor will promote construct 
growth and understanding of mechanical stimulation on cartilage development.  Studies 
include characterizing the fluid regime of the PCC bioreactor and determining the 
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relationship directional shear stress has on cartilage construct growth.  Parallel studies 
include comparison of cartilage growth between the PCC bioreactor to the previously 
described concentric cylinder (CC) bioreactor (Saini 2001), as well as comparison of 
mechanical forces: perfusion and shear to shear only.  In addition, methods for preserving 
cartilage constructs produced in the PCC bioreactor were assessed. 
Therefore, the specific aims of this project were: 
 
Aim 1.  To compare the development of engineered cartilage constructs produced using 
two different concentric cylinder bioreactor designs. 
 The PCC bioreactor was designed and built in our lab (Rangamani 2005), based 
on a previously characterized CC bioreactor (Saini 2001).  Initial studies characterized 
the pressure gradients, velocity, shear stress, nutrient profile, composition, and structure 
that occurred within the PCC bioreactor.  Properties of cartilage grown in the PCC 
bioreactor were then characterized and compared to constructs grown in the CC 
bioreactor. 
 
Aim 2.  To assess the direct effects of orthogonal shear via perfusion on engineered 
cartilage constructs exposed to surface shear.   
 The PCC bioreactor was designed to employ both perfusion of fluid through the 
construct thickness and fluid-induced shear stress over the surface of the constructs.  
Growth of cartilage constructs cultured under both perfusion and shear was compared to 
growth in a PCC bioreactor that employed only shear.  In addition, in vivo 
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chondrogenesis supported by tissue-engineered cartilage constructs (TECCs) grown 
under these two shear regimes was assessed in a rat xiphoid chondral defect model. 
 
Aim 3.  To identify conditions that affect cryopreservation of engineered cartilage 
constructs grown in a bioreactor. 
 Clinical use of TECCs requires consideration of long-term storage strategies. 
TECCs were cultured in the PCC bioreactor and different cryopreservation methods were 
employed to assess their effect on cell viability upon re-warming.  Initial studies varied 
cryoprotectant agents formulation and step-wise method of introduction and elution of 
cryoprotectants on the harvested TECCs.  The PCC bioreactor was then used to permeate 
cryoprotectant agents as a means to minimize handling from culture to preservation in a 
one-step process.   
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CHAPTER 2 
BACKGROUND 
 
2.1 Articular Cartilage 
Articular cartilage is found in weight bearing joints.  It reduces friction between 
two opposing bones and supports and distributes loads, relieving any pressure that could 
be damaging to the bones.  The synovial fluid that fills the open cavity between the bones 
reduces the coefficient of friction over the cartilage aiding the ease of movement for the 
joint.  The tissue is comprised of chondrocytes surrounded by an extracellular matrix 
(ECM) primarily consisting of proteoglycan and collagen type II (Kuettner, Aydelotte et 
al. 1991).  Organized into a complex three-dimensional structure, cartilage is highly 
adapted to its mechanical environment where proteoglycan and collagen fibers interact to 
provide resistance to compressive and shear forces (Mow, Ratcliffe et al. 1992; Muir 
1995).  Cartilage, due to its avascular structure, depends heavily on mechanical forces, 
fluid-induced shear across the surface, perfusion of fluid through the cartilage, and 
compression during motion of the joint, to maintain cartilage tissue function and 
structure.  The lack of blood vessels (which provide oxygen and nutrition), however, 
contributes to the limited regenerative ability of articular cartilage in vivo (Hunziker 
2000; Imhof, Sulzbacher et al. 2000; Eyre 2002).  
 
2.1.1 Ultrastructure 
The ultrastructure and components of cartilage are responsible for its mechanical 
properties.  Therefore, an understanding of these properties is important for producing 
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functional tissue-engineered cartilage (Mow, Holmes et al. 1984; Poole, Kojima et al. 
2001; Laasanen, Töyräs et al. 2003; Mansour 2004).  Seen in Figure 2.1, cartilage is not a 
homogeneous tissue but can be divided into four zones based on differences in the size, 
shape, amounts, and distribution of chondrocytes, proteoglycan, and collagen.  Water 
makes up 70 - 85% of the whole tissue depending on the zone.  Close to the subchondral 
bone is the calcified cartilage zone, which serves as the boundary between cartilage and 
bone.  Next is the deep zone containing mostly proteoglycan with tightly packed collagen 
fibers oriented orthogonal to the surface and relatively little water.  Cells here are aligned 
in columns that are perpendicular to the flow of the fluids across the articular cartilage 
surface.  The middle zone, located between the surface and deep zone, has less 
proteoglycan and more collagen fibrils arranged in a mesh-like pattern (see inset in 
Figure 2.1).  The surface zone, exposed to the fluid flow from the surrounding synovial 
fluid, has the least amount of proteoglycan and the most water with densely packed thin 
collagen fibrils organized into layers.  The cells here are oval in shape and are arranged to 
align with the surface flow (Maroudas and Bullough 1968; Lipshitz, Etheredge et al. 
1975; Mow, Holmes et al. 1984; Jeffery, Blunn et al. 1991; Eyre 2002; Mansour 2004). 
As a result, this zone has the highest tensile properties to accommodate the compressive, 
shear, and tensile forces experienced on the joints (Krishnan, Park et al. 2003). 
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Figure 2.1.  Cross section of articular cartilage, showing all zones (Saini 2001).  Inset in 
the middle zone indicates the interaction of the collagen fibers and proteoglycan forming 
a mesh-like structure. 
 
 
 
2.1.2 Chondrocytes 
The cells located in cartilage are known as chondrocytes and are normally round 
in morphology except near the tissue surface.  Chondrocytes are a differentiated cell type 
originating from mesenchymal stem cells (Caplan, Elyaderani et al. 1997; Alsalameh, 
Amin et al. 2004).  Compared to other tissues, the cell density of chondrocytes is low 
with little cell-to-cell contact and comprises 10% of the tissue volume (Stockwell 1979).  
Chondrocytes are responsible for the synthesis, secretion, and organization of collagen, 
glycoprotein, proteoglycan, and hyaluronan composing the extracellular matrix 
surrounding them (Archer and Francis-West 2003).  The large density of the matrix 
proteins protects chondrocytes from damage due to mechanical forces when cartilage is 
under loading.   
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2.1.3 Proteoglycan 
Proteoglycan plays a major role in the stiffness, hydration, and pore size of 
cartilage.  Aggrecan is the main type of proteoglycan core protein found in articular 
cartilage and proteoglycan aggregates comprise up to 30% of the dry weight in native 
tissue (Mansour 2004).  Seen in Figure 2.2, proteoglycan consists of aggrecan to which 
glycosaminoglycan (GAG) chains attach to form a bottlebrush-like formation.  The core 
protein consists of three disulphide-bonded globular regions (G1, G2, and G3).  The G1 
region is primarily responsible for interacting with the link protein and the hyaluronan 
backbone (Roughley 2006).  GAG chains (keratan and chondroitin sulfate) covalently 
link in a region between G2 and G3.  Chondroitin sulfate (CS) and keratan sulfate (KS) 
are the two main forms of glycosaminoglycan, where chondroitin sulfate outnumbers 
keratan sulfate twelve to one in newborn calf cartilage (Wheeless 2005).  Keratan sulfate 
attachment is adjacent to the G2 region while chondroitin sulfate is adjacent to the 
keratan sulfate region ending next to the G3 region (Roughley 2006).  The sulfated GAG 
are polysaccharide chains where CS consists of disaccharide units D-glucuronate and 
N-acetyl-D-galactosamine-4-sulfate or N-acetyl-D-galactosamine-6-sulfate and KS 
consists of D-galactose and N-acetyl-D-glycosamine-6-sulfate (Voet and Voet 2004).  
The proteoglycan monomers then aggregate and link to the backbone of a hyaluronic acid 
chain (a non-sulfated glycosaminoglycan with disaccharide units D-glucuronate and 
N-acetyl-D-glucosamine) via the link proteins.  The resulting macromolecules seen in 
Figure 2.3 can weigh up to 200 million Daltons (Mow and Lai 1980; Mansour 2004). 
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Figure 2.2.  Aggrecan bound to a link protein consisting of keratan and chondroitin 
sulfate chains. 
 
 
 
 
Figure 2.3.  Aggrecan chains aggregated to a glycosaminoglycan chain hyaluronan 
(Currey 2005).  
 
 
 
Chondroitin sulfate and keratan sulfate are negatively charged due to the sulfate 
and carboxyl groups.  As tissue is compressed due to loading and water flows out, the 
resulting high concentration of negatively charged proteoglycan provides resistance to 
loading and adds to the stiffness in cartilage until equilibrium is achieved (Mansour 
2004).  Once loading has ceased, the proteoglycan creates a large osmotic swelling 
pressure drawing back in the water molecules.  However, the macromolecular movement 
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is also restricted by collagen fibrils, preventing free swelling (Kuettner, Aydelotte et al. 
1991).  Thus, proteoglycan helps the cartilage to expand back to its original shape after 
loading. 
 
2.1.4 Collagens 
Collagen is a major stress-bearing component providing the tensile strength in 
cartilage, as well as in other collagen containing tissue.  In cartilage 60 – 70% of dry 
weight is collagen, where type II is the dominant form (Eyre 2002; Mansour 2004).  
Collagen type IX and XI are also present in cartilage, but in smaller amounts (Mow, 
Ratcliffe et al. 1992; Eyre 2002).  Type II collagen serves as a marker for differentiated 
chondrocytes and mechanically functional articular cartilage (Riesle, Hollander et al. 
1998), whereas type I collagen presence is indicative of dedifferentiated chondrocytes 
into fibroblast-like cells, resulting in fibrocartilage, which cannot support weight-bearing 
loads.  The arrangements and orientation of the collagen fibrils allow cartilage to support 
stress in all directions, giving the function and stability of articular cartilage. 
Seen in Figure 2.4, collagen type II consists of three identical polypeptide 1[II] 
chains arranged in a triple helix.  Collagen is unique in that a third of the amino acids in 
the chains are glycine (Gly) and 15 - 30% are proline (Pro) and 4-hydroxyproline (Hyp).  
The hydroxyproline residues are formed after the collagen polypeptides are synthesized; 
proline residues are catalyzed to hydroxyproline with prolyl hydroxylase, which requires 
ascorbic acid to maintain the enzyme’s activity.  The hydroxyproline’s hydrogen bonds 
interact with water molecules to maintain collagen stability, which would otherwise 
denature at room temperature (denatures instead at 39ºC) (Voet and Voet 2004).  Each 
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chain has the repeating amino acid sequence Gly-X-Y, where position X is usually Pro 
and Y is usually Hyp (Voet and Voet 2004).  The Gly-X-Y motif is responsible for the 
triple helix conformation through interchain hydrogen bonding, contributing to the 
rigidity of the entire structure.  In type II collagen, these triple helical structures then link 
and pack themselves in a staggered array into fibrils parallel to the fibrils’ axis.  This 
arrangement provides the tensile strength of collagen.  Fibrils covalently cross-link to 
each other using lysine and histidine side chains and collagen type IX in order to increase 
collagen rigidity.  The degree of cross-linking increases due to age (Riesle, Hollander et 
al. 1998; Voet and Voet 2004). 
  
 
Figure 2.4.  Collagen triple helix structure.  Note the repeating Gly-X-Y amino acids 
(Genitrix). 
 
 
 
Collagen type II controls the dynamic tissue response.  The fibers are interspersed 
among the proteoglycan aggregates forming a collagen/proteoglycan network and 
restricting movement within the matrix, thus providing resistance and maintaining shape 
and form of cartilage under large forces.  Under static conditions, collagen interspersed 
throughout the proteoglycan mesh, constantly restrains proteoglycan’s swelling pressure 
to stabilize the cartilage matrix (Riesle, Hollander et al. 1998; Mansour 2004). 
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2.1.5 Cartilage Oligomeric Matrix Protein  
Cartilage oligomeric matrix protein (COMP) is a noncollagenous glycoprotein 
found in the ECM making up approximately 1% of the wet weight of cartilage (Luan, 
Kong et al. 2008).  The protein, 524 kDa, consists of five identical glycoprotein subunits 
(pentameric) each approximately 110 kDa (Hedbom, Antonsson et al. 1992).  Each 
subunit starts with an amino-terminal domain (stabilized by disulfide bonds and the site 
of pentamerization) and consists of epidermal growth factor-like domains, then calcium-
binding domains, and ending with a COOH-terminal globular domain, which interacts 
and binds with type I, type II, and type IX collagen (Holden, Meadows et al. 2001; Thur, 
Rosenberg et al. 2001; Holden, Keene et al. 2005).  The glycoprotein consists of N-linked 
oligosaccharides mainly consisting of glucosamine, galactosamine, glucuronic acid, and 
galactose (Hedbom, Antonsson et al. 1992).  The main function of COMP is in matrix 
assembly and organization, by influencing collagen fibrils organization and collagen 
type II cross-linking (Farina, Lemaire et al. 2006).  COMP is down regulated when 
articular cartilage dedifferentiates into fibrocartilage.  Fragments of COMP have been 
detected in the surrounding synovial fluid and cartilage of patients with knee injuries, 
rheumatoid arthritis, and osteoarthritis, emphasizing its role in ECM structure, 
maintenance, and stabilization (Zaucke, Dinser et al. 2001).     
 
2.1.6 Cartilage Mechanics 
A completely elastic material deforms under stress but returns to its original shape 
after load is released, while viscous materials do not stretch but flow in response to load 
and do not return to their original shape.  The mechanical behavior of articular cartilage is 
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dictated by the components in the ECM and their assembly.  Cartilage is composed of 
both solid and fluid materials, allowing the tissue to behave as compressible material, 
while having incompressible components.  This means that under stress the cartilage 
deforms and “flows” to an extent, but regains its shape once the load is removed, i.e. it is 
mechanically viscoelastic (Laasanen, Töyräs et al. 2003; Mansour 2004).  
The compressive or tensional modulus is defined as deformation of a material due 
to loading normal to the surface of a material.  The compressive modulus for native 
healthy knee cartilage tissue is around 0.1 - 6 MPa for normal activities such as walking.  
However, pressures as high as 18 MPa have been measured in the knee joint in vivo 
during high stress activities (Hodge, Fujan et al. 1986; Mow and Guo 2002; Laasanen, 
Töyräs et al. 2003).  Permeability is defined as the measurement of a material’s ability to 
transmit fluids.  Cartilage is regarded as impervious, with permeability constants ranging 
between 10-14 and 10-16 m4/(N*s) (Cohen, Chorney et al. 1994; Heneghan and Riches 
2008).  Dynamic modulus is defined as the deformation of a material due to cyclical 
loading, which can be calculated from the results of shear, compression, or tension tests.  
This measurement allows interstitial fluid within the cartilage to exert pressure in 
response to external loading instead of exuding out due to a constant static load.  
Physiological frequencies occur between 0.01 and 2 Hz (Park, Hung et al. 2004).  Shear 
modulus is defined as deformation parallel to the surface of a material.  For native bovine 
knee cartilage, the complex shear modulus is approximately 0.16 MPa at 0.01 Hz (Zhu, 
Mow et al. 1993).  Phase angle is defined as the angle between displacement 
(deformation) and load.  The angle is a measure of a material’s viscous behavior to elastic 
behavior, where an elastic material’s angle is zero degrees and a viscous material’s is 
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ninety degrees.  Viscoelastic materials such as cartilage fall between zero and ninety 
degrees.  For bovine native cartilage the phase angle is approximate 15 degrees at a 
frequency of 1 Hz, and approximately 30 degrees at 0.1 Hz (Park, Hung et al. 2004).  The 
ability of articular cartilage to handle both compressive and shear loading differently 
indicates that articular cartilage can handle multi-directional loads (anisotropic). 
 
2.1.7 Mechanotransduction and Biochemical Conditioning  
Mechanotransduction is the signaling pathway undertaken as cells respond to an 
external mechanical load.  The mechanical loading can be in the form of hydrostatic 
pressure, fluid-induced shear, compression, or tension.  Chondrocytes make up a small 
portion of cartilage with little cell-to-cell contact.  Their processes do not extend far 
enough to reach other cells, and therefore, must rely on cell-matrix interaction for 
cartilage maintenance.  Any type of deformation of the tissue can cause changes in 
pressure, osmolarity, cation concentration, interstitial fluid flow, and cell shape (Wilkins, 
Browning et al. 2000).  In turn, the mechanical forces that cartilage experience modulate 
the biosynthetic and metabolic activities of chondrocytes.  Mechanical stimulation within 
physiological range can result in increase aggrecan and collagen expression, as well as, 
decrease in MMP expression (matrix metalloproteinases that degrade cartilage matrix) 
with a net result in maintaining cartilage structure and function (Salter, Wright et al. 
2004).  In addition, the variation in cell shape and size throughout the different zones of 
cartilage are believed to be an important mechanotransducer that regulates the 
biosynthetic activity in each zone (Urban 2000; Hunziker, Quinn et al. 2002).  For 
example, chondrocytes in the middle zone have up to ten times more synthetic activity 
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than the surface zone, suggesting variation in the matrix synthesis rate between zones 
(Wong, Wuethrich et al. 1996).  However, little is known about how chondrocytes sense 
mechanical signals and translate them into a chemical response to maintain cartilage 
architecture and function.  
A number of studies have been done to elucidate possible mechanotransduction 
pathways as a response to external mechanical loading.  Many of the cell surface 
receptors (Valhmu and Raia 2002), integrins (Loeser 2002), stretch activated channels 
(Wright, Jobanputra et al. 1996), membrane transporters (ion channels) (Wilkins, 
Browning et al. 2000; Browning, Saunders et al. 2004), and transmembrane proteins, 
including G proteins (Erickson, Alexopoulos et al. 2001) and neural associated molecules 
(Salter, Wright et al. 2004), are responsible for relaying outside signals across the cell 
membranes (Urban 2000).  Inside the cells, signaling cascades occur to regulate gene 
expression and metabolism for the maintenance of cartilage and its response to load.  The 
pericellular matrix is a zone that immediately surrounds the cell surface and is the 
location of the cell-matrix interaction.  As the extracellular matrix experiences 
mechanical loading, the force is transmitted to the pericellular matrix to reach the 
chondrocytes (Urban 2000).  The pericellular environment has different amounts and 
types of ECM components than the matrix experiencing the mechanical loads 
(Orazizadeh, Lee et al. 2008).  
One of the primary mechanoreceptors is the 51 integrin (Millward-Sadler, 
Wright et al. 2000).  As mechanical load is detected, this integrin activates downstream 
intracellular signaling, as well as changes in cytoskeleton and release of cytokines, 
including interleukin-4 (IL-4), thereby regulating cell shape, function, and metabolism 
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(Millward-Sadler, Wright et al. 1999; Millward-Sadler, Wright et al. 2000; Millward-
Sadler, Wright et al. 2000).  Under fluid-induced shear stress, chondrocytes in monolayer 
culture normally spread out and change morphology and increase proteoglycan and 
collagen synthesis.  However, Spiteri et al. found that when the 51 integrin was blocked 
this effect was negated, with ECM production decreasing by 75%, implicating this 
integrin’s role in signal transduction (Spiteri, Young et al. 2008).  The downstream 
signaling pathways include focal adhesion kinases (FAK) and mitogen activated protein 
(MAP) kinases, which in turn modulate transcription factors affecting gene expression for 
proliferation, survival, and matrix remodeling (Loeser 2002).  MAP kinases are known to 
interact with cytokines, including interlukins and tumor necrosis factors (TNF), which 
can regulate matrix metalloproteinases that assist in cartilage degradation.  Fitzgerald et 
al. showed a link between mechanical stimulation and gene expression through the MAP 
kinase pathway, where MAP kinase activity, aggrecan expression, and collagen type II 
expression increased when exposed to dynamic compression (Fitzgerald, Jin et al. 2008).         
Despite cartilage’s aneural structure, neural associated molecules have been found 
to act as mechanotransducers under applied load.  Salter et al. has found that N-methyl-
D-aspartate (NMDA) receptors, which is linked to Substance P (a neuropeptide) is a 
transmembrane protein.  The receptor is activated with protein kinases (PKC and PI3K) 
and forms a complex to interact with actin cytoskeleton.  This leads to influx in calcium 
and results in increase in nitric oxide synthetase (NOS) activity, which can actually 
decrease proteoglycan synthesis (Salter, Wright et al. 2004).   
Transport pathways that allow ions and nutrients to traverse the cell membrane 
are influenced by mechanical stress (Mobasheri, Carter et al. 2002).  As the ECM 
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compresses, fluid flows out, concentrating extracellular ions and nutrients, as well as 
drawing in cations due to the negatively charged proteoglycan.  Concentrated calcium, 
sodium, and hydrogen ions create an electrochemical gradient, which leads to an osmotic 
imbalance, thus decreasing cell volume to regain osmotic balance.  This in turn, can 
increase intracellular ions and solutes.  Guilak et al. showed that changes in intracellular 
calcium ions occur within seconds due to mechanical deformation on cartilage (Guilak, 
Zell et al. 1999).  Meanwhile, Wilkins et al. showed how applied pressure can stimulate 
the Na-H pump exchange, where the increase in cation concentration is able to up-
regulate gene expression and transporter activity (Wilkins, Browning et al. 2000).  
Browning et al. showed that by applying hydrostatic pressure, intracellular [Ca2+] 
increased and by applying osmotic pressure, intracellular [Na+] increased (Browning, 
Saunders et al. 2004).  Inositol triphosphate (IP3) levels, which are secondary messengers 
responsible for the release of Ca2+ from storage organelle sacs, also increase due to 
hydrostatic pressure (Valhmu and Raia 2002).  This phosphatidylinositol (PtdIns) 
pathway releases Ca2+ from intracellular stores, activating calcium modulated protein-
dependent enzymes, which translocates to the nucleus to activate transcriptional 
complexes such as those on the aggrecan gene (Valhmu and Raia 2002).  The end result 
due to this applied deformation is an increase in GAG synthesis (Valhmu and Raia 2002; 
Browning, Saunders et al. 2004).   
Another characteristic of cartilage mentioned earlier is that the tissue is avascular, 
where most nutrient and waste transport occurs via diffusion through the tissue from the 
surrounding synovial membrane and perfusion from the subchondral bone (Imhof, 
Breitenseher et al. 1999; Imhof, Sulzbacher et al. 2000; Archer and Francis-West 2003).  
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The lack of blood vessels creates a low oxygen tension (1 - 3%) to which cells have 
adapted well to by undergoing glycolysis for their energy needs (Brighton and 
Heppenstall 1971; Rajpurohit, Koch et al. 1996; Archer and Francis-West 2003).  
Reduced oxygen tension increases GAG production and retention in engineered cartilage 
(Saini and Wick 2004).  Reduced oxygen tension has also been shown to up-regulate 
aggrecan and collagen type II expression (Murphy and Athanassios 2001; Wernike, Li et 
al. 2008) and down-regulate collagen type I expression (Wernike, Li et al. 2008).  
Grimshaw and Mason in particular showed that chondrocytes cultured under low oxygen 
tension had anabolic genes up-regulated including TGF- and other growth factors, as 
well as increased levels of TIMP-1 (inhibits the degradation of the ECM) (Grimshaw and 
Mason 2001).  The pathway to elicit gene expression response (including energy 
metabolism, cell proliferation, and ECM production) to low oxygen tension is possibly 
regulated through the activation of the transcriptional complex hypoxia-inducible factor-1 
(HIF-1), due to an increased expression of HIF-1 under hypoxic conditions (Coimbra, 
Jimenez et al. 2004).  
Figure 2.5 shows a diagram giving a summary of the possible 
mechanotransduction pathways that occur within cartilage.  The conclusion drawn from 
these studies suggests that not one single pathway is directly responsible for translating 
mechanical signals to chemical responses.  Instead, the various mechanotransduction 
pathways most likely act sequentially or parallel with each other, combining at certain 
steps or acting separately from each other eliciting different biosynthetic responses.  
Clearly, this is a field of study that needs further expansion.  Understanding pathways 
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allows better control of mechanical stress in order to elicit the regulation of desired 
biosynthetic and metabolic activities.   
 
 
 
Figure 2.5.  Schematic of the mechanotransduction pathways due to loading of the 
cartilage tissue.  Mechanical deformation leads to an increase in fluid flow expulsion 
creating osmotic imbalances surrounding the cell.  Concentration of ions leads to increase 
in intracellular Ca2+.  Load signals are transduced through integrins, receptors, G protein 
complexes, focal adhesion kinases (FAK), and mitogen activated protein kinases 
(MAPK).  Secondary messengers such as calcium ions and inositol triphosphase (IP3) 
affect transcription, regulating ECM and function.  Mechanical load can cause release of 
nitric oxide (NO), ECM components, cytokines (interlukins (IL)-4 and -6), and tissue 
inhibitors of metalloproteinases (TIMPs) as well matrix metalloproteinases (MMPs).  
Figure adapted from Urban (2000) and Loeser (2002). 
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2.2 Cartilage: Injury, Repair, and Treatments 
Healthy cartilage is a balance between degradation and synthesis processes.  
Cartilage injuries and diseases begin when the catabolic pathways overtake synthesis.  
The most commonly known cartilage disease is the degenerative osteoarthritis.   
Traumatic injuries such as blunt trauma or cartilage fractures can lead to the degradation 
of cartilage as well.  Cartilage fractures can occur with injuries to the surface or below 
originating from the subchondral bone and can occur when bones are forced to move 
under high impact forces.  This leads to necrosis in the region of injury, and the inability 
of cartilage to repair effectively can lead to decrease cartilage function and eventually 
progress to osteoarthritis (Frenkel and Di Cesare 1999).  Sport activities and trauma 
injuries can be a common source of these blunt traumas and fractures due to repetitive 
high impact loading.   
 
2.2.1 Osteoarthritis 
In 2005 approximately 46.4 million Americans were diagnosed with some form of 
joint disorder, the most common of which was osteoarthritis (National Center for Health 
Statistics 2007).  After the age of 50 a significant gender disparity exists, where women 
affected by osteoarthritis outnumber men.  The disparity increases further with advancing 
age (Cecil and Archer 1925; Felson and Nevitt 1998; Richette, Corvol et al. 2003). 
Osteoarthritis is characterized by the slow wearing away of the articular cartilage 
in weight bearing joints, such as the knee or hip.  As the cartilage wears away, 
fibrillations and cracks appear in the once smooth articular surface.  Attempts at self-
repair are limited by the avascular nature of cartilage, and results in the formation of 
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fibrocartilage that has poorer mechanical function and lacks long-term stability compared 
to healthy tissue (Hunziker 2000; Imhof, Sulzbacher et al. 2000; Eyre 2002).  The disease 
starts with the chondrocytes attempting to repair the damaged and frayed extracellular 
matrix by remodeling the damaged matrix, but the limited regenerative capability hinders 
such self-repair.  By then, pro-inflammatory cytokines such as IL-1 and TNF- are up-
regulated, this in turn releases matrix metalloproteinases responsible for cartilage erosion 
(Fernandes, Martel-Pelletier et al. 2002).  In osteoarthritis patients, nitric oxide levels are 
higher than average, also indicating degradation, since NO is also responsible for 
cartilage breakdown (Yasuda 2006).  Unable to keep up the matrix synthesis rate to repair 
the damaged matrix, enzymes, such as the matrix metalloproteinases and aggrecanases 
that digest the matrix, overtake and result in tissue degradation (Frenkel and Di Cesare 
1999; Caterson, Flannery et al. 2000; Roughley 2001).  The continuous and eventual 
wearing away of cartilage leads to full thickness defects.  The complete degradation of 
cartilage exposes the underlying bone, increasing inflammatory responses, painful 
swelling, thickening of the subchondral bone, and stiffness of the joint for the patient 
(Brittberg, Lindahl et al. 1994).  
 
2.2.2 Repair and Treatments   
Current treatment options include anti-inflammatory drugs, hormone replacement 
therapy, chondral shaving, mesenchymal cell regeneration, autologous grafts, and total 
hip or knee replacement.  Anti-inflammatory drugs mainly serve as pain relievers without 
treating the cause, merely blocking the enzymes responsible for pain.  A treatment geared 
towards the gender disparity that exists for osteoarthritis patients is hormone replacement 
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therapy for post-menopausal women (Zhang, McAlindon et al. 1998).  In the 
Framingham study, some postmenopausal women who partook in estrogen replacement 
therapy (ERT) showed less symptoms of osteoarthritis compared to women who did not 
take ERT (Zhang, McAlindon et al. 1998).  Chondral shaving refers to shaving down the 
rough and fibrillated cartilage to a smooth surface to allow friction-free movement.  The 
method can treat large defect areas; however, the treatment provides only temporary 
relief without regenerating tissue, leaving less cartilage than before to provide normal 
function.  Mesenchymal stem cells are precursors to chondrocytes and have the ability to 
differentiate into chondrocytes when exposed to the right environment (such as solutions 
containing transforming growth factor-beta.  Implantation of mesenchymal cells into 
cartilage defects is limited by regenerated tissue that is less stiff and more permeable than 
native tissue (Kim, Moran et al. 1991; Wakitani, Goto et al. 1994).  Osteochondral grafts 
are transplantations of cartilage and bone typically from the same patient in a non-weight 
bearing region and grafted to the cartilage defect.  But, because this tissue is from a non-
weight bearing region, it may not have the same properties and composition as the 
affected region.  Also, implantation of osteochondral allografts risks disease and low cell 
viability post grafting (Minas and Nehrer 1997).  The most drastic treatment of 
osteoarthritis is total knee or hip replacement with prosthetics.  This method is typically 
reserved for older patients who do not lead an active lifestyle where a prosthetic can limit 
mobility.   
A common treatment especially for the initial stages of osteoarthritis is moderate 
exercises such as walking.  This treatment provides regular mechanical stimulation to the 
articular joint and improves nutrient transport as fluid is forced through the cartilage, 
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ultimately slowing degradation.  In a four-month trial Roos et al. showed that patients at 
risk of osteoarthritis who started moderate exercises showed an increase in cartilage GAG 
content than those who were not given a supervised exercise regiment (Roos and 
Dahlberg 2005).  Even intense exercises for patients showed that within three weeks they 
improved in mobility, function, and lessened in pain (Bulthuis, Drossaers-Bakker et al. 
2007).  The role of mechanical stimulation for arthritis highlights the role mechanical 
forces play in maintaining cartilage function and composition.  
Many of these treatment options treat only the painful symptoms and small 
lesions, but not the underlying cause, nor do they offer any long-term successful repair.  
Research in tissue engineering to provide cartilage constructs suitable for implantation is 
seen as a viable long-term treatment for cartilage defects (Freed, Vunjak-Novakovic et al. 
1993). 
 
2.3 Tissue Engineering 
A promising and long-term solution to cartilage degradation is the implantation of 
tissue-engineered (TE) cartilage constructs that can repair full thickness defects.  The 
ultimate goal of tissue engineering is to grow healthy functional tissue in vitro with 
suitable structure and properties, which can be implanted and integrate into damaged 
areas, naturally healing the affected region.  The challenge lies in finding the appropriate 
cell source, scaffold material, culture environment, and storage conditions to produce and 
maintain viable cartilage (Langer and Vacanti 1993; Nerem and Sambanis 1995; 
Hardingham, Simon et al. 2002; Ochoa and Vacanti 2002).  Biochemical signals, 
mechanical forces (such as shear stress, compression, and perfusion), and various other 
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environmental cues stimulate the growth, functionality, and preservation of engineered 
cartilage.  Bioreactors provide the necessary chemical and mechanical environment to 
affect the kinetics, material properties, and preservation of chondrocytes to produce 
cartilage.  The method for growing tissue-engineered cartilage can be visualized as flow 
chart, where cells are seeded onto scaffolds implanted into bioreactors.  While in the 
bioreactors, the seeded scaffolds are stimulated under the right environment for a set 
culture period.  After the cartilage is harvested they undergo preservation for long-term 
storage or implantation into cartilage defects.  The bioprocess is illustrated in Figure 2.6 
where the end result is to market tissue-engineered cartilage constructs that are suitable 
for implantation.   
 
 
Figure 2.6. Bioprocess schematic for tissue-engineered cartilage constructs.  Cells are 
seeded onto scaffolds and cultured in a bioreactor.  Harvested constructs are preserved, 
packaged, or implanted into defects. 
 
 
 
2.3.1 Cell Sourcing  
The source of cells used affects the growth, function, and properties of tissue-
engineered cartilage.  Besides chondrocytes as a cell source for engineering cartilage, 
mesenchymal progenitor cells, precursors to the differentiated chondrocytes, have also 
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been studied, and when given the right signals can differentiate into chondrocytes 
(Martin, Shastri et al. 2001; Sharma and Elisseeff 2004; Marion and Mao 2006).  Adult 
stem cells are seen as a reservoir of cells found in the body and can be removed by 
minimally invasive means to potentially heal any tissue, such as bone and cartilage.   
The age of the chondrocytes is also a concern where adult chondrocytes have 
slower growth rates and metabolic activity than those from immature sources (Adolphe, 
Ronot et al. 1983).  Even within adult cells, proliferation is affected by the donor’s age.  
Barbero et al. were able to show that between the ages of 20 and 90 cell proliferation rate 
decrease by 50%.  However, by adding a combination of growth factors to the culture 
media the proliferation rate in the same age range decrease only by 30% (Barbero, 
Grogan et al. 2004).  Thus, while limitations may occur due to the source of cells used, 
they can possibly be overcome by culturing them under the right environment.   
This lab focuses on bovine chondrocytes, but other animals such as pigs and goats 
have also been used mainly due to the large number of cells harvested from a single 
source (Passaretti, Silverman et al. 2001; Slivka, Neil C. Leatherbury et al. 2001).  
However, animals vary in their proliferation and differentiation behavior, which means 
that using animal models to predict the behavior of human chondrocytes may not be 
entirely accurate (Giannoni, Crovace et al. 2005).  
 
2.3.2 Biomaterials 
Scaffold materials need to provide the three-dimensional support to promote cell 
attachment, maintain their differentiated phenotype, minimize diffusional constraints for 
nutrient transfer, promote and support proliferation and matrix growth, and degrade at a 
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rate comparable to ECM synthesis rate in order to produce cartilage similar in structure 
and function of native tissue (Saini 2001).  Some biomaterials can be woven into a mesh-
like structure, which have the advantage of directing cartilage growth into a structure 
similar to the ultrastructure of native cartilage.  Natural polymers such as collagen, fibrin, 
silk, cellulose, and alginate have advantages such as ease of cell attachment and non-
toxic fragments when degraded into the body, lessening the possibility of an 
inflammatory response.  The fibers in collagen scaffolds also provide a matrix similar to 
native cartilage.  Disadvantages in natural polymers lie in finding the right source, 
maintaining sterility, and difficulty in processing (Stoop 2008).  Biodegradable synthetic 
scaffolds, such as poly-l-lactic acid (PLLA), poly-glycolic acid (PGA), and copolymers 
of these two (PLGA), have advantages over natural polymers in terms of 
biocompatibility, controllable degradation rate, strength, and ease of processing (Cima, 
Vacanti et al. 1991; Temenoff and Mikos 2000).  They can be processed into different 
shapes, composition, strength, and porosity to provide a large surface area for cell 
attachment and proliferation (Saini 2001).  Studies have shown that chondrocytes 
attached to these polymers retain their differentiated cell function, multiply, and create 
cartilage in the shape of the scaffold (Vacanti, Langer et al. 1991; Kim, Vacanti et al. 
1994).  One of the disadvantages in using synthetic scaffolds is the rise in pH when 
degraded into their acidic fragments causing possible inflammatory responses in the host 
(Stoop 2008). 
High seeding density maintains important cell-to-cell interactions that influence 
proliferation, matrix synthesis, and differentiation (Watt 1988).  Cell seeding density 
studies showed that scaffolds seeded at high densities maintained their differentiated 
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phenotype secreting more ECM, while those at low densities contained less ECM 
(Bruckner, Horler et al. 1989; Vunjak-Novakovic, Obradovic et al. 1998).  In another 
study by Puelacher et al., constructs seeded with less than 20x106 cells/cm3 created more 
fibrous and inferior cartilage (Puelacher, Kim et al. 1994).  Additional studies in 
bioreactors showed significantly more ECM content per construct when seeded at 
34x106 cells/cm3 or 43x106 cells/cm3 than when seeded at 26x106 cells/cm3 (Saini 2001).  
With suitable scaffold materials and a high seeding density, the growth of TE cartilage is 
then influenced mainly by its environment, i.e. bioreactor conditions. 
 
2.3.3 Bioreactors 
Bioreactors provide the appropriate culture environment to grow three-
dimensional tissue using biologically relevant scaffolds.  The bioreactor environment can 
be programmed to modulate and preserve cartilage growth, especially when applying 
mechanical stimuli such as shear, perfusion, and compression.  The premise that those 
mechanical and chemical stimuli that modulate chondrocytes’ behavior in vivo will also 
influence their behavior in vitro (Saini and Wick 2003; Sharma and Elisseeff 2004) has 
led to a number of studies showing that seeded scaffolds are influenced by their 
surrounding environment, stimulating chondrogenesis and matrix synthesis (Freed, 
Vunjak-Novakovic et al. 1993; Vunjak-Novakovic, Freed et al. 1996; Pazzano, Mercier 
et al. 2000; Davisson, Kunig et al. 2002; van Osch, Mandl et al. 2002; Darling and 
Athanasiou 2003; Saini and Wick 2003).  Bioreactors allow changes in the culture 
environment to affect the kinetics and properties of the tissue grown, where a well 
defined fluid regime can elucidate mechanotransduction pathways to understand the 
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relationship between mechanical forces and kinetics of chondrocytes.  To understand and 
identify the relationship between culture conditions and tissue properties that achieve 
suitable cartilage growth in a bioreactor requires knowledge of the interaction between 
cell behaviors and their mechanical and chemical stimuli (Runstadler 1992). 
As stated previously, healthy native cartilage is avascular and well suited to carry 
out normal metabolic activities under low oxygen tension.  Such observation has led to a 
number of in vitro studies showing positive effects on chondrogenesis under low oxygen 
levels compared to normal levels.  For example, passaged chondrocytes in alginate lost 
their characteristic phenotype markers, but regained them when cultured in 5% oxygen 
with an increase in collagen type II and aggrecan expression when compared to 20% 
oxygen (Murphy and Athanassios 2001).  Additional studies in bioreactors showed that 
engineered cartilage cultured under 5% oxygen tension demonstrated a significant 
increase in GAG content (Saini and Wick 2004).  These studies demonstrate that an in 
vivo characteristic of cartilage, low oxygen tension, can be an important bioprocessing 
factor in the in vitro development of cartilage. 
Monolayer studies have shown that fluid shear at 35 dynes/cm2 up-regulates 
chondrocytes proliferation (Malaviya and Nerem 2002).  However, when translated to 
three-dimensional culture, Vunjak-Novakovic et al. showed that the culture of TE 
cartilage under high shear stresses in bioreactors created elongated cells and collagen 
fibrils in regions exposed to shear and increased cell content, GAG, and collagen by 70%, 
60%, and 125%, respectively, when compared to static cultures (Vunjak-Novakovic, 
Freed et al. 1996).  Davisson et al. seeded ovine chondrocytes under perfusion at 
0.05 mL/min and then perfused with culture media at 0.8 mL/min where after nine days 
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GAG content increased by 40% along with cell content compared to static culture 
(Davisson, Sah et al. 2002).  Some of the reasons speculated as to why bioreactors 
enhance growth compared to static cultures are that they increase nutrient and oxygen 
transfer due to increased mixing patterns, that they distribute cells more uniformly due to 
the design of the bioreactors, and that they stimulate chondrogenesis due to 
hydrodynamic forces with specified magnitude and type (Freed, Hollander et al. 1998; 
Lee, Grad et al. 2005).  Currently, however, bioreactors engineer cartilage with lower 
matrix content and inferior material properties compared to native tissue, and little is 
known of the matrix organization in engineered cartilage (Saini and Wick 2003; Sharma 
and Elisseeff 2004).  
Previous studies of cartilage development in bioreactors have shown that seeded 
scaffolds can be stimulated to undergo chondrogenesis developing three-dimensional 
cartilage constructs.  Early cartilage bioreactor models include the spinner flasks (Freed, 
Vunjak-Novakovic et al. 1993; Sucosky, Osorio et al. 2004) and rotating wall vessel 
bioreactors (Freed and Vunjak-Novakovic 1997).  Even though these bioreactors grow 
cartilage, they produce turbulent or non-uniform fluid environments.  Our lab previously 
developed the concentric cylinder (CC) bioreactor that provides a uniform loading 
environment to grow tissue-engineered cartilage, but is limited to a one-directional 
hydrodynamic environment (Saini and Wick 2003). 
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2.3.3.1 Spinner Flask Bioreactor 
One of the more common types and earliest model of bioreactors for TE cartilage 
is the spinner flask bioreactor.  Seen in Figure 2.7A, spinner flasks are containers where 
scaffolds are attached to needles protruding from the cap.  Suspended in culture media, an 
impeller or magnetic stirbar then mixes the media allowing adequate penetration of 
nutrients into the scaffolds and creating shear forces on the constructs to stimulate 
cartilage growth.  However, the engineered cartilage has poor mechanical function and 
low material properties due to non-uniform tissue growth and thickening of tissue in the 
peripheral edges of the constructs when compared to other types of bioreactors (Vunjak-
Novakovic, Martin et al. 1999).  Shear stress varies throughout the flask both spatially 
and temporally, especially with the occurrence of turbulent eddies, making it difficult to 
quantify the non-uniform shear stress and mass transfer effects on TE cartilage (Freed, 
Vunjak-Novakovic et al. 1993; Sucosky, Osorio et al. 2004).  Another drawback is the 
complexity in scaling up the design to meet patient demands, limiting the system to 
bench-top research (Saini 2001).  
 
2.3.3.2 Cone and Plate Bioreactor 
 The cone and plate bioreactor is based on the geometry of the cone and plate 
viscometer, which is used in rheological studies to measure the viscosity or shear 
modulus of a substance.  As seen in Figure 2.7B, a cone is placed over a flat plate 
containing media.  The angle between the cone and plate is small and as the cone rotates, 
the fluid resists in the stationary plate, resulting in a laminar shear stress over the bottom 
surface (depending on the speed of the cone rotation).  Cells are grown in a monolayer 
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arrangement and respond to the set shear stress created by the cone, where the small 
angle allows for all the cells, regardless of location, to experience the same shear stress.  
Dewey et al. was one of the earliest research groups to use the cone and plate apparatus to 
culture endothelial cells.  At a shear stress between 5 and 10 dynes/cm2 cells elongated in 
the direction of flow, indicating the response cells had to mechanical stress (Dewey, 
Bussolari et al. 1981).  The cone and plate bioreactor is restricted to monolayer culture 
and is useful for elucidating mechanotransduction pathways.  The CC bioreactor used to 
culture three-dimensional tissue-engineered cartilage is modeled after the cone and plate 
bioreactor and is discussed in detail in the Materials and Methods section.     
 
2.3.3.3 Rotating Wall Vessel Bioreactor 
Another early bioreactor model is known as the rotating wall vessel (RWV) 
bioreactor.  This bioreactor was developed to create a microgravity environment to 
stimulate the growth of tissue-engineered cartilage.  It has been used to measure long-
term growth of cartilage.  Developed by NASA and seen in Figure 2.7C, the annulus 
between two cylinders situated on a horizontal plane is filled with media and cells.  Both 
the inner and outer cylinders rotate independently, and when rotated at the same rate in 
opposite direction, the cells remain suspended in the media and kept in a stationary 
location.  This effect is replicated in space without the aid of rotating cylinders in order to 
keep the cells suspended.  Long-term growth of tissue-engineered cartilage in a 
microgravity environment was tested in RWV bioreactors.  Freed et al. showed that those 
cultured in the RWV bioreactors in space had significantly less GAG content and poorer 
mechanical properties than those cultured on earth; however, even after seven months of 
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culture the bioreactors could not produced cartilage with ECM content and mechanical 
properties at level with native cartilage (Freed, Langer et al. 1997).          
 
 
2.3.3.4 Perfusion Bioreactor 
 Fluid flow can be manipulated in a bioreactor to flow through a porous scaffold.  
This type of convective flux increases mass transfer of nutrients and waste removal 
compared to diffusive flux alone.  The pores can be approximated as separate cylindrical 
tubes.  As fluid flows through the tissue at a set rate, it exerts shear stress at the walls of 
the pores.  Thus, perfusion bioreactors apply shear stress on the constructs stimulating 
growth, just as the spinner flask.  The difference lies in the direction of flow.  One of the 
considerations regarding the perfusion bioreactor is ensuring fluid flows through the 
porous scaffolds and not around, as fluid tends to flow in the path of least resistance.  
This is usually done by creating a tight seal surrounding and securing the scaffold in 
place, such that fluid has no choice but to flow through.  Another consideration is 
choosing the right scaffold material, where those with poor mechanical strength like 
alginate (with a compressive modulus less than 10 kPa) (LeRoux, Guilak et al. 1999) are 
unable to withstand high flow rates.  Typically, a perfusion bioreactor will have a 
connecting reservoir for media storage and to allow for sufficient gas exchange.  As seen 
in Figure 2.7D, a pump is used to flow fluid from the reservoir to an inlet region of the 
bioreactor, then pumped out through an exit region, and back to the reservoir creating a 
closed loop.  Multiple perfusion bioreactors can attach to a single reservoir easing the 
scalability of the system.  Thus, perfusion bioreactors can meet patient demands due to its 
simple geometric design for scaling up.   
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Figure 2.7.  Bioreactor models used to culture tissue-engineered cartilage.  Images in the 
second column magnify the fluid profile.  (A) Spinner flask bioreactor; (B) cone and 
plate bioreactor with angle  (C) rotating wall vessel bioreactor; (D) perfusion 
bioreactor.  Images adapted from Martin et al. (Martin, Wendt et al. 2004) 
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2.4 Cryopreservation 
Long-term success of TE cartilage as a viable treatment option can only be 
achieved if suitable preservation methods maintain viability and functionality of TE 
cartilage.  Cryobiology is the study of effects of low temperature on cells, tissues, and 
organs; where as, cryopreservation is the application of subzero temperatures, halting 
metabolic activity until re-warmed for the storage of such biological systems.  Simply 
lowering the temperature of cells and tissues to below their freezing point invariably 
destroys them because the ice crystals that form in the water-laden cells and tissues break 
through the delicate cell membranes.  In addition, high salt concentrations inside the cells 
that result from the ice formation create a toxic imbalance.  When thawed the cells and 
tissues are damaged beyond repair.  If the formation of ice crystals can be minimized 
while still halting metabolic activity of cells at low temperatures, then the viability and 
functionality of the preserved tissue can be maintained.  There are important variables to 
successful cryopreservation that maximizes cell survival: cryoprotectant agent, 
cryoprotectant concentration, method of introduction, method of elution, cooling rate, 
temperature exposure, storage temperature, and warming rate (Brockbank, Covault et al. 
2001). 
 
2.4.1 Cryoprotectants 
Cryoprotectants can be divided into groups based on their role in protecting cells 
and tissues during freezing.  In 1949, Polge, Smith, and Parkes discovered a significant 
breakthrough in the role of glycerol as an intracellular cryoprotectant, minimizing ice 
formation within cells (Polge, Smith et al. 1949).  Later on, other cryoprotectant agents 
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(CPAs) were discovered, such as dimethyl sulfoxide (DMSO) (Lovelock and Bishop 
1959), and extracellular CPAs such as starches, sucrose, etc. (Mazur 1981).  In 1969 
De Vries and Wohlschlag discovered ice blockers such as antifreeze glycoproteins in 
arctic fish that enabled fish to survive in freezing temperatures (DeVries and Wohlschlag 
1969). 
Intracellular CPAs suppress high salt concentrations and reduce cell shrinkage 
during preservation.  The ability to protect cells is not so much due to the CPAs 
individual chemical properties, but rather their colligative properties the solution has due 
to the presence of the CPAs (Lovelock and Bishop 1959).  As the water surrounding the 
cells or tissues freezes, intracellular water migrates out to freeze, causing high solute 
concentrations inside the cells, dehydration, and cell shrinkage.  DMSO and glycerol 
have low molecular weights such that at concentrations between 0.5 and 3 M and slow 
cooling rates they penetrate the cells (Brockbank, Covault et al. 2001).  These and other 
intracellular CPAs slow the migration of water and prevent intracellular ice formation.  
By replacing the intracellular water such that intracellular ice is minimized, cells are 
vitrified in ice-free channels of the frozen solution.  DMSO and glycerol are common 
intracellular CPAs and they are traditionally employed for the freezing down of cell 
stocks.  The negatively charged DMSO groups and hydroxyl groups in glycerol most 
likely form hydrogen bonds with water to prevent water from crystallizing (Muldrew and 
McGann 1998).  Other chemicals, such as formamide and acetamide, reduce the need to 
have high concentrations of CPAs; by reducing the amount of CPAs, the toxicity of the 
cryopreservation solution is reduced.  Amides in general are weak cryoprotectants, but 
when combined with CPAs, they improve cell viability (Fahy, Levy et al. 1987).  
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Known as extracellular CPAs, high molecular weight CPAs such as sugars and 
starches are used for preserving tissues and organs and protect the cell membranes 
without penetrating the cells (Brockbank, Covault et al. 2001).  The cell membrane is a 
delicate region of the cell and easily damaged by ice crystals.  Upon re-warming, the 
damaged membranes result in cell death.  The CPAs may also play a role in extracellular 
vitrification; where as, intracellular CPAs guide intracellular vitrification (Brockbank, 
Covault et al. 2001).  Mannitol in particular acts as an osmotic buffer raising the 
osmolality to balance against intracellular osmotic pressure (Pegg, Wusteman et al. 
2006).  Another way these extracellular CPAs protect the cells is through their many 
hydroxyl groups.  Through hydrogen bonding, these groups can draw out water from the 
cells, dehydrating them early in the sub freezing process (Muldrew and McGann 1998), 
while intracellular CPAs permeate across the membranes, thus protecting them from 
intracellular ice formation.  Combinations of intracellular and extracellular CPAs can 
result in additive or synergistic effects on cell viability upon re-warming of cryopreserved 
samples (Brockbank, Covault et al. 2001). 
Ice blockers such as antifreeze protein and glycoprotein have been found naturally 
in plants (Bravo and Griffith 2005), insects (Tomchaney, Morris et al. 1982), and fish 
(DeVries and Wohlschlag 1969), which allow them to survive subfreezing temperatures.  
These ice blockers, typically less than 30 kD, work by inhibiting natural ice formation.  
Water needs a nucleating agent (seed) in order to form the lattice structure characteristic 
of ice.  Ice blockers either direct the plane the ice forms along the c-axis or a-axis or by 
directly bonding to the nucleating agent halting crystal growth (Muldrew and McGann 
1998; Zachariassen and Kristiansen 2000).  Synthetic antifreeze compounds such as 
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ethylene glycol and polyvinyl alcohol can prevent ice crystals from forming by 
interfering in the lattice array binding to the nucleating agent, similar to antifreeze 
proteins.  The use of ice blockers can reduce the need to have high concentrations of 
CPAs, reducing toxicity of the cryoprotectant solution (Fahy, Levy et al. 1987). 
 Table 2.1 lists many of the common cryoprotectants used in cryopreservation of 
cells, tissues, and organs. 
 
 
Table 2.1. Chemicals used for cryopreservation 
Chemical Type 
Antifreeze proteins and glycoproteins Natural ice blockers 
Ethylene glycol Synthetic ice blocker 
Polyvinyl alcohol Synthetic ice blocker 
1,2-propanediol Intracellular CPA/ice blocker 
Dimethyl sulfoxide Intracellular CPA 
Formamide Intracellular CPA 
Glycerol Intracellular CPA 
Sucrose Extracellular CPA 
Lactose Extracellular CPA 
D-mannitol Extracellular CPA 
 
 
 
CPAs in general are viscous and as temperature drops or their concentration 
increases, the CPAs solution become more viscous.  This increase in viscosity affects the 
penetration rate through tissues and organs.  The time needed for the CPAs to equilibrate 
with the tissues plays a role in cell viability.  Carsi et al. calculated that the diffusivity 
coefficients of 10% DMSO and 10% glycerol are 0.61x10-9 m2/s and 0.77x10-9 m2/s, 
respectively, for the penetration into human articular cartilage at 4ºC (Carsi, Lopez-
Lacomba et al. 2004).  This observation means that equilibration (full penetration) with 
the CPAs for a 2 mm thick sample would take approximately 20 to 30 minutes, which 
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may be too long of an exposure to the cytotoxic CPAs.  Relying on diffusive flux alone 
may not be enough to fully penetrate the tissues, instead applying convective flow may 
better permeate and reduce the total exposure time to CPAs before and after storage.  
Many of the CPAs are cytotoxic at concentrations often needed for preservation.  
Introducing or eluting the CPAs at temperatures where metabolic activity has slowed or 
halted can minimize the lethality of the solutions to the cells.  Often this is done by 
introducing or removing the CPAs at 4ºC.  CPAs are also introduced or eluted gradually 
to tissues and organs to prevent dehydration and maintain osmotic balance between the 
cells and environment.  Seen schematically in Figure 2.8, the CPAs are added initially at 
a low dosage and increased gradually in discrete steps before fully exposing cells to the 
full-strength mixture during the cooling stage (before storage).  Similarly, when the CPAs 
are removed during the warming stage (after storage), the dosage is decreased gradually 
in discrete steps from its full-strength mixture. 
 
 
Figure 2.8.  Step-wise introduction and elution of CPAs.  CPAs are gradually added in 
discrete steps before cooling down and removed after warming up to maintain 
equilibrium between the cells and tissues and the surrounding cryoprotectant solution. 
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2.4.2 Cooling and Re-warming 
There are two main approaches to cryopreservation for cells, tissues, and organs.  
Traditional cryopreservation by freezing techniques, which require the substitution of up 
to 30% of cell water by a cryoprotective compound (usually DMSO), permits the storage 
of many types of cells in vitrified channels within ice at deep subzero temperatures 
(typically lower than -80°C) (Brockbank, Covault et al. 2001).  Traditional freezing relies 
on slow cooling and re-warming rates.  In contrast, vitrification is the use of high 
concentrations of CPAs, resulting in greater than 50% replacement of water in the cell, 
combined with fast freezing and re-warming rates, thus avoiding both intracellular and 
extracellular ice formation.   
Vitrification, the amorphous solidification of a super-cooled liquid, can be achieved 
by adjusting the solute composition and the cooling rate such that nucleation and growth of 
ice crystals is prevented (i.e. fast cooling and warming rates).  This method minimizes or 
prevents formation of ice within the tissues, creating a “glass”, while still halting 
metabolic activity and maintaining osmotic balance between the cells and environment.  
The major limitation of vitrification, however, is the potential cytotoxicity of the high 
concentrations of CPAs (Brockbank, Covault et al. 2001).  Seen in Figure 2.9 is a sample 
of a vitrified compound compared to a traditionally frozen compound.   
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Figure 2.9.  Vitrification versus traditional freezing.  The sample on the left has been 
vitrified with a glass-like appearance, while the sample on the right has been frozen and 
thus has a white appearance due to ice crystals (Nawroth, Rahimi et al. 2005). 
 
 
 
Cells are composed of up to 85% water and as water freezes cells react.  At room 
temperature or above water is free-flowing.  Metabolic activity is normal and cells 
maintain an osmotic balance between themselves and surrounding environment.  At 4ºC 
water is at its most dense and metabolic activity begins to decrease.  Metabolically-driven 
pumps have slowed or are inactivated due to the low temperatures; and so, the balance 
between the intercellular and extracellular environment is regulated mainly by physical 
means.  As temperature is lowered to 0ºC, extracellular water turns to ice given a 
nucleating agent, expanding and concentrating solutes.  As the concentration of 
extracellular solutes increase, intracellular water migrates out via osmosis to maintain 
osmotic balance, resulting in cell shrinkage.  However, CPAs that permeate cell 
membranes can adjust the ionic imbalances by substituting for water and non-permeating 
CPAs (extracellular CPAs) can raise the osmolality to balance against the intracellular 
osmotic pressure (Pegg, Wusteman et al. 2006).  However, Pegg et al. has found that 
chondrocytes in particular are resistant to osmotic stress (Pegg, Wang et al. 2006), and so 
the role of extracellular CPAs in preserving cartilage may in fact be minimal. 
FrozenVitrified
 41
A phase diagram shown in Figure 2.10 describes the pathway water takes as a 
sample is either vitrified (red curve) or traditionally frozen (blue curve).  With traditional 
freezing, water changes phase from liquid to solid ice as it passes the melting temperature 
(Tm).  If the fluid is pure, then phase transition does not occur until it is supercooled and 
passes its temperature of homogenous nucleation (Th).  Nucleation is the seeding agent 
(ions, salt, etc.) required for ice crystals to form and expand.  If the region of nucleation 
can be avoided as in fast cooling or high concentration of CPAs, then the phase transition 
from liquid to ice is avoided.  This occurs during vitrification where the liquid water 
reaches its glass transition temperature (Tg) and changes to an amorphous solid instead of 
ice.  Vitrification is achieved when the viscosity of the fluid is so high (~1015 P) that 
molecular movement has ceased (Brockbank, Covault et al. 2001).  The glass transition 
stage is associated with sudden changes in density, which results in high mechanical 
stresses.  This can result in cracking and eventually ice formation.  This devitrification 
problem is avoided by maintaining the sample at or right below the glass transition 
temperature (Brockbank, Covault et al. 2001).  Once vitrified, the storage temperature 
plays a role to prevent crystallization.  As water turns to ice, an exothermic reaction, 
causing a localized rise in temperature (latent heat of fusion), can start a chain reaction of 
ice formation.  By keeping the storage temperature below –90ºC, this can be avoided 
(Muldrew and McGann 1998).  The glass transition temperature for water is generally 
accepted at –135ºC (Angell 2002), and storage at -150ºC in a mechanical freezer provides 
adequate storage without a severe risk of devitrification.  Not only does the rate of 
cooling affect ice crystallization, but the rate of re-warming as well.  Generally, fast 
cooling requires fast warming because seed crystals that formed during cooling process 
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can have a chance to re-crystallize and expand rapidly if warming is too slow, thus 
damaging the cells (Best 2006).    
 
 
Figure 2.10.  Phase diagram of ice formation during freezing.  The red curve describes 
the path of vitrification as fluid bypasses nucleation and thus remains “liquid” as 
temperature drops.  The blue curve describes traditional freezing as ice crystals form 
during the nucleation stage and water turns solid as temperature drops.  In heterogeneous 
nucleation the nucleating object can be any substance in the fluid mixture for the ice 
crystals to form, where as in homogeneous nucleation the object is water.  Figure adapted 
from Best (Best 2006).   
 
 
 
Guan et al. demonstrated the need for CPAs to preserve tissues.  They showed 
that 51% viability occurred when bovine cartilage was vitrified with CPAs and only 5% 
viability occurred when bovine cartilage was vitrified without CPAs.  The visual damage 
to cells was also much more pronounced in the cartilage subjected to vitrification without 
the CPAs (Guan, Urban et al. 2006).  In a study conducted by Song et al. on rabbit 
articular cartilage, vitrification (80.0% viability) proved significantly better than 
traditional freezing (12.8% viability), leading to the hypothesis that traditionally frozen 
cells could not move away from extracellular ice formation while confined in the tissue 
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as isolated cells can in frozen cell solutions (Song, Lightfoot et al. 2003).  The 
cryopreservation studies carried out show that many variables are responsible for 
affecting cell viability and that protocols for one tissue type does not necessarily apply 
for other tissue or even the same tissue type from different animals.  More studies are 
needed to measure the factors that affect cell viability of tissue-engineered cartilage to 
see vitrification as a viable method for long-term storage. 
 
2.5 Research Motivation 
 These studies show that there is a limited understanding in the direct role of 
mechanical forces on chondrogenesis.  The forces studied that affect cartilage construct 
development have thus far been limited to one-directional loading and one type of force 
(shear, perfusion, or compression).  A greater understanding of multiple forces in 
multiple directions, which occur in vivo, is needed to understand their role in 
mechanotransduction pathways and function in cartilage tissue engineering.  
Furthermore, the effect of chondrogenesis in vivo, supported by mechanically stimulated 
tissue-engineered cartilage constructs, has only recently been explored.  In the end, this 
knowledge can be applied to tailor bioreactor protocols that develop tissue-engineered 
cartilage with the biochemical and mechanical properties needed for implantation into 
cartilage defects.  To address this gap in understanding, this research project aims to 
identify multiple mechanical loading variables that influence chondrogenesis.  
Specifically, a perfusion concentric cylinder bioreactor that was developed in our lab and 
employs both perfusion and shear orthogonal to each other on scaffolds seeded with 
chondrocytes, was used to assess the role perfusion and shear had on chondrogenesis. 
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 While tissue-engineered cartilage has emerged as a possible treatment for 
cartilage defects, few studies have investigated long-term storage of engineered tissues.  
The investigation of long-term storage is an important field in tissue engineering.   To 
date, most cryopreservation studies have focused on native tissues and organs.  Recent 
studies have also shown that cryopreservation protocols for one type of tissue do not 
necessarily apply for other tissue types or even the same type from different animals.  
This research project hopes to address the need to investigate the effectiveness of 
cryopreservation protocols applicable for tissue-engineered cartilage.  Furthermore, the 
bioprocess scheme for tissue engineering involves multiple steps from cell sourcing to 
culture to preservation.  This research project hopes to simplify this scheme by testing the 
effectiveness of using a bioreactor to culture and then preserve tissue-engineered 
cartilage in a one-step process.   
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CHAPTER 3  
MATERIALS AND METHODS 
 
Unless stated otherwise chemicals were purchased from Sigma-Aldrich based in 
St. Louis, MO and supplies from VWR based in West Chester, PA.  The most common 
solutions used in these experiments were culture media and phosphate buffered saline 
with EDTA (PBE).  Culture media were comprised of Dulbecco’s Modified Eagle 
Medium (DMEM) (containing primarily 4.5 g/L of glucose and L-glutamine), 10% fetal 
bovine serum, nonessential amino acids (0.1 mM), proline (0.4 mM), 1% penicillin-
streptomycin, sodium bicarbonate (44 mM), HEPES buffer (10 mM), ascorbic acid 
(0.28 mM), and fungizone (0.5 g/mL) (Invitrogen, Carlsbad, CA) and pH to 7.2.  PBE 
was comprised of 120 mM sodium chloride, 2.7 mM potassium chloride, 10 mM 
phosphate buffer salts, and 1 mM EDTA and pH to 7.2. 
 
3.1 Scaffold Preparation 
Poly-l-lactic acid (PLLA) polymer scaffolds of 90% porosity were prepared by an 
organic solvent/salt leaching method previously described (Saini and Wick 2003).  PLLA 
crystals (0.5 g) (Polysciences, Inc., Warrington, PA) were dissolved in methylene 
chloride (5 mL) (Fisher Scientific, Pittsburgh, PA) overnight.  Sodium chloride crystals, 
106 - 150 m in diameter (4.5 g), were added to the dissolved PLLA and cast into a 5 cm 
Teflon Petri dish overnight to allow the solvent (which has a high evaporation rate) to 
completely evaporate leaving a PLLA-salt disk.  The salt crystals were then leached out 
by placing the scaffold into a beaker of deionized (DI) water for 48 hours, leaving a 90% 
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porous PLLA scaffold with pore sizes between 106 and 150 m in diameter.  A 10 mm 
biopsy punch was used to punch out polymer scaffolds used in the bioreactors.  Average 
thickness of the scaffolds was approximately 1.87 mm (Saini 2001).  Only scaffolds used 
in the CC bioreactors were affixed with a plastic shim (8 mm x 8 mm) by a silicone 
adhesive (CVS, Woonsocket, RI) on one side of the scaffold in order to adhere them to 
the CC inner bob.  All scaffolds were sterilized in triplicate washings 15 minutes each 
with 70% ethanol then triplicate washings 15 minutes each with sterile DI water.  
Scaffolds were dried and UV sterilized for 30 minutes and then affixed to the bioreactors 
before UV sterilized again for 30 minutes.  Finally, scaffolds were pre-wetted with 
culture media in the bioreactors for 48 hours prior to seeding to facilitate cell attachment.  
All experimental runs used PLLA scaffolds of the same dimension and volume. 
 
3.2 Knee Harvesting, Cartilage Digestion, and Cell Isolation 
Male calf knees (2-14 days old) were purchased from an abattoir (Research 87, 
Boylston, MA).  After slaughter the knees were shipped overnight on ice to Georgia 
Institute of Technology.  The knee joints were cleaned of muscle, fat, etc. to expose the 
articular cartilage.  Articular cartilage slices were harvested aseptically from the femoral-
patellar groove and femoral condyles and placed in PBE in sterile Petri dishes (Freed, 
Marquis et al. 1993; Freed, Vunjak-Novakovic et al. 1993).  The slices were then cut into 
2 - 3 mm3 cubes in media.  The cartilage chunks were spooned into a series of 50 mL 
centrifuge tubes (approximately 3 g per tube) containing approximately 30 mL per tube 
of collagenase enzyme solution (1.5 mg/mL of collagenase type II (activity >200 U/mg; 
Worthington, Lakewood, NJ) in media).  The tubes were then wrapped in parafilm and 
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placed on an orbital shaker at 100 rpm.  The enzyme solution cleaved the extracellular 
collagen matrix in the cartilage chunks overnight (16 - 18 hours) at 37ºC/5% CO2 to 
isolate the cells.  Longer digestions would compromise cell viability.  Afterwards, 
undigested chunks were removed from the tubes leaving only digested cartilage in 
collagenase.  The cells were spun down in a centrifuge at 600 rpm (70 gc) for 12 minutes.  
The supernatant was aspirated and the cells were then washed three times in PBE, 
spinning down cells between each wash and combining them to completely remove the 
collagenase and reduce the number of tubes.  Repeated pipetting using 10 mL and 5 mL 
pipettes broke up the pellets.  The chondrocytes were then resuspended in approximately 
50 mL of media and counted either with a hemacytometer or Vi-Cell Analyzer.  Both 
methods used the trypan blue exclusion method to assess cell concentration and cell 
viability, where dead cells took up trypan blue.  Approximately 200x106 to 400x106 cells 
was isolated from one knee joint with variations due to the animal source.  Cells were 
then seeded in the bioreactors at a specified concentration for each system.  No more than 
60 hours passed from the time of slaughter to the seeding of the bioreactors. 
 
3.3 Bioreactor Design and Development 
3.3.1 Concentric Cylinder Bioreactor 
The CC bioreactor (Figure 3.1) was previously developed and characterized in our 
lab and modeled after a cone and plate viscometer (Williams, Saini et al. 2002; Saini and 
Wick 2003).  It consisted of an immobile polypropylene inner bob (Professional Plastics, 
Austin, TX) with scaffolds affixed via silicone adhesives.  The 16 scaffolds were 
arranged in two rows near the bottom of the bob in a staggered array to promote nutrient 
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transport and efficient seeding.  The inner bob was placed in an outer Pyrex glass cup 
manufactured by Wilmad-Glass, Buena, NJ.  The inside of the glass cup had rounded 
corners to reduce stagnation regions during rotation.  The gap between the inner and 
outer cup was 3 mm and filled with 62 mL of culture media, which covered the scaffolds.  
The cylinders were covered with a polypropylene cap to prevent contamination and the 
entire system was placed in a rotating polypropylene base, which was connected to a 
motor that was mounted on a structural steel support base located inside an incubator.  
The top of the inner bob was attached to a support bar that was also mounted with screws 
to the steel base to keep the inner bob immobile as the outer cup rotated.  The motor was 
connected to a control box containing a speed dial, on/off switch, and timer.  The outer 
cup could rotate at variable speeds.  For this research project the outer cup was chosen to 
rotate at a constant speed of 38 rpm based on Dr. Saini’s research into the optimum 
growth of engineered cartilage in the CC bioreactor (Saini 2001).  At 38 rpm, a 
homogeneous laminar flow regime within the gap developed, and changing direction 
every twelve hours (using the timer) maintained similar shear stress on both sides of the 
constructs.  Numerical simulations have verified that 95% of the construct surface 
experienced uniform hydrodynamic loading with the average surface shear stress exerted 
on the constructs at 1.2 dynes/cm2 (Williams, Saini et al. 2002).  
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Figure 3.1.  Schematic of the concentric cylinder bioreactor (Saini 2001).  The CC 
bioreactor consisted of a stationary inner bob with affixed scaffolds arranged in a 
staggered array placed inside a glass cup.  The gap between the inner bob and outer cup 
was 3 mm.  Not drawn to scale. 
 
 
3.3.2 Perfusion Concentric Cylinder Bioreactor 
The PCC bioreactor (Figure 3.2) was developed in our lab to include fluid 
perfusion orthogonal to the surface shear created by the outer cup rotation. 
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Figure 3.2.  Schematic of the perfusion concentric cylinder bioreactor. The PCC 
bioreactor consisted of a stationary inner bob with 16 spokes (arranged in two rows), 
which contained embedded constructs radiating from a central hub.  The gap between the 
construct holders and outer cup was 0.14 mm.  The peristaltic pump flowed media from 
the outer cup region to the interior of the central hub to exit radially through the spokes at 
an average set flow rate of 0.6 mL/min/construct.  Inset represents a close-up of construct 
arm.  The diagram is not strictly to scale, but the dimensions are correct. 
 
The clear polycarbonate or acrylic (McMaster Carr, Atlanta, GA) inner bob was 
redesigned from the CC bioreactor inner bob design to include 16 cylindrical spokes 
(2 cm in length at 0.66 cm in diameter before increasing in diameter to 1 cm for 0.4 cm) 
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arranged in two rows radiating from a central hub (5.08 cm in diameter).  Like the CC 
bioreactor, the inner bob was placed in an outer cup and covered with a cap.  The system 
was then mounted on a rotating base and structural steel support base located in the 
incubator.  The bioreactors were machined by Mr. Andrews of the Georgia Tech Machine 
Shop or by the Machine Services Department. 
Scaffolds 1 cm in diameter and approximately 1.87 mm in thickness were 
embedded 0.4 cm into these construct arms (cylindrical spokes) leaving an open cavity 
approximately 0.213 cm in height and 1 cm in diameter to surround and affix the 
embedded scaffolds.  Because the diameter of the construct arms and scaffolds were both 
1 cm, a tight fit was ensured, which prevented fluid perfusion around the scaffolds during 
bioreactor operation.  Figure 3.3A showed a red dye solution permeating as it flowed 
through and stained a wet scaffold.  (Note the necessity of pre-wetted scaffolds as fluid 
tried to flow around a dry hydrophobic scaffold, or the path of least resistance in 
Figure 3.3B.)   
 
    
Figure 3.3.  Visualization of fluid flow through a scaffold embedded in a construct arm.  
(A) Wet scaffold; (B) dry scaffold 
 
 
A B
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The clear polycarbonate or acrylic inner bob allowed us to monitor the pressure 
gradient (between the interior and exterior of the central hub) and fluid regime inside the 
central hub.  Fluid perfusion was introduced via a peristaltic pump (Cole-Parmer 
Instrument, Vernon Hills, IL) using size #16 tubing (Cole-Parmer) though the central hub 
and then exited radially through the arms at an average flow rate, Q, of 
0.6 mL/min/construct.  Fluid was then pumped out from the region between the cylinders 
at the same rate it was pumped into the central hub.  By maintaining a closed loop, fluid 
was continuously pumped into and out of the bioreactor at the same flow rate.  A constant 
flow rate of 0.6 mL/min/construct was maintained by calibrating the pump to flow at a 
multiple of the number of constructs in the bioreactor at the time.  For example, when 16 
constructs were in the bioreactor, the central pump flowed fluid at 10 mL/min; however, 
when 4 constructs remained, the central pump flowed fluid at 2.5 mL/min with silicone-
coated aluminum plugs inserted in vacated arms to prevent fluid flow through the arms 
not containing a tissue construct.  Table 3.1 shows the flow rate into the central hub 
versus the number of constructs in the PCC bioreactor.   
 
Table 3.1.  Fluid flow rate in PCC bioreactor.  Flow through the central hub as a function 
of the number of constructs in the PCC bioreactor. 
 
Constructs in PCC 
bioreactor 
Flow rate into central 
hub (mL/min) 
Flow rate per construct 
(mL/min/construct) 
16 10 0.6 
13 8.1 0.6 
10 6.3 0.6 
7 4.4 0.6 
4 2.5 0.6 
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The Reynolds number, determining laminar or turbulent flow, for flow through a 
tube was: 
 

 DVmRe             Equation 3.1 
where, 
2)2/(D
QVm                       Equation 3.2 
 
For culture media, the density, , was approximated to the density of water (0.99 g/cm3) 
and the viscosity, , was 0.695 cP at 37ºC.  The porosity, , was 0.9 for flow through the 
scaffolds and 1 for flow through the arms.  The mean velocity, Vm, of fluid through the 
cylindrical arms (diameter, D, was 0.66 cm) and at a flow rate of 0.6 mL/min was 
0.03 cm/s.  Therefore, the Reynolds number for flow through the arms was 3, and was 
much lower than the stability criteria for steady flow (NRe < 2000).  The dimensions of 
the cylindrical arms ensured that parabolic flow was fully developed before perfusing 
through the scaffolds, assuming inlet velocity was uniform.  That is, the entrance length, 
LV, (LV = (D/2)*(1.18+0.112*Re)) (Atkinson, Brocklebank et al. 1969) required for a 
fully developed flow was 0.5 cm, which was less than the length of the construct arms 
(2.4 cm).  Assuming cylindrical pores with a diameter, d, between 106 and 150 m and 
uniform flow distribution across the scaffold surface, with parabolic flow through the 
pores, the Reynolds number and the shear stress at the wall inside the scaffolds was 
calculated (Goldstein, Juarez et al. 2001):  
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07.001.0Re  
 dVm           Equation 3.1 
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w                 Equation 3.3 
   
To determine if fluid flowed evenly through the construct arms, a red dye was 
pumped into the bioreactor system to observe its distribution throughout (Figure 3.4).  
Without constructs, fluid flowed through the PCC bioreactor construct arms.  Figure 3.4A 
(top view) shows a snapshot of red dye flowing evenly through the radial spokes as fluid 
was pumped into the central hub.  The dye distributed evenly initially through the bottom 
row of 8 construct arms before radiating evenly through the top row (Figure 3.4B).  This 
demonstrated that pressure gradients greatly affected the flow rate through the extruding 
construct arms.   
Using the inner bob of the PCC bioreactor, the flow rate at various pressure 
gradients was measured through PLLA scaffolds to calculate the relative difference of 
volumetric flow rate between the top and bottom rows of the construct holders.  The 
pressure gradient, P, between the two rows was less than 0.25% however flow rate 
varied by 69% (See Figure 3.5).  At an average rate of 0.6 mL/min/construct with a 69% 
change between the top and bottom row determined that the top row experienced 
0.19 mL/min/construct and the bottom row 1.01 mL/min/construct.  Despite these 
observations the PCC bioreactor was run as if the average flow rate through the construct 
holders was held constant at the assumed rate of 0.6 mL/min/construct to simplify 
velocity and shear stress calculations. 
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Figure 3.4.  Fluid flow distribution through the construct arms of a PCC bioreactor. 
(A) Top view; (B) side view 
 
 
A
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Figure 3.5.  Pressure gradient as a function of flow rate between the two rows of a PCC 
bioreactor. 
 
 
 
The gap between the edge of the construct arms and outer cup (10.16 cm 
diameter) was 0.14 mm and the bioreactor was filled with 350 mL of culture media 
during the seeding period (4 days) and 400 mL of culture media during the rest of the 
bioreactor run.  The radius ratio, K, defined for this system as the radius of the inner 
bob’s central hub (Ri) divided by the outer cup radius (Ro), was 0.5 for this bioreactor.  
However, the radius of the inner bob’s central hub plus the length of the cylindrical arms 
was 4.94 cm, which gave a radius ratio of 0.972 for this bioreactor.  Values close to 1 
ensure stability in flow and constant shear stress at the edge of the construct arms before 
flowing into the open cavity containing the scaffolds.  Like the CC bioreactor, the outer 
cup rotated at a constant speed, , of 38 rpm, changing direction every twelve hours via a 
timer.  The Reynolds number between annulus of the two concentric cylinders was based 
on the rotation rate and radius: 
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
2Re R             Equation 3.4 
 
The Reynolds number for this rotation rate and outer cup radius was 3660 near the wall 
of the central hub and increased to 14600 near the wall of the outer cup, well below the 
stability criteria for steady flow (NRe < 50000) (Saini 2001).  Based on the Navier-Stokes 
equation, the fluid velocity exposed to the construct arms before entering the open cavity 
was calculated; assuming that the region between the inner bob and outer cup mimicked 
two concentric cylinders and that there was no slippage at the walls (Bird, Stewart et al. 
2002):  
 
scm
r
R
R
r
K
R
v i
i
i /28.19
1 2



 
         Equation 3.5   
 
A more detailed derivation is shown in Appendix A.  For comparison, the velocity where 
the constructs were located in the CC bioreactor was 12.74 cm/s.  The velocity profile 
between the two cylinders can be seen in Figure 3.6 for both the PCC and CC bioreactor.  
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Figure 3.6.  Velocity profile within the bioreactor.  The velocity profiles between the two 
cylinders were represented for both the PCC and CC bioreactor as the outer cup rotated at 
38 rpm.  The gap between the cylinders in the CC bioreactor was smaller and thus 
showed a steeper increase in speed from the immobile inner cylinder bob to the rotating 
outer cup. 
 
 
 
 The oxygen concentration profile within the construct of the PCC bioreactor was 
based on the species continuity equation (Bird, Stewart et al. 2002) for oxygen with 
constant density and diffusivity of oxygen, DO2, in media or TE cartilage: 
 
22
2
22
2
OOOO
O RCDC
t
C 
 v                     Equation 3.6 
where, 
CO2 is the concentration of oxygen, 
v is the velocity through the constructs, 
and RO2 is the reaction rate describing the consumption of oxygen by cells. 
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The diffusivity of oxygen in water was estimated from the Wilke-Change correlation (see 
Appendix A) at 3.23x10-9 m2/s at 37ºC and the diffusivity of oxygen in tissue was 
determined from literature at 2.0x10-9 m2/s (Macpherson, O'Hare et al. 1997).  The 
consumption of oxygen by cells was assumed to be fixed at a rate of 
0.5 mol O2/106 cells/hr, which was based on the metabolic rates for mammalian cells 
(Cartwright 1994).  This correlated to a zeroth-order reaction (Williams, Saini et al. 2002) 
where for an average of 106 cells per construct and a construct volume of 147 mm3 the 
reaction rate was 9.46x10-4 mol O2/m3/s.  The time for oxygen to reach steady-state 
equilibrium with the gas phase in the incubator was calculated from Equation 3.6.  
However, given the long culture time, media were assumed to be saturated with oxygen 
and at equilibrium with the gas phase environment in the incubator, which was at 
20% O2, 5% CO2 and 75% N2 at 37ºC, for the calculation of the steady-state oxygen 
profile through the constructs.  The equilibrium concentration of oxygen in media was 
therefore 0.212 mol/m3, which was based on Henry’s Law (see Appendix A) and seen as 
a boundary condition for Equation 3.6.   
The Peclet number describes the ratio between the convective and diffusive flux 
through a construct of thickness L (1.87 mm): 
   
2O
m
D
LVPe              Equation 3.7 
 
The Peclet number was 316 for perfusion through a construct in the PCC bioreactor, 
assuming the diffusivity through the construct was the same order of magnitude as the 
diffusivity of oxygen through tissue.  The value indicated that convective flux dominated 
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and the diffusivity term in Equation 3.6 could be neglected.  If there was no convective 
flow in the PCC bioreactor (i.e. when there was no perfusion) then diffusivity dominated.  
Taken together the steady-state oxygen profile through the construct was calculated for 
the entire culture period.   
 
3.3.2.1 Computational Methods 
The open cavity of the construct arms after placement of the scaffolds affected the 
velocity profile and consequently the shear stress experienced on the constructs.  The 
fluid flow profile hence was altered and Equation 3.5 was not an accurate assessment for 
the velocity experienced on the surface of the constructs.  To compensate and determine 
the shear stress profile a CFD code in FORTRAN provided by Dr. Nenes was used to 
solve the Navier-Stokes equations for momentum (Nenes 2003):  
 
0 v             Equation 3.8 
 
vvvv 21 



 pt          Equation 3.9 
 
The three-dimensional cylindrical cavity was transposed and solved as a discrete two-
dimensional rectangular cavity over the surface of the scaffold’s diameter 
(0.00213 m x 0.01 m) with a “moving lid” at a speed of 0.1928 m/s (see Figure 3.7).  The 
assumptions made include an incompressible, Newtonian fluid flow at steady state with 
no-slip boundary conditions at the “moving lid” and surface of the scaffold.  Because of 
the symmetry and even spacing of the construct arms, the profile generated in one cavity 
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applied to all construct arms.  The Navier-Stokes equations were solved numerically 
using a finite volume discretization formulation with a rectangular grid with 2304 cells.  
The spreadsheets generated of the velocity profile in the x and y direction allowed us to 
calculate the shear stress over the scaffold’s surface numerically using Newton’s law of 
viscosity: 
  
v              Equation 3.10   
where shear stress was approximated as: 
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Both the velocity and shear stress in the open cavity over the surface of the constructs 
along the diameter were then plotted as a contour map to determine the velocity and shear 
stress experienced on the surface of the constructs’ diameter in the PCC bioreactor. 
 
 
Figure 3.7.  Diagram of the transposed two-dimensional open cavity model used for CFD 
modeling over the surface of the scaffold along its diameter. 
 62
3.3.3 Static Bioreactor 
The static bioreactors were sterile 6-well polystyrene dishes (low cell binding-
treated).  One scaffold was placed in each well and filled with 5 mL of culture media.  
The plates were placed in the incubator at 37ºC/5% CO2 on an orbital shaker at 
approximately 50 rpm. 
 
3.4 Bioreactor Sterilization and Assembly 
The outer glass cups, the inner bobs of the PCC and CC bioreactor, and the 
aluminum plugs used for the PCC bioreactors were coated with Sigmacoat.  Sigmacoat 
provided a microscopically thin layer of silicone on the surface of the bioreactor parts to 
repel water and prevent cell attachment.  Because the silicone was suspended in heptane, 
the bioreactor parts were allowed to dry for 48 hours under a fume hood before washed, 
wrapped in absorbent paper towels, and placed in sterilization bags.  The outer glass 
cups, the inner bobs for the CC bioreactors, bioreactor caps, plugs, and tubing for the 
PCC bioreactors were steam sterilized at 121ºC/2.2 atm for 20 minutes.  The inner bob of 
the PCC bioreactor, composed of either acrylic or clear polycarbonate, could not be 
steam sterilized because of the risk of warping at high temperatures.  Therefore, the inner 
bobs of the PCC bioreactors were washed in triplicates for 15 minutes each with 70% 
ethanol and then in triplicates for 15 minutes each with sterile DI water, where the inner 
bobs were placed in sterile 1000 mL beakers to facilitate the washing.  Finally, the inner 
bobs were UV sterilized for 30 minutes.  After sterilization all bioreactor pieces for both 
types of bioreactors were assembled under sterile conditions in a laminar flow hood.  
Scaffolds were then affixed to the inner bobs and UV sterilized again for 30 minutes.  
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Silicone adhesives were used to affix the scaffolds with plastic shims to the inner bobs of 
the CC bioreactors in a staggered array (see Figure 3.1) and allowed to dry for 
approximately 6 hours.  Scaffolds were affixed via tension inside the construct arms of 
the PCC bioreactors (see Figure 3.2).  The outer cups were filled with culture media and 
the bioreactors were mounted in the incubator for 48 hours prior to seeding to pre-wet the 
scaffolds.   
After experiencing contamination involving the PCC bioreactor, the sterilization 
method of the PCC bioreactor changed to ethylene oxide (EtO) sterilization.  This method 
provided a safer alternative for the heat sensitive components of the PCC bioreactors.  
The inner bobs of the PCC bioreactors were exposed to EtO, which is a colorless and 
odorless gas that kills bacteria, mold, and fungi without the need for heat.  Afterwards, 
the inner bobs of the PCC bioreactors were soaked in sterile DI water for 15 minutes to 
remove any lingering traces of the toxic gas and UV sterilized for 30 minutes before 
assembly as mentioned earlier. 
 
3.5 Bioreactor Runs 
3.5.1 Concentric Cylinder Bioreactor 
The experimental runs involving the CC bioreactor lasted 28 days.  On Day 0 
100x106 to 150x106 cells were suspended in media and placed inside the outer cup for a 
total volume of 62 mL of media.  The CC bioreactor was then mounted inside the 
incubator (37ºC/5% CO2).  Under hydrodynamic forces, cells attached to the scaffolds.  
After two days, 50% of the culture media were replaced with fresh media.  On Day 4 of 
the run, 100% of the culture media were replaced, which completed the seeding period.  
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Fresh ascorbic acid (0.28 mM) was added as well.  Subsequently, every two days 80% of 
the media were replaced and every four days ascorbic acid was added to the culture 
media until the completion of the experimental runs at Day 28.  Media samples (three 
1 mL samples) were taken from the spent media that were replaced every four days 
(Day 4, 8, 12, 16, 20, 24, and 28) and stored at –20ºC in Eppendorf tubes for soluble 
GAG analysis.  The pH of the bioreactor was also monitored.  After feeding, 
approximately 30 mL of spent media along with approximately 30 mL of fresh media 
were stored in the incubator overnight.  The next day the pH of spent media was 
measured and compared to the control.  Any significant drop in pH would indicate 
possible contamination, which was verified microscopically or with gram staining.  
Constructs were harvested in triplicates on Day 4, 7, 14, and 21 and the final four 
constructs were harvested on Day 28.  All feedings and construct harvestings were 
handled under sterile conditions in a laminar flow hood.  Under the hood the inner bob 
was removed from the outer cup and placed on a sterile Petri dish.  With sterile tweezers 
the constructs were removed from the inner bob and washed in PBE.  The culture media 
in the outer cup were replaced on feeding days.  The inner bob was then placed back 
inside the outer cup and the system was placed back inside the incubator. 
 
3.5.2. Perfusion Concentric Cylinder Bioreactor 
 The experimental runs involving the PCC bioreactors lasted 6, 7, or 28 days.  On 
Day 0 100x106 to 150x106 cells were suspended in media and placed inside the outer cup 
for a total volume of 350 mL of media.  After the PCC bioreactor was mounted in the 
incubator, no perfusion through the constructs occurred for four days.  Instead, the only 
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hydrodynamic loading during the seeding stage was due to the outer cup rotation, which 
caused fluid-induced shear on the surface of the constructs.  During the seeding period 
cells attached to the polymer scaffolds.  After four days all the media were removed to 
halt the seeding process and replaced with 400 mL of fresh media and 0.28 mM of 
ascorbic acid.  Except for the shear only conditions in the PCC bioreactor, perfusion of 
culture media through the constructs also started on Day 4.  The shear only studies had no 
perfusion during the course of the experimental run.  All of the culture media were 
replaced every four days; however, some media in the tubing and inside the central hub, 
which amounted to approximately 1% of the total volume, were not removed due to risk 
of contamination.  Like the CC bioreactor, media samples were taken from the spent 
media that were replaced every four days and stored at –20ºC in Eppendorf tubes for 
soluble GAG analysis.  The pH of the bioreactor was also monitored in the same way as 
the CC bioreactor.  Experimental runs continued for 6, 7, or 28 days depending on the 
study.  All feedings occurred under sterile conditions in a laminar flow hood and treated 
in a manner similar to the CC bioreactor mentioned above.  On month-long experimental 
runs constructs were harvested in triplicates on Day 4, 7, 14, and 21 and four were 
harvested on Day 28.  For cryopreservation studies, all 16 constructs were harvested the 
day the cryopreservation experiments started (Day 6, 7, 14, or 28).  All constructs were 
harvested under the hood using sterile tweezers to twist the constructs out from the 
construct arms and washed in PBE.  Sterile silicone-coated plugs were placed inside the 
vacated arms to retard fluid flow through them before placing the inner bob back inside 
the outer cup and the system back inside the incubator to continue the experimental run.    
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3.5.3 Static Bioreactor 
 Cells were suspended at a density of 9.38x106 cells per 5 mL of culture media and 
added to a scaffold located in a well of a 6-well plate dish on Day 0.  A total of 16 
scaffolds were used in a static bioreactor and thus a total of 150x106 cells were seeded to 
the scaffolds.  Culture media were changed completely every two days and ascorbic acid 
(0.28 mM) was added to the culture media every four days until the completion of the 
experimental run (28 days total).  Media samples and the pH of the spent media were 
taken in the similar manner as the PCC and CC bioreactor mentioned above.  Constructs 
were harvested and washed in PBE in triplicates on Day 4, 7, 14, and 21 and four 
constructs were harvested and washed on Day 28.  All feedings and construct harvestings 
occurred under sterile conditions in a laminar flow hood, where media were aspirated out 
of each well and 5 mL of fresh media were added on feeding days, and where sterile 
tweezers were used to remove the constructs on harvesting days. 
     
3.6 Tissue-Engineered Cartilage Construct (TECC) Growth Studies 
 Different studies were performed to characterize the growth of TECCs in the PCC 
bioreactor and to optimize the viability of cryopreserved TECCs.  The studies can be 
divided into four main groups.  The PCC validation studies included biochemical, 
histological, and viability analysis of constructs cultured in the PCC bioreactor over the 
course of 28 days after seeded with 150x106 cells.  Velocity, shear stress, and oxygen 
transport profiles were also calculated for constructs in the PCC bioreactor.  The PCC 
versus CC studies consisted of one PCC bioreactor and one CC bioreactor seeded with 
100x106 to 150x106 cells with chondrocytes from the same animal source.  Over the 
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course of 28 days, the constructs were analyzed for biochemical composition, 
biochemical distribution, gene expression, and cell viability.  The perfusion+shear versus 
shear studies consisted of two PCC bioreactors seeded with 100x106 to 150x106 cells 
with chondrocytes from the same animal source.  After four days, one PCC bioreactor 
exposed constructs to both perfusion and shear (perfusion+shear bioreactor), while the 
other PCC bioreactor exposed construct to shear only forces (shear bioreactor).  Over the 
course of 28 days, the constructs were analyzed for biochemical composition, 
biochemical distribution, mechanical properties, and cell viability.  With regards to the 
animal studies, a static bioreactor was included in the perfusion+shear versus shear 
comparison.  The cryopreservation studies had seven experiments, which can be seen in 
detail in Table 3.2.  Constructs were cultured in the PCC bioreactor with 150x106 cells 
and after 6, 7, 14, or 28 days were harvested for the cryopreservation study.  Each 
experiment divided the constructs into two treatment groups, one of which served as the 
control.  Constructs were analyzed for cell viability and cellular content after each 
treatment.  The experimental studies are outlined in Table 3.2.   
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Table 3.2.  Lists of experiments 
Experiment Name Bioreactors Culture Time Number of Experiments
PCC Validation 
CFD Modeling and Oxygen 
Transport Calculation PCC N/A 1 
Biochemical Analysis PCC 28 days 1 
Live/Dead PCC 28 days 1 
Histological PCC 28 days 1 
PCC vs. CC Comparison 
Biochemical Analysis PCC, CC 28 days 2 
Live/Dead PCC, CC 28 days 1 
Histology PCC, CC 28 days 1 
Gene Expression PCC, CC 28 days 2 
Perfusion+Shear vs. Shear Comparison 
Biochemical Analysis PCC 28 days 2 
Live/Dead PCC 28 days 1 
Histology PCC 28 days 1 
Mechanical Testing PCC 28 days 1 
Animal Study PCC, Static 28 days post implantation 1 
Cryopreservation Optimization 
Frozen vs. VS55 6/7 PCC 7 days 1 
VS55 6/7 vs. VS83 6/7 PCC 6 days 1 
VS55 6/7 vs. VS70 6/7 PCC 6, 7, 14 or 28 days 5 
VS55 6/7 vs. VS70 6/7 no 
vitrification PCC 7 days 4 
VS55 vs. VS70 on native tissue PCC N/A 1 
VS70 6/7 vs. VS70 4/4 PCC 6 or 7 days 4 
Orbital Shaker vs. PCC 
Bioreactor PCC 7 days 3 
 
 
3.7 Animal Surgeries 
 TECCs were cultured under three types of mechanical stimulation: perfusion and 
shear (in the PCC bioreactor), shear (in the PCC bioreactor), and no mechanical 
stimulation (static bioreactor).  After 28 days the TECCs were harvested and washed in 
PBE.  A 3 mm biopsy was punched out of the center of each construct and implanted into 
a xiphoid chondral defect in a rat model.   
 69
All procedures involving the rat model were performed under the Georgia Tech 
Institutional Animal Care and Use Committee (IACUC) guidelines.  All animal surgeries 
and euthanasia were performed in the Physiological Research Laboratory at Georgia 
Institute of Technology.  The animals used were 5 weeks old athymic nude male rats and 
purchased from Harlan Sprague Dawley, Inc., Indianapolis, IN.  The rats had a reduced 
immune system to prevent rejection of the bovine implants.  A total of 30 rats were used, 
divided evenly into six groups.  Each group was treated according to the Table 3.3.   
 
Table 3.3. Animal study groups 
Group Xiphoid Treatment 
Group A Xiphoid defect only 
Group B PLLA scaffold, no cells 
Group C TECC from static bioreactor 
Group D TECC from perfusion+shear (in the PCC bioreactor) 
Group E TECC from shear (in the PCC bioreactor) 
Group F 5x106 cells with no PLLA scaffold 
 
 
 
The rats were anesthetized with inhalation of 5% isoflurane and maintained with 2 - 3% 
isoflurane while undergoing the surgery.  Their skin covering the xiphoid region was 
cleaned and sterilely prepared for surgery.  A standard parasagittal incision and sharp 
dissection was made left of the xiphoid region such that the integrity of the ribs was not 
violated.  The xiphoid cartilage (located at the base of the sternum) was exposed.  A 
cartilage defect was created in the center of the xiphoid of the rats by using a biopsy 
punch out to create a 3 mm circular hole.  The TECCs, PLLA scaffolds, or 5x106 cells 
(the cells were in pellet form and were not embedded into scaffolds) were implanted into 
the defect (see Figure 3.8) or otherwise left empty (Group A).  The inferior and superior 
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margins were covered with SepraFilm (Genzyme Biosurgery, Cambridge, MA).  The 
incision through the muscle was sutured (4.0 absorbable suture) and the skin was sealed 
with wound clips.  The rats were monitored for pain and administered buprenorphine 
(0.03 mg/kg) via a subcutaneous injection on their dorsal side post surgery. 
 
 
Figure 3.8.  Implant location in an athymic nude male rat xiphoid chondral defect. 
 
Ten days after surgery the wound clips were removed.  At four weeks the rats 
were euthanized with CO2 asphyxiation in covered animal containers.  The xiphoid and 
implant were excised from each animal for histological analysis.  Dr. Hunter Moyer 
performed both the surgeries and the removal of the xiphoid and implant after euthanasia. 
 
3.8 Cryopreservation 
Vitrification solutions (VS) used in the cryopreservation studies consisted of 
dimethyl sulfoxide (DMSO), formamide, and 1,2-propanediol as the cryoprotectant 
agents (CPAs) in 5xEuroCollins (5xEC) solution (0.97 M dextrose, 0.07 M potassium 
Xiphoid 
Cartilage 
Implant 
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phosphate monobasic (KH2PO4), 0.21 M potassium phosphate dibasic (K2HPO4), 0.08 M 
potassium chloride (KCl), and 0.05 M sodium bicarbonate (NaHCO3)) and 0.01 M 
HEPES buffer with pH between 7.9 and 8.1.  The solution used for traditional freezing 
contained 1 M DMSO in culture media.  The three vitrification solutions, VS55, VS70, 
and VS83, used in this study varied in concentration (8.4 - 12.6 M) of the CPAs and their 
formulations are listed in Table 3.4.  The full-strength removal solutions (solutions added 
to the TECCs after vitrification) contained half the CPAs in the formulations listed in 
Table 3.4 and mannitol (400 mM).  Thus, the full-strength mixture of the removal 
solutions contained 50% VS, 20% 5xEC, and 400 mM mannitol in DI water, and pH to 
7.9-8.1.  The mannitol had to be dissolved on a hot plate in 5xEC before the addition of 
the CPAs to make the formulations.   
 
Table 3.4.  Vitrification solution formulations 
Vitrification Solution DMSO formamide 1,2-propanediol HEPES Total 
VS55 3.1 M 3.1 M 2.21 M 0.01 M 8.4 M 
VS70 3.97 M 3.97 M 2.83 M 0.01 M 10.8 M 
VS83 4.65 M 4.65 M 3.3 M 0.01 M 12.6 M 
 
  
The viability (see section 3.10.4 AlamarBlue Assay) of the harvested TECCs was 
tested before the cryopreservation process began.  The full-strength mixture of each 
vitrification solution (both the addition and removal solutions) was introduced/eluted 
into/out of the TECCs at 4ºC in a step-wise method consisting of discrete steps 15 
minutes each of exposure to the vitrification solution increasing (addition solutions) or 
decreasing (removal solutions) in strength.  The solution used for traditional freezing was 
introduced and eluted in one step.  The step-wise method of introducing addition 
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solutions gradually exposed the TECCs to the CPAs to equilibrate with the surrounding 
solution and to maintain osmotic balance.  Table 3.5 shows the percentage of vitrification 
solution in 1xEC solution (0.19 M dextrose, 0.01 M potassium phosphate monobasic 
(KH2PO4), 0.04 M potassium phosphate dibasic (K2HPO4), 0.02 M potassium chloride 
(KCl), and 0.01 M sodium bicarbonate (NaHCO3) with a pH between 7.9 and 8.1) for 
each addition solution increasing in strength from A1 to A6.  Studies that involved six 
steps introduction method included all six solutions, whereas, studies that involved four 
steps included A1, A3, A5, and A6 solutions only. 
 
Table 3.5.  Solutions for the step-wise introduction of CPAs 
Vitrification Solution CPA Volume 1xEC Volume 
A1 0% 100% 
A2 18.7% 81.3% 
A3 25% 75% 
A4 50% 50% 
A5 75% 25% 
A6 100% 0% 
 
 
 
In a similar manner, the step-wise method of introducing removal solutions 
gradually removed the CPAs from the TECCs.  Table 3.6 shows the percentage of the 
vitrification solutions in 1xEC solution for each removal solution decreasing in strength 
from R1 to R7.  Studies that involved seven steps eluting method included all seven 
solutions, whereas, studies that involved only four steps included R1, R4, R6, and R7.  
The 1xEC solution used in the removal method contained 200 mM of mannitol for 
solutions R1 to R6 and R7 solution contained 1xEC with 0 M of mannitol.  After the R7 
solution was removed, culture media was added for 15 minutes before removal.  Finally, 
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more culture media was added to each TECC and stored in the incubator (37ºC) for a 
one-hour recovery before the viability was tested.  
 
Table 3.6.  Solutions for the step-wise removal of CPAs 
Vitrification Solution CPA Volume 1xEC Volume 
R1 100% 0%* 
R2 75% 25%* 
R3 50% 50%* 
R4 25% 75%* 
R5 12.5% 87.5%* 
R6 0% 100%* 
R7 0% 100% 
* 1xEC with 200 mM of mannitol 
 
 
In the step-wise introduction method, TECCs were exposed to 5 mL of each 
addition solution in 6-well dishes on ice (4ºC) on an orbital shaker (approximately 
100 rpm) to facilitate diffusion.  The TECCs were then placed in scintillation vials filled 
with 5 mL of A6 (the full-strength mixture) solution and 0.8 mL of isopentane (EMD 
Chemicals Inc., Darmstadt, Germany) to limit direct air contact (Song, Lightfoot et al. 
2003).  Samples, along with a blank vial filled with VS55 and a thermocouple, were 
loaded into a tube rack and then placed in a pre-cooled isopentane bath located in a 
-150ºC mechanical storage freezer (Thermo Fisher Scientific, Inc., Waltham, MA or 
Sanyo Moriguchi, Japan) or in a small-scale bench-top apparatus 
(53 cm x 34 cm x 30 cm) which contained approximately 7 L of liquid nitrogen.  The 
temperature was monitored via the thermocouple.  When samples went from 4ºC to 
-100ºC they were removed from the isopentane bath and placed on a shelf in the 
mechanical freezer or in the vapor phase of the liquid nitrogen to slowly drop from 
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-100ºC to -135ºC.  After samples reached -135ºC they were stored in the freezer 
overnight or in the case of the bench-top system, were removed immediately to begin the 
re-warming process.  Vitrification occurred when drop in temperature from 4ºC to -100ºC 
occurred at approximately -40ºC per minute.  The traditional freezing method occurred at 
a slow cooling rate of approximately -1ºC per minute to -180ºC. 
Samples were re-warmed slowly by removing the vials from the freezer to room 
temperature.  The temperature went from -135ºC to -100ºC and then quickly re-warmed 
from -100ºC to 4ºC when the vials were placed in a 37ºC water bath.  Fast re-warming 
was at a rate approximately 40ºC per minute.  TECCs were then removed from the vials 
and placed in 6-well dishes filled with 5 mL of the first of the removal solutions (R1) on 
an orbital shaker at 4ºC.  The removal solutions were then introduced in a step-wise 
manner, which decreased in strength of CPAs.  The traditional freezing method occurred 
at a slow warming rate similar to the cooling rate.  The freezing solution was removed in 
one-step. 
In the no vitrification study, TECCs were not subjected to vitrification to -150°C.  
Instead, TECCs were kept at 4°C in the full-strength mixture of VS55 or VS70 for 
approximately 30 minutes.  Thirty minutes was chosen because the total time for samples 
to vitrify from 4°C to -135°C and to re-warm back to 4°C took approximately 30 minutes 
(without overnight storage at -150°C). 
 While the step-wise method introduced/eluted the CPAs in discrete steps on the 
orbital shaker the bioreactor introduced/eluted the CPAs gradually.  Three reservoirs 
filled with 150 mL of A3, A5, and A6 were connected via tubing to pump the solution 
into the central hub of the PCC bioreactor, which contained the TECCs at 4ºC.  The 
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TECCs were harvested from the PCC bioreactor and tested for viability and then eight 
TECCs were placed back into the bottom row of the inner bob of the PCC bioreactor.  
The top row was not utilized in this study.  The outer cup was filled with 150 mL of A1 
solution, which was not enough to penetrate the top row, but permeated the constructs 
only (due to a pressure gradient between the inner hub and outer cup region) when the 
inner bob was placed inside the outer cup.  After 15 minutes the A3 solution from the 
first reservoir was pumped at 10 mL/min (or a perfusion rate of 1.25 mL/min/construct) 
into the PCC bioreactor as the A1 solution was pumped out into a waste beaker at the 
same rate.  A5 solution was pumped in as A1 was pumped out after 15 minutes.  A6 
solution was then pumped in as A5 was pumped out after 15 minutes.  After 10 minutes 
of the A6 solution pumping in, the TECCs were removed from the PCC bioreactor and 
placed in scintillation vials containing A6 solution and isopentane as mentioned earlier.  
Vitrification and re-warming proceeded in the method described earlier.  The TECCs 
were then placed back into the bottom row of the inner bob of the PCC bioreactor and the 
removal solutions were pumped in using the reservoir method, where four reservoirs 
containing 150 mL of R4, R6, R7, and culture media at 4ºC were used.  The TECCs were 
harvested after the last of the media perfused through the constructs and placed in 6-well 
dishes containing media and stored in the incubator for a one-hour recovery.  The 
viability of the TECCs were then measured and compared to their viability before the 
cryopreservation process began.  A flow chart in Figure 3.9 shows the diagrams of the 
bioreactor introduction/elution method.    
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Figure 3.9.  Bioreactor introduction/elution diagram for the addition and removal of 
vitrification solutions. 
 
 
 The viscosity of the vitrification solutions, VS55 and VS70, were measured with a 
viscometer.  The solutions were prepared and allowed to equilibrate in the viscometer at 
4ºC.  The efflux time was recorded in a size 50 M710 Cannon-Fenske viscometer, which 
had the viscometer constant 0.004 centistokes per second.  Multiplication of the constant 
to the efflux time determined the kinematic viscosity, .  The average density of the 
components of the vitrification solution was 1.09 g/mL.  The viscosity of the vitrification 
solution was calculated using Equation 3.12:  
 

             Equation 3.12  
 
By knowing the viscosity and the perfusion flow rate through the PCC bioreactor, the 
shear stress exerted on the construct during the introduction and elution of the 
vitrification solution was derived according to Equation 3.3. 
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3.9 Construct Harvesting and Digestion 
Harvested constructs were washed in PBE in 50 mm sterile Petri dishes and stored 
in Eppendorf tubes at –20ºC for biochemical analysis.  After all the constructs were 
harvested from each experimental run they were then dried overnight in a speed vacuum 
system (Labconco Corporation, Kansas City, MO), which dehydrated the samples under 
vacuum pressure.  Each sample was then digested in 1 mL of 0.5% papain (v/v) (activity 
23.2 U/mg) (Worthington) in PBE containing 1.75 mg/mL cysteine overnight 
(16 - 18 hours) at 60ºC.  The papain enzymes broke down cellular and extracellular 
components within the TECCs, releasing them from the scaffold for biochemical 
analysis.  Samples were then stored at –20ºC and used for various biochemical 
composition assays.  Samples tested for mechanical properties were washed in PBE and 
stored in PBE with 1x protease inhibitor cocktail I (Calbiochem, Darmstadt, Germany) at 
–20ºC to prevent the breakdown of the cartilage extracellular matrix before they were 
tested.  Those used for histological analysis (including the animal implants) were washed 
in PBE and stored in 10% formalin for fixation in 15 mL centrifuge tubes at 4ºC until 
processed.  Samples used for live/dead analysis under the confocal microscope were 
washed in PBE and immediately viewed before stored in Eppendorf tubes at -20ºC, 
lyophilized, and papain digested as mentioned in the procedure for samples analyzed for 
biochemical composition.  Samples tested for gene expression were chopped into cubes 
1 - 2 mm3 in size before treated with Trizol reagent (Invitrogen) for RNA extraction and 
stored at -80ºC until analyzed. 
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3.10 Construct Analysis 
3.10.1 DNA Assessment 
DNA content was determined from a PicoGreen DNA determination kit 
(Invitrogen).  The PicoGreen reagent was a sensitive fluorescent nucleic acid stain and 
was used to quantify double-stranded DNA strands.  A DNA stock solution was prepared 
from calf thymus DNA (100 g/mL) provided by the kit.  The stock solution of 2 g/mL 
was prepared using a TE buffer solution (10 mM Tris·Cl, 1 mM EDTA, and pH 7.5).  A 
standard curve was made from diluting the DNA stock solution in accordance to 
Table 3.7.   
 
Table 3.7.  DNA standard formulations 
DNA Stock Solution TE Solution Final Concentration 
1000 L 0 L 2 g/mL 
500 L 500 L 1 g/mL 
300 L 700 L 0.6 g/mL 
100 L 900 L 0.2 g/mL 
10 L 990 L 0.02 g/mL 
1 L 999 L 0.002 g/mL 
0 L 1000 L 0 g/mL 
 
 
Samples were typically diluted 1:80 v/v in order for samples to fall within range of the 
standard curve.  Aliquots of the diluted samples and controls were measured with the 
PicoGreen reagent.  In accordance with the kit’s protocol, the reagent was diluted 
200-fold with TE buffer and added in a 1:1 ratio to the samples in black 96-well plates.  
Fluorescence was read in a fluorescence plate reader at an excitation of 480 nm and 
emission of 520 nm.  Correlated to the standard curve, DNA content per construct was 
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determined.  Cell number was determined by correlating 7.7 pg of DNA per cell for 
chondrocytes (Kim, Sah et al. 1988). 
 
3.10.2 Glycosaminoglycan Assessment 
Glycosaminoglycan (GAG) concentration in harvested TECCs and spent media 
samples was measured using a dimethylmethylene blue (DMMB) spectrophotometric 
assay (Farndale, Sayers et al. 1982).  DMMB binds to the sulfate groups located on 
chondroitin sulfate and keratan sulfate to result in a detectable color shift.  The 
absorbance was measured in a spectrophotometer at 525 nm.  A stock solution of 
chondroitin sulfate A (CS) from bovine trachea was prepared at a concentration of 
200 g/mL.  Table 3.8 lists the formulations for the GAG standard curve where the 
diluent was either PBE for measuring GAG in TECCs or media for measuring GAG in 
spent media.  
 
 
Table 3.8.  GAG standard formulations 
 
CS Stock Solution Diluent* Final Concentration 
0 L 1000 L 0 g/mL 
125 L 875 L 25 g/mL 
250 L 750 L 50 g/mL 
375 L 625 L 75 g/mL 
500 L 500 L 100 g/m L 
625 L 375 L 125 g/mL 
750 L 250 L 150 g/mL 
875 L 125 L 175 g/mL 
1000 L 0 L 200 g/mL 
 * PBE or media 
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Typical dilution for measuring GAG concentration in TECCs was 1:10 and 1:1 for spent 
media samples.  The DMMB dye solution (46.0 mM DMMB, 40.5 mM NaCl, 40.5 mM 
glycine, 8.7 mM HCl, and pH 3.0) was added in a 26:1 ratio to aliquots of the diluted 
samples and controls in 96-well plates.  Soluble GAG in media released per construct 
was determined from knowing the total volume of media in the bioreactor and the 
number of constructs in the bioreactor when media samples were taken. 
 
3.10.3 Collagen Assessment 
Total collagen concentration in TECCs was determined via hydroxyproline 
quantification.  The ratio of total collagen to hydroxyproline content was 9:1 (Woessner 
1961).  A stock solution of cis-4-hyroxyproline was prepared at a concentration of 
100 g/mL.  Table 3.9 lists the formulations for the hydroxyproline standard curve.  
 
 
Table 3.9.  Hydroxyproline standard formulations 
 
Hydroxyproline Stock Solution DI Water Final Concentration 
0 L 1000 L 0 g/mL 
100 L 900 L 10 g/mL 
200 L 800 L 20 g/mL 
400 L 600 L 40 g/mL 
500 L 500 L 50 g/mL 
600 L 400 L 60 g/mL 
800 L 200 L 80 g/mL 
900 L 100 L 90 g/mL 
1000 L 0 L 100 g/mL 
 
 
 
The collagen in the samples, controls, and standards were hydrolyzed with 6 N HCl in a 
1:1 ratio at 110ºC for 3 - 4 hours and at 95ºC for 18 hours or until dried in glass tubes 
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capped loosely with glass covers.  A stock buffer (0.24 M monohydrate citric acid, 
0.85 M NaOH, 0.12 g/mL sodium acetate trihydrate, and 1.2% v/v acetic acid) and 
working buffer (66.7% v/v stock buffer, 13.3% v/v DI water, 20% v/v isopropanol, and 
pH 6.0) were prepared beforehand to make a chloramine-T solution (0.05 M 
chloramines-T, 20% v/v DI water, 20% v/v isopropanol, and 80% v/v working buffer).  
After samples, controls, and standards were hydrolyzed, they were resuspended in 1 mL 
of water.  50 L of each sample, control, or standard was plated in a 96-well plate, then 
50 L of the chloramine-T solution was added to each sample, control, or standard and 
incubated at room temperature in the dark for 20 minutes to oxidize the hydroxyproline.  
Next, a p-dimethylaminobenzaldehyde (pDAB) solution was prepared (60% v/v 
isopropanol, 0.15 g/mL pDAB, 26% v/v 60% perchloric acid, and 14% v/v n-propanol) 
and added (50 L) to each sample, control, and standard.  The pDAB reacted with the 
intermediate pyrrole to produce a color change (Stegemann and Stalder 1967).  The 
solution was then incubated for 30 minutes at 60ºC, and absorbance was read at 550 nm 
on a spectrophotometer.  Typically, samples were diluted 2-fold to fall within the 
standard curve. 
 
3.10.4 AlamarBlue Assay 
The cell viability in TECCs treated in the cryopreservation studies was 
quantitatively determined from an alamarBlue dye (Invitrogen).  The alamarBlue dye was 
both fluorometric and spectrometric and was used to measure the metabolic activity of 
cells.  During incubation, metabolically active cells converted the oxidized form of 
alamarBlue (non-fluorescent and blue) to its reduced form (fluorescent and red) with 
 82
mitochondrial and cytosolic enzymes (Gonzalez and Tarloff 2001).  Aliquots of the 
media and alamarBlue solution were measured in a 96-well plate on a fluorescence plate 
reader at an excitation of 544 nm and emission of 590 nm.  Each TECC was incubated 
with 2.5 mL of media and 250 L of alamarBlue and allowed to incubate for 3 hours at 
37ºC/5% CO2.  Controls were media and alamarBlue with no cells.  Because the dye was 
non-cytotoxic the assay was performed on the TECCs just before cryopreservation and 
again right after cryopreservation to determine the percentage of cells that survived the 
various preservation treatments, thus giving quantifiable cell viability levels. 
 
3.10.5 Live/Dead Assay 
The cell viability in TECCs was qualitatively determined from a fluorescent 
live/dead viability kit (Invitrogen).  The live/dead solution contained calcein AM (1 M) 
and ethidium homodimer-1 (EthD-1) (2 M) in PBE.  Nonfluorescent calcein AM was 
converted to green fluorescent calcein (excitation/emission 495 nm/515 nm) by 
intracellular esterase, where esterase activity was characteristic of live cells.  EthD-1 
stains for dead cells by entering cells through damaged cell membranes and then 
producing a 40-fold enhancement of red fluorescence (excitation/emission 
495 nm/635 nm) upon binding to nucleic acids.  Immediately after harvesting TECCs 
from the bioreactor or after finishing the alamarBlue assays the samples were washed in 
PBE for 30 minutes to remove media or alamarBlue.  Samples were then treated with 
150 L of the live/dead solution and incubated at 37ºC/5% CO2 for 30 minutes before 
viewed under a laser scanning confocal microscope (Carl Zeiss Inc., Thornwood, NY) to 
assess cell viability and distribution in the constructs.  Images were taken at the center of 
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the construct and imaged approximately 1% of the whole construct.  Fluorescent intensity 
(red or green) of the cells and fragments in the images taken was measured using ImageJ 
software (National Institutes of Health, Bethesda, MD).  The relative intensity of the live 
and dead cells was then used to determine relative cell viability levels. 
 
3.10.6 Histology 
 All samples for histological analysis were fixed in 10% neutral buffered formalin 
and stored at 4ºC prior to embedding.  Samples were then dehydrated with a series of 
graded ethanol stations to be replaced with xylene in order to be miscible with paraffin.  
Liquefied paraffin (60ºC) infiltrated into the samples to penetrate all interstitial spaces in 
the TECCs.  The paraffin wax provided the support needed for thin sectioning.  The 
paraffin-infiltrated samples were further embedded into a liquid mold of paraffin, which 
solidified at room temperature.  After solidification, the blocks containing the samples 
were cut with a microtome into thin sections (5 m in thickness) and positioned onto 
slides for staining.  All sections were cut across the thickness of the TECCs.   
Sections were stained with hematoxylin and eosin (H&E) for cells, fast 
green/Safranin-O for cytoplasm/GAG, and immunostained for collagen type II and 
collagen type I.  Immunohistochemical staining was carried out with the primary 
monoclonal antibody for type II collagen (II-II6B3, Developmental Hybridoma Studies 
Bank, Iowa City, IA), for type I collagen (MAB3391, Chemicon, Inc. Temecula, CA), 
and a biotintylated anti-mouse secondary antibody (BA2020, Vector Laboratories, 
Burlingame, CA).  Prior to staining the sections were deparaffinized and rehydrated to be 
miscible with the water-soluble dye or antibody used.  After staining the samples were 
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dehydrated with ethanol, cleared with xylene, and coverslipped with mounted media for 
long-term preservation.  Tables 3.10 - 3.12 lists the protocols for each of the stains used 
on the TECCs. 
 
 
Table 3.10.  Hematoxylin and eosin protocol 
 
Step Procedure Number of washes Duration 
1 Xylene 3 3 minutes 
2 100% alcohol 3 2 minutes 
3 95% alcohol 2 2 minutes 
4 70% alcohol 1 2 minutes 
5 DI water 1 2 minutes 
6 Hematoxylin 1 0.5-1 minute 
7 0.5% acid alcohol 1 1 dip 
8 Water 1 1 minute 
9 Bluing reagent 1 30 seconds 
10 Water 1 1 minute 
11 95% alcohol 1 1 minute 
12 1% alcoholic eosin 1 30 seconds 
13 95% alcohol 1 30 seconds 
14 100% alcohol 3 1 minute 
15 Xylene 3 1 minute 
16 Coverslip and mount media -- -- 
 
 
 
Table 3.11. Safranin-O protocol 
 
Step Procedure Number of washes Duration 
1 Xylene 3 3 minutes 
2 100% alcohol 3 2 minutes 
3 95% alcohol 2 2 minutes 
4 70% alcohol 1 2 minutes 
5 DI water 1 1 minute 
6 Weigert’s hematoxylin 1 15-30 seconds 
7 Tap water 1 2 minutes 
8 1% acid alcohol 1 Dip 
9 Tap water 1 2 minutes 
10 0.2% aqueous fast green 1 1 minute 
11 1% acetic acid 1 3 seconds 
12 0.5% Safranin-O 1 5 minutes 
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Table 3.11. Safranin-O protocol (continued) 
 
13 95% alcohol 1 1 minute 
14 Reagent alcohol 3 1 minute 
15 Xylene 2 1 minute 
16 Coverslip and mount media -- -- 
 
 
 
Table 3.12. Immunohistochemical staining for collagen type II and collagen type I 
procedure 
 
Step Procedure Number of washes Duration 
1 Xylene 3 3 minutes 
2 100% alcohol 3 2 minutes 
3 95% alcohol 2 2 minutes 
4 70% alcohol 1 2 minutes 
5 Rehydrate in PBS 2 5 minutes 
6 Antigen retrieval with pepsin (37°C) 1 20 minutes 
7 PBS 2 5 minutes 
8 Block 1% gelatin in PBS 1 20 minutes 
9 
Primary antibody (1:1 for 
collagen type II, 1:80 for 
collagen type I) dilution in 
1% BSA in PBS 
1 1 hour 
10 PBS 2 5 minutes 
11 Secondary antibody (1:400) dilution in 1% BSA in PBS 1 30 minutes 
12 PBS 2 5 minutes 
13 
Vector ABC Reagent 
(Vector Laboratories, 
Burlingame, CA) 
1 30 minutes 
14 PBS 2 5 minutes 
15 DAB* peroxidase substrate 1 Until stain develops 
16 Tap water rinse 1 -- 
17 Counter stain with Hematoxylin 1 2 minutes 
18 Tap water rinse 1 -- 
19 95% alcohol 1 30 seconds 
20 100% alcohol 3 1 minute 
21 Xylene 3 1 minute 
22 Coverslip and mount media -- -- 
 * 3,3’-diaminobenzidine tetrahydrochloride 
 86
All slides were viewed under a light microscope (Nikon’s Eclipse E600) at 4x, 
10x, or 20x magnification and images were taken at the center of the constructs using a 
Retiga 1300 Q imaging camera.  Histology was performed at the histology lab located in 
the Institute of Bioengineering and Bioscience (IBB) at the Georgia Institute of 
Technology or by the Center for Metabolic Bone Disease Core Laboratory at the 
University of Alabama at Birmingham, Birmingham, AL. 
 
 
3.10.7 Gene Expression 
Reverse-transcription polymerase chain reaction  (RT-PCR) was used to evaluate 
the gene expression of tissue-engineered cartilage harvested from the bioreactors by 
measuring mRNA expression for collagen type II, collagen type I, aggrecan, COMP, and 
glyceraldehyde 3-phosphate dehydrogenase (GAPDH).  Primary bovine articular 
chondrocytes were used as positive controls for collagen type II, aggrecan, and COMP.  
Primary bovine osteoblasts were used as positive controls for collagen type I.  The 
primary sequences, annealing temperatures, and product size for each gene marker were 
as follows:  
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Table 3.13. Gene sequences for reverse transcriptase PCR 
Accession 
Number 
Forward Primer 
Reverse Primer 
Annealing 
Temperature 
Product 
size 
Collagen Type II 
AF138957 5’-GAA GGT GGA AAA CCA GGT GA-3’ 5’-CAT TCC CTG AAG ACC TGG AG-3’ 57ºC 228 bp 
Collagen Type I 
AB098910 5’-GAA GAG CGG AGA ATA CTG G-3’ 5’-GTG GTA GGT GAT GTT CTG G-3’ 59.8ºC 301 bp 
Aggrecan 
AF019755 5’-TGC TAC ACA GGT GAA GAC-3’ 5’-TGG ACT CTC TGG GAA AGG-3’ 54.5ºC 307 bp 
COMP* 
X74326 5’-TTC GGA ACG CAC TGT GG-3’ 5’-TGC AGG AAC CAG CGG TA-3’ 58.1ºC 302 bp 
GAPDH 
U85042 5’-CGA GAA GTA TAA CAA CAC C-3’ 5’-GGT AGA AGA GTG AGT ATC G-3’ 54ºC 472 bp 
* (Bosnakovski, Mizuno et al. 2006) 
 
After TECCs were harvested from the bioreactors, washed, and chopped into 
1 - 2 mm3 cubes, each sample was stored in 4 mL of Trizol reagent (a mixture of phenol, 
guanidine isothiocyanate, red dye, and other proprietary components which disrupted the 
cells and isolated the RNA) in a 15 mL centrifuge tube at -80ºC until the end of the 
experimental run.  At the end of each run, each sample was treated with 0.8 mL of 
chloroform for 2 - 3 minutes and centrifuged (Sorvall, SH-3000 rotor) at 4700 rpm 
(4575 gc) for 30 minutes to separate the aqueous and organic phases.  The RNA, located 
in the aqueous phase was removed and precipitated out with isopropanol (2 mL).  After 
incubation at room temperature for 10 minutes, the RNA was spun down at 4700 rpm for 
20 minutes to pellet form.  The supernatant was decanted and the RNA pellet was washed 
and mixed in 8 mL of cold 75% ethanol.  The RNA was spun down to pellet form again 
(4700 rpm for 12 minutes) and the ethanol decanted.  Before dissolution in 60 L of 
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diethyl pyrocarbonate (DEPC)-treated water (RNase free water), the RNA pellet was air-
dried for approximately 20 minutes.  The RNA was quantified by UV spectrophotometer, 
which required a 1:10 dilution of the samples with DEPC-water before measurement.  
The RNA/DNA ratios  (absorbance 260/280 nm) for all the samples were above 1.5 as an 
indicator of RNA purity.  The RNA concentration per construct was recorded.  The mean 
concentration was then determined for each day (Day 4, 7, 14, 21, and 28).  The construct 
whose RNA value was closest to its mean value (the smallest variance) was chosen to use 
for gene expression analysis for collagen type II, collagen type I, aggrecan, COMP, and 
GAPDH. 
Reverse transcription using a PCR machine (iCycler, Bio-Rad Laboratories, 
Hercules, CA) was performed on the RNA to make cDNA (complementary DNA). 
Unless otherwise noted materials used for PCR were purchased from Qiagen, 
Duesseldorf, Germany and primers were purchased from VWR.  Samples were diluted 
with DEPC-water to a total volume of 8 L (DEPC-water volume = 8 L - [RNA]-1) 
before placed in the PCR machine.  The RNA was denatured at 65ºC for 10 minutes and 
cooled to 4ºC for 5 minutes.  Then to each sample the following was added: 2 L of 10X 
Buffer RT, 2 L of dNTP (5 mM), 1 L of Omniscript RT, 5 L DEPC-water, and 2 L 
of their respective reverse primer.  The mixed samples were then placed back into the 
PCR machine for one hour at 37ºC to finish the first set of cDNA. 
To amplify the cDNA content, 1 L of the cDNA was added to the following: 
2.5 L 10X PCR Buffer, 17.375 L of DEPC-water, 1 L dNTP (5 mM), 1 L of MgCl2, 
0.125 L of Taq DNA polymerase (Fisher), 1 L of the forward primer, and 1 L of the 
reverse primer.  Placed back into the PCR machine and after activation of the Taq 
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polymerase for four minutes at 95ºC, the sample mixture was allowed to reach 95ºC to 
separate DNA strands for 30 seconds, then cooled to the respective annealing temperature 
for 1 minute for the attachment of primers to single DNA strands, and then heated to 
72ºC for 30 seconds to elongate the DNA, all before repeating the cycle again.  
Approximately 30 cycles were performed to produce enough cDNA for gel 
electrophoresis. 
Gel electrophoresis allowed visualization of the amplified cDNA for the gene 
tested.  To each agarose gel, a mixture of 10 L of the PCR product or DNA ladder 
standard (BioVentures, Inc., Murfreesboro, TN) and 2 L of loading dye (BioVentures) 
was added to each well of a pre-made Ready Gel (Bio-Rad).  Placed in a gel 
electrophoresis apparatus (Bio-Rad) and filled with 300 mL of 1x TBE Buffer (0.89 M 
Tris Base, 0.89 M boric acid (Bio-Rad), 20 mM EDTA, and pH to 8.0), the gel was 
exposed to 100 V for 55 minutes for the migration of the cDNA through the gel.  
Afterwards, the gel was covered with 50 mL of DI water and 5 L of ethidium bromide 
(Bio-Rad) for 5 minutes on a shaker (ethidium bromide fluoresces when bound to DNA).  
After rinsing with DI water for 25 minutes, the gel was read on a Versadoc machine (Bio-
Rad), which exposed the gel to UV light and imaged the florescent cDNA throughout the 
gel.  The cDNA from the samples and controls were imaged (Quantity One 4.41 
software, Bio-Rad) and compared to the ladder gradient to verify the correct product size.  
The intensity of the bands on each harvest day was measured and compared to each other 
for an increase or decrease in gene expression. 
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3.10.8 Mechanical Testing 
In one experimental run, TECCs harvested and stored at –20°C with protease 
inhibitors from the PCC bioreactor were tested for mechanical properties.  The protease 
inhibitors prevented the breakdown of ECM during storage and testing.  The samples 
were thawed to room temperature for 30 minutes prior to testing.  From each TECC a 
biopsy punch was used to punch out one 5 mm disk, and two 4 mm disks.  The 5 mm 
sample was tested for its compressive modulus and permeability, while the two 4 mm 
disks were tested for its dynamic modulus and phase angle.  The thickness of each 
sample, h0, was measured with digital calipers prior to testing to calculate the appropriate 
strain required in the tests.  
 
 
3.10.8.1 Confined Compression 
The compressive modulus for each TECC grown in the PCC bioreactor was 
measured via a confined compression chamber loaded onto an ELF uniaxial loading 
machine (ELF 3200, Bose, Eden Prairie, MN) located in the mechanical testing lab in 
IBB.  The chamber (Figure 3.10A) was filled with PBE containing protease inhibitors 
and the 5 mm TECC was placed inside the chamber’s confining chamber section (5 mm 
in diameter).  A non-permeable indenter was loaded onto the sample until the load read 
0.01 N (where stress, , was defined as load over the cross-sectional area of the sample).  
WinTest software was used to program the stress relaxation tests.  Each stress relaxation 
test was programmed to apply strains at 5, 10, 15, and 20% on each sample.  The strains 
were reached at a rate, V0, of 0.0005 mm per second (dynamic loading) and the software 
recorded the resulting load.  After reaching each strain the samples were allowed to relax 
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for 15 minutes.  During relaxation, resulting equilibrium loads were recorded.  The 
compressive modulus was determined from plotting the equilibrium stress values (the 
mean of the last ten seconds of the relaxation portion of the test) versus the applied strain.  
A linear fit using regression analysis was used to calculate the slope between the stress 
and strain, and thus, the equilibrium modulus, HA, for each TECC. 
From the dynamic portion of the confined compression test, the permeability 
constant, k0, of the TECCs was determined.  The dynamic portion preceded the relaxation 
portion of the test and measured the stress-strain relationship before the equilibrium strain 
was reached.  The TECCs were modeled as a nonlinear biphasic material consisting of 
both solid and fluid that interacted to provide resistance to load.  The strain-dependent 
permeability relationship for an isotropic homogeneous tissue was described by the 
following (Lai, Mow et al. 1981; Holmes and Mow 1990; Heneghan and Riches 2008):  
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The displacement height, h, and resulting bulk stress, , were measured from the 
confined compression test.  We assumed that bulk stress, , was equivalent to the 
pressure difference across the thickness of the sample, given that the pressure was zero at 
the boundary of the porous platen (when z = h in Figure 3.10A) (Soltz and Ateshian 
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1998).  The fluid velocity, v, was determined from the ramp strain rate selected, V0, for 
the dynamic portion of the compression test.  That is, fluid was forced in one direction at 
a rate of 0.0005 mm/s through the confined constructs.  Curve-fitting the dynamic portion 
of the stress-strain curve resulted in the determination of the permeability constant and 
the strain dependent coefficient, M.  Four dynamic stress-strain relationships were 
measured before reaching equilibrium at 5, 10, 15 and 20% strain.  The stress-strain 
curve before 5% strain was reached was not included in the permeability calculations.  
This was due to the large lag time in stress resulting from strain displacement, which 
resulted in poor fitting.  The three permeability constants calculated before each strain 
was average together as the final value for the permeability constant.  An example 
calculation for the compressive modulus and permeability constant is seen in Appendix 
A.   
 
3.10.8.2 Rheology 
The dynamic/shear modulus and phase angle for each TECC was determined 
from an oscillation test that was performed on a CVO 120 rheometer (Bohlin 
Instruments, Malvern Instruments Ltd., Worcestershire, UK) located in the mechanical 
testing lab in IBB.  The 4 mm samples were loaded onto the rheometer (Figure 3.10B) 
and immersed in PBE containing protease inhibitors to keep the samples hydrated.  The 
indenter (upper platen), 4mm in diameter, was lowered to a 10% uniaxial strain and the 
sample was allowed to equilibrate for 30 minutes before testing.  As the upper platen 
rotated at a 0.5% strain, a frequency sweep between 0.01 and 1 Hz was carried out with a 
logarithmic increase in frequency.  The three frequencies used were 0.01, 0.1, and 1 Hz.  
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The final outcome resulted in a frequency-dependent dynamic shear modulus, G*, and 
phase angle,.  The phase angle defined the ratio of the viscous response to deformation 
of the sample to its elastic response, thus measuring the viscoelastic behavior of each 
TECC.  
 
 
 
 
Figure 3.10.  Schematic of the mechanical testing apparatus. (A) Confined compression 
apparatus; (B) rheometer 
 
 
 
A 
B 
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3.11 Statistical Analysis 
For each data set, values were represented as mean ± standard error mean (SEM) 
for n constructs or N experimental trials.  Comparison was made within each bioreactor 
in cartilage growth studies.  That is, for 28-day long experiments, Student’s t-test (two-
tailed) was performed between each day compared to Day 4 values.  Comparison 
between different bioreactor treatments was also carried out, where Student’s t-test was 
performed between each bioreactor treatment (for example, between the CC and PCC 
bioreactor) for each day measured.  Most experimental trials in which statistics were 
performed were repeated but not averaged together to confirm similar trend in each run.  
This was partially due to the large variation that occurred in construct development from 
using separate animal sources for each experiment, where each experimental trial had 
chondrocytes harvested from a single animal source (Saini and Wick 2003).  Significance 
was achieved for p-values less than 0.05.   
Student’s t-test was also performed between each cryopreservation treatment 
method for the study that was carried out.  In each study, treatment was normalized to a 
control within the experiment to measure relative difference in viability.  Repeated 
experimental trials that were normalized were then pooled and averaged together for 
statistical analysis.  The p-values were stated for each cryopreservation comparison 
study. 
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CHAPTER 4 
RESULTS 
 
4.1 Characterization of the Perfusion Concentric Cylinder Bioreactor 
4.1.1 Momentum Transport across Construct in the Perfusion Concentric Cylinder 
Bioreactor 
Computational fluid dynamics (CFD) calculations with the parameters mentioned 
in the Materials and Methods section were carried out over the diameter of the constructs 
embedded in the cylindrical spokes.  Velocity contours (Figure 4.1A) inside the open 
cavity revealed that 80% of the scaffold diameter experienced a flow rate between 0.02 
and 0.04 cm/s and approximately 20% at the edge experienced recirculation with an 
average flow rate of 0.6 cm/s.  The fluid recirculation zone can be seen on the right-hand 
side of the open cavity in Figure 4.1A.  The shear stress profile (Figure 4.1B) revealed 
distinct regions of varying shear stress across the diameter of the scaffold.  Between 0 
and 0.4 cm the average shear stress was 0.02 dynes/cm2, between 0.4 cm and 0.8 cm the 
average was 0.4 dynes/cm2, and between 0.8 cm and 1 cm where recirculation of fluid 
occurred, the average shear stress was 3 dynes/cm2.  Since fluid flow changed direction 
every twelve hours across the diameter, the center of the scaffolds experienced a constant 
shear stress of 0.4 dynes/cm2, while the edges were exposed to oscillations between high 
and low shear stresses. 
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Figure 4.1.  Fluid modeling of open cavity within the PCC bioreactor. (A) Velocity 
profile within the open cavity located over scaffold diameter; (B) shear stress profile 
within the open cavity located over scaffold diameter.  Insets represent a diagram of the 
open cavity in the construct arm. 
 
 
 
4.1.2 Oxygen Transport within the Perfusion Concentric Cylinder Bioreactor 
 The oxygen transport profile within the PCC bioreactor was modeled after the 
species continuity equation.  The time taken to reach equilibrium levels based on 
diffusivity alone for oxygen in water was less than 24 hours (see Appendix A).  
Therefore, a steady-state profile was assumed and that the oxygen in media was at 
equilibrium with the oxygen in the incubator for all calculations, CO2 = 0.212 mol/m3.   
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Before Day 4, when there was no perfusion, the oxygen transport through the 
thickness of the construct depended solely on diffusion in one direction.  This reduced the 
species continuity equation to: 
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By assuming 106 cells per construct (volume 147 mm3) the reaction rate was calculated at 
RO2 = 9.46x10-4 mol O2/m3/s.  The boundary conditions were: 
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Thus, the oxygen profile up to Day 4 followed a parabolic distribution: 
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After Day 4, convective transport dominated in one direction and reduced the species 
continuity equation to:  
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By assuming 5x106 cells per construct on Day 14 the reaction rate was calculated at 
4.73x10-3 mol O2/m3/s.  Also, by assuming approximately 10x106 cells per construct on 
Day 28 the reaction rate was calculated at 9.46x10-3 mol O2/m3/s.  With the boundary 
conditions the same as for when diffusivity dominated, the oxygen profile thus followed a 
linear dependence on position through the thickness of the construct: 
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Figure 4.2 plots the oxygen concentration through the thickness of the construct, showing 
that oxygen reached the interior with a 97.4% drop from equilibrium oxygen levels in the 
media to the center of the construct for Day 4.  In contrast, the drop in oxygen levels in 
media was 6.9% for Day 14 and 13.9% for Day 28 at the center of the construct. 
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Figure 4.2.  Oxygen profile through the thickness of the construct.  On Day 4 diffusion 
dominated and followed a parabolic distribution.  After Day 4, convection dominated and 
followed a linear distribution. 
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4.1.3 Construct Growth in the Perfusion Concentric Cylinder Bioreactor 
The cell seeding efficiency, measured from Day 4 values, was low compared to 
the number of cells initially loaded into the bioreactor at 2.1 ± 1.3% 
(0.2x106 ± 0.1x106 cells per construct).  However, by Day 28 cell number increased to 
7.1x106 ± 0.6x106 cells per construct (Figure 4.3A).  Cell number had increased by 
37 ± 3 fold from initial Day 4 values.  Glycosaminoglycan content increased to 
0.31 ± 0.03 mg/construct (Figure 4.3B) and total collagen content increased to 
1.3 ± 0.1 mg/construct after 28 days in culture (Figure 4.3C).  Total collagen production 
continued to increase over the course of 28 days, while GAG content leveled out by 
Day 14.  There was an increase in resistance to flow as a function of time.  The increase 
in the pressure gradient across the constructs was due to the decrease in porosity and pore 
size as extracellular matrix deposition into the scaffolds increased.  By maintaining the 
overall flow rate and accounting for the decrease in porosity and pore size, the increase in 
shear stress exerted on the scaffolds due to perfusion over the course of 28 days was 
noted but not determined in this study.  Bioreactor pH levels varied between 7.1 and 7.5 
over the course of the run, which was within range considered physiologically relevant 
for cartilage (Razaq, Wilkins et al. 2003).  To determine overall GAG synthesis, soluble 
GAG levels were measured in media samples taken from spent media and combined with 
GAG content retained by the constructs.  Over the course of 28 days, about 92 - 99% of 
total GAG produced was released into the media.     
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Figure 4.3. Cartilage growth in the PCC bioreactor.  Data are presented for one 
experimental run and are presented as mean ± SEM (n = 3 constructs).  
(A) Cells/construct; (B) GAG/construct; (C) total collagen/construct.  By Day 28 PCC 
bioreactor had significantly more ECM deposition with a 37-fold increase in cell number 
per construct. (* p < 0.05 vs. Day 4) 
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Histologically, over the course of 28 days, cells and matrix growth propagated 
preferentiality on the construct face that experienced surface shear (Figure 4.4).  
However, growth also occurred on the face that experienced bulk perfusion albeit less so 
than the surface shear face.  By Day 28, histological analyses determined that most of the 
cartilage development occurred on the shear face of the constructs, whereas some 
extracellular matrix deposition occurred on the perfusion face.  Immunohistochemical 
staining showed presence of collagen type II indicating cells expressed articular cartilage 
phenotype.  Positive staining for GAG (red stain) was not present at the surface exposed 
to shear, but was detected in the interior away from direct exposure to surface shear 
forces.  Seen in Figure 4.5, at higher magnification (20x) cartilage lacunae were seen 
surrounding cells, further indicating cartilage formation.  Lack of staining for cells and 
extracellular matrix in the center of the constructs and presence of polymer indicated lack 
of cartilage development at the center of the cross-section of the constructs. 
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Figure 4.4.  Histological images, taken at 10x, over a 4 week run.  Upper left corner is the 
“front side” of the construct exposed to surface shear (solid arrow), while lower right 
corner is the “back side” of the construct exposed to perfusion (dashed arrow). 
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Figure 4.5. Histology for Day 28 tissue-engineered cartilage constructs from the 
perfusion concentric cylinder bioreactor.  Constructs were sectioned through the 
thickness and viewed at the center.  Arrows indicate direction of fluid flow in relation to 
construct.  Solid arrows indicate fluid flowed over the top surface of the constructs 
(shear) and dashed arrows indicate fluid flowed through the constructs from the backside 
(perfusion).  Constructs were stained with hematoxylin and eosin for cells, safranin-O for 
GAG (stained red), and immunostained for collagen type II.  At higher magnification 
(20x) lacunae were seen surrounding cells (indicated by the small triangles) and then 
surrounded by ECM.  Scale bar represents 100 m. 
 
 
 
Seen in Figure 4.6, by Day 28, cells were 82 ± 1% viable.  Confocal images 
showed that live and dead cells were distributed over the surface of the TECCs when 
cultured over the course of 28 days.  By Day 21, most cells were viable as seen in 
Figure 4.6, indicated by the green fluorescent cells.  Dead cells were present throughout 
the constructs.  The three-dimensional compilation indicated that cells grew along the 
rough surface of the scaffold adopting its three-dimensional shape. 
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Figure 4.6.  Live/dead analysis of constructs grown in the PCC bioreactor.  Data are 
presented for one experimental run and are presented as mean ± SEM (n = 3 constructs).  
Confocal fluorescence images are constructs grown in the PCC bioreactor after 21 and 28 
days.  Cells grew along the rough surface of the PLLA scaffold.  Images represent the 
front surface of the constructs that experienced shear.  Green fluorescent indicated live 
cells, while red indicated dead cells or fragments. 
 
 
 
4.2 Comparison of Construct Growth between the Concentric Cylinder and 
Perfusion Concentric Cylinder Bioreactor 
Both bioreactors had low seeding efficiencies.  By Day 4 the CC bioreactor had 
1.8 ± 0.5 x106 cells per construct (seeding efficiency 27 ± 8%), while the PCC bioreactor 
had 0.8 ± 0.2 x106 cells per construct (seeding efficiency 11 ± 2%) (Figure 4.6A).  After 
28 days in culture the PCC bioreactor increased in cell number by 12 ± 1 fold, whereas 
the CC bioreactor increased by 7.1 ± 0.9 fold (p < 0.05).  However, both bioreactors by 
Day 21 
Day 28 
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Day 28 had about 10 million cells per construct (Figure 4.7A).  After the seeding period, 
the CC bioreactor continuously produced significantly more GAG per construct than the 
PCC bioreactor.  By Day 28 the CC bioreactor had 1.3 ± 0.1 mg of GAG per construct 
while the PCC produced 0.7 ± 0.1 mg/construct (p < 0.05) (Figure 4.7B).  GAG 
production reached peak levels by Day 14 in the PCC while by Day 7 in the CC 
bioreactor before leveling off.  By Day 28 the CC bioreactor produced 1.8 ± 0.3 mg of 
total collagen per construct, significantly more than the PCC bioreactor at 
0.8 ± 0.1 mg/construct (p< 0.05) (Figure 4.7C).  As with GAG production, the production 
for total collagen reached peak levels by Day 7 for the CC bioreactor and Day 14 for the 
PCC bioreactor.  However, total collagen content for the CC bioreactor continued to 
increase after Day 7, whereas after Day 21 total collagen content leveled out for the PCC 
bioreactor.  By Day 28 little variation existed between harvested constructs from the PCC 
bioreactor and CC bioreactor in their cell number and extracellular matrix content 
(Table 4.1).  Bioreactor pH levels varied between 7.1 and 7.5 over the course of the run 
for the PCC bioreactor; and though still mostly in physiological range, the CC bioreactor 
varied between 6.7 and 7.5.  Over the course of 28 days, 79 - 91% of GAG was released 
into the media for the PCC bioreactor while only 40 - 58% of GAG was released into the 
media for the CC bioreactor.  Repeat of this study showed the same trend with the CC 
bioreactor producing significantly more extracellular matrix than the PCC bioreactor, but 
with roughly equal number of cells per construct by Day 28 (Table 4.1).  The PCC 
bioreactor also repeated the significantly higher fold increase in cell number per construct 
than the CC bioreactor.  Results of this second study can be seen in detail in Appendix B.    
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Figure 4.7.  Chondrocyte proliferation and matrix deposition in the PCC bioreactor 
compared to the CC bioreactor.  Data are presented for one experimental run and are 
presented as mean ± SEM (n = 3 constructs for Day 4 - 21 and n = 4 for Day 28).  
(A) Cells/construct; (B) GAG/construct; (C) total collagen/construct.  By Day 28, 
constructs from the CC bioreactor had significantly more extracellular matrix deposition 
than the PCC while both bioreactors had roughly the same number of cells per construct.  
(* p < 0.05 vs. CC Day 4; # p < 0.05 vs. PCC Day 4; and $ p < 0.05 between PCC and 
CC) 
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Table 4.1. Individual construct composition for two experimental runs: PCC versus CC 
    First Experimental Run Second Experimental Run 
CC Bioreactor  Day 4 Day 28 Day 4  Day 28 
 1.37 10.7 2.65  7.68 
 1.23 10.1 2.26  7.24 
 2.89 14.5 2.18  6.79 
Cells/construct 
(x106/construct) 
  17.2    
mean ± SEM  1.83 ± 0.53 13.1 ± 1.7 2.37 ± 0.15  7.24 ± 0.26 
 0.36 1.70 0.29  1.14 
 0.38 1.86 0.49  1.52 
 0.68 1.65 0.33  1.33 
Glycosaminoglycan 
(mg/construct) 
  2.00    
mean ± SEM  0.47 ± 0.10 1.80 ± 0.08 0.37 ± 0.06  1.33 ± 0.11 
 0.10 1.36 0.07  1.83 
 0.07 1.25 0.06  1.93 
 0.07 2.31 0.09  1.64 
Collagen 
(mg/construct) 
  2.41    
mean ± SEM  0.08 ± 0.01 1.83 ± 0.31 0.07 ± 0.01  1.80 ± 0.09 
        
PCC Bioreactor  Day 4 Day 28 Day 4  Day 28 
 0.78 9.76 0.19  10.81 
 0.99 11.85 0.41  9.56 
 0.49 9.90 0.07  7.10 
Cells/construct 
(x106/construct) 
  6.63    
mean ± SEM  0.75 ± 0.15 9.5 ± 1.1 0.22 ± 0.10  9.16 ± 1.09 
 0.31 0.54 0.31  0.80 
 0.38 0.98 0.23  0.79 
 
Glycosaminoglycan 
(mg/construct)  0.10 0.82 0.28  0.44 
    0.39    
mean ± SEM  0.26 ± 0.08 0.68 ± 0.13 0.28 ± 0.02  0.67 ± 0.12 
 0.05 0.81 0.04  1.64 
 0.02 1.00 0.03  1.48 
 0.04 0.76 0.03  1.48 
Collagen 
(mg/construct) 
  0.54    
mean ± SEM  0.03 ± 0.01 0.77 ± 0.10 0.03 ± 0.00  1.54 ± 0.05 
Data are cells, glycosaminoglycan, and collagen content for individual constructs 
harvested after 4 (n = 3) or 28 (n = 3 or 4) days in culture from the indicated bioreactor.  
Comparisons within bioreactors indicated relatively uniform construct composition. 
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Seen in Figure 4.8, by Day 28, cells were approximately 52% viable with no 
difference between the two bioreactors.  Confocal images showed no discernable 
difference in viability between the two bioreactors and by Day 28, most cells were viable, 
indicated by the green fluorescent cells.  Dead cells were present throughout the 
constructs. 
 
 
       
 
 
     
 
 
 
 
Figure 4.8.  Live/dead analysis of constructs grown in the PCC or CC bioreactor.  Data 
are presented for one experimental run and are presented as mean ± SEM 
(n = 3 constructs) (* p < 0.05 vs. CC Day 4; # p < 0.05 vs. PCC Day 4).  Confocal 
fluorescence images are constructs grown in the PCC or CC bioreactor after 28 days.  
Live cells fluoresced green and dead cells or fragments fluoresced red. 
 
 
 
Perfusion Concentric
Cylinder Bioreactor 
Concentric Cylinder Bioreactor
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By Day 28 extracellular matrix stained more intensely from constructs harvested 
from the CC bioreactor than the PCC bioreactor (Figure 4.9).  The constructs from the 
CC bioreactor produced more intense staining for collagen type II than the PCC 
bioreactor, which correlated to the biochemical analysis that the CC bioreactor produced 
more collagen and GAG.  However, cells and deposition of collagen type II and GAG 
were restricted to the surface shear face of the constructs from the CC bioreactor, 
whereas, while preferentially deposited on the surface shear face, cells and extracellular 
matrix were also found on the perfusion face of the constructs from the PCC bioreactor. 
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Figure 4.9.  Histology for tissue-engineered cartilage constructs at 10x magnification.  
Constructs cultured for 28 days were harvested and stained with hematoxylin and eosin 
for cells, safranin-O for GAG (stained red), and immunostained for collagen type II.  
Column labeled samples represent constructs grown in either the CC or PCC bioreactor.  
Arrows indicate direction of fluid flow exerted on the constructs.  All sections show 
construct face experienced surface shear (solid arrows) on the upper left-hand side and 
perfusion (dashed arrows) on the lower right-hand side (for the PCC bioreactor only).  
Open areas indicate presence of polymer. 
     
 
Both the CC and PCC bioreactor expressed articular cartilage markers, aggrecan, 
collagen type II, and COMP (Figure 4.10).  Neither bioreactors showed definitive 
increase or decrease in aggrecan and collagen type II gene expression over the course of 
28 days.  Seen in Table 4.2, both bioreactors showed a decrease in COMP expression by 
Day 21 with a 40% decrease for the PCC bioreactor and 60% decrease for the CC 
Perfusion Concentric 
Cylinder Bioreactor 
Concentric 
Cylinder Bioreactor 
Cells
Glycosaminoglycan
Collagen Type II
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bioreactor compared to Day 14 values.  Both bioreactors also expressed collagen type I 
mRNA, indicative of possible dedifferentiation or fibroblastic cells.  However, constructs 
from the PCC bioreactor expressed a 30% decrease in collagen type I by Day 21 
compared to Day 14 values, while constructs from the CC bioreactor neither increased 
nor decreased in collagen type I expression by more than 18%.  
 
 
 
Figure 4.10.  Characterization of tissue-engineered cartilage cultured in either CC or PCC 
bioreactor using RT-PCR.  NT: Native Tissue.  The phenotype of the chondrocytes 
cultured in the bioreactor was measured by mRNA expression for aggrecan, collagen 
type II, collagen type I, COMP, and GAPDH. Throughout the 28 day culture, both 
bioreactors showed expression for aggrecan, collagen type II, collagen type I, COMP, 
and GAPDH.  Presence of collagen type I indicate that cells have partially 
dedifferentiated towards fibroblastic tissue, however collagen type II presence indicated 
some retention of articular cartilage tissue. 
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Table 4.2.  Gene expression normalized to GAPDH* 
 
CC Collagen Type I Collagen Type II COMP Aggrecan 
Day 4 1.18 1.10 1933.62 1.11 
Day 7 0.96 1.03 1013.17 1.03 
Day 14 0.89 1.08 1638.11 1.03 
Day 21 1.02 1.13 657.50 1.08 
Day 28 0.94 0.96 516.79 0.99 
Native Tissue 1.12 1.11 1762.99 1.06 
       
PCC Collagen Type I Collagen Type II COMP Aggrecan 
Day 4 1.28 103.86 9.09 49.08 
Day 7 1.48 118.97 11.39 61.60 
Day 14 1.44 113.91 9.05 48.98 
Day 21 1.01 107.00 5.10 55.03 
Day 28 1.13 93.37 5.19 46.17 
Native Tissue 1.34 110.28 9.79 66.13 
       * Values are ratio of specified gene intensity to GAPDH 
 
 
 
4.3 Effect of Mechanical Stimulation on Tissue-Engineered Cartilage Growth 
4.3.1 Perfusion and Shear versus Shear Cartilage Construct Growth: Biochemical 
Composition 
After four days in culture, both bioreactors had equivalent low seeding efficiency 
with the perfusion+shear bioreactor having 4.1 ± 0.7% efficiency at 
0.4 ± 0.1 x106 cells/construct and the shear bioreactor 3.9 ± 1.1% efficiency at 
0.4 ± 0.1 x106 cells/construct (Figure 4.11A).  However, by Day 28 the difference 
between the two bioreactors was more noticeable.  After 28 days in culture, the 
perfusion+shear bioreactor increased in cell number by 33 ± 1 fold to 
13.4 ± 0.3 x106 cells/construct, whereas the shear bioreactor increased by 11 ± 4 fold to 
4.0 ± 1.7 x106 cells/construct (p < 0.05) (Figure 4.11A).  From Figure 4.11B, GAG 
deposition was the same in either bioreactor by Day 28, where the perfusion+shear 
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bioreactor produced 1.2 ± 0.1 mg/construct and the shear bioreactor produced 
1.2 ± 0.3 mg/construct.  GAG production rate peaked by Day 14 for the perfusion+shear 
bioreactor and by Day 7 in the shear bioreactor before the rates leveled out by Day 21.  
By Day 28 total collagen production in the perfusion+shear bioreactor was 
2.8 ± 0.2 mg/construct, which was significantly greater than the 1.2 ± 0.1 mg/construct 
produced in the shear bioreactor (Figure 4.11C) (p < 0.05).   Total collagen production 
continued to increase over the course of 28 days in the perfusion+shear bioreactor, while 
in the shear bioreactor collagen production leveled out by Day 14.  Bioreactor pH levels 
varied between 7.0 and 7.5 over the course of the run for both bioreactors, which were 
within physiological range for cartilage.  Over the course of 28 days, 71 - 91% of GAG 
were released into the media for the perfusion+shear bioreactor while 62 - 94% of GAG 
were released into the media for the shear bioreactor.  Repeat of this study showed the 
same trend with the perfusion+shear bioreactor producing significantly more cells and 
total collagen than the shear bioreactor, but with roughly equal number of GAG per 
construct by Day 28 (Table 4.3).  The perfusion+shear bioreactor also repeated a 
significantly higher fold increase in cell number per construct from Day 4 values than the 
shear bioreactor.  
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Figure 4.11.  Chondrocyte proliferation and matrix deposition in the perfusion+shear 
PCC bioreactor compared to the shear only PCC bioreactor.  Data are presented as 
mean ± SEM (n = 3 constructs).  (A) Cells/construct; (B) GAG/construct; (C) total 
collagen/construct.  By Day 28, constructs from the perfusion+shear bioreactor had 
significantly more cells and total collagen than the shear bioreactor while both 
bioreactors had roughly the same amount of GAG per construct.  ($ p < 0.05 vs. Shear 
Day 4; + p < 0.05 vs. Perfusion+Shear Day 4; and * p < 0.05 between Perfusion+Shear 
and Shear) 
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Table 4.3. Individual construct composition for two experimental runs: perfusion+shear 
versus shear 
 
      First Experimental Run   Second Experimental Run 
Perfusion+Shear  Day 4 Day 28  Day 4  Day 28 
 0.47 13.8  0.19  10.8 
 0.47 12.8  0.41  9.56 
Cells/construct 
(x106/construct) 
 0.27 13.4  0.07  7.10 
mean ± SEM   0.40 ± 0.07  13.4 ± 0.3   0.22 ± 0.10   9.16 ± 1.09 
 0.15 1.36  0.31  0.80 
 0.12 0.94  0.23  0.79 
Glycosaminoglycan 
(mg/construct) 
 0.06 1.19  0.28  0.44 
mean ± SEM   0.11 ± 0.03  1.16 ± 0.12   0.28 ± 0.02   0.67 ± 0.12 
 0.04 2.88  0.04  1.64 
 0.05 2.36  0.03  1.48 
Collagen 
(mg/construct) 
 0.07 3.15  0.03  1.48 
mean ± SEM   0.05 ± 0.01  2.80 ± 0.23   0.03 ± 0.00   1.54 ± 0.05 
           
Shear  Day 4 Day 28  Day 4  Day 28 
 0.59 4.89  0.38  4.55 
 0.27 6.40  0.05  3.47 
Cells/construct 
(x106/construct) 
 0.28 0.77  0.05  3.39 
mean ± SEM   0.38 ± 0.11  4.02 ± 1.68   0.16 ± 0.110   3.80 ± 0.38 
 0.07 1.30  0.27  0.46 
 0.07 1.71  0.27  0.52 
Glycosaminoglycan 
(mg/construct) 
 0.06 0.58  0.27  0.38 
mean ± SEM   0.06 ± 0.00  1.20 ± 0.33   0.27 ± 0.00   0.46 ± 0.04 
 0.08 1.20  0.04  0.83 
 0.05 1.43  0.04  0.87 
Collagen 
(mg/construct) 
 0.03 1.07  0.05  0.67 
mean ± SEM   0.06 ± 0.01  1.23 ± 0.11   0.04 ± 0.00   0.79 ± 0.06 
Data are cells, glycosaminoglycan, and collagen content for individual constructs 
harvested after 4 or 28 days in culture from the indicated bioreactor (n = 3).  
Comparisons within bioreactors indicated relatively uniform construct composition. 
 
Histologically, over the course of 28 days in bioreactor culture, cells and matrix 
growth propagated preferentiality on the construct face that experienced surface shear.  
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However, growth also occurred on the backside of the constructs, away from surface 
shear in both bioreactors.  Even though no perfusion occurred for the shear bioreactor, the 
constructs cultured in the shear bioreactor showed no discernable difference in cell 
growth and extracellular matrix deposition compared to the perfusion+shear bioreactor.  
Seen in Figure 4.12, by Day 28 histological analyses determined that most of the cartilage 
development occurred on the shear face of the constructs, whereas some extracellular 
matrix deposition occurred on the backside (perfusion face for the perfusion+shear 
bioreactor).  Positive staining for GAG (red stain) was not present at the surface exposed 
to shear, but was detected in the interior away from direct exposure to surface shear 
forces. Immunohistochemical staining showed presence of collagen type II, which 
indicated cells expressed articular cartilage phenotype.  The presence of collagen type I 
was also detected and indicated possible dedifferentiation and fibroblast-like tissue.  Lack 
of staining for cells and extracellular matrix in the center of the constructs and presence 
of polymer indicated lack of cartilage development at the center of the cross-section of 
the constructs. 
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Figure 4.12.  Histological analysis of TECCs cultured either in the perfusion+shear 
bioreactor or the shear bioreactor at 10x magnification.  Constructs cultured for 28 days 
were harvested and stained with hematoxylin and eosin for cells, safranin-O for GAG 
(stained red), and immunostained for collagen type II (stained brown) and collagen type I 
(stained brown).  Arrows indicate direction of fluid flow exerted on the constructs.  All 
sections show construct face experiencing surface shear (solid arrows) on the left-hand 
side and perfusion (dashed arrows) on the right-hand side (for the perfusion+shear 
bioreactor only).  Open unstained areas indicated presence of polymer.  The cross-
sectional area of the constructs at 10x was larger than the field of view.  As such, two 
images across the thickness of the construct were imaged and cropped together to give 
one image representative of the cross-sectional area. 
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Seen in Figure 4.13, by Day 28, cells were approximately 51% viable with no 
difference between the two bioreactors.  Confocal images showed no discernable 
difference in viability between the two bioreactors; however, the perfusion+shear 
bioreactor showed more cells than the shear bioreactor.  By Day 28, most cells were 
viable, indicated by the green fluorescent cells and dead cells were present throughout the 
constructs (Figure 4.13). 
 
 
 
 
        
 
 
 
 
Figure 4.13.  Live/dead analysis of constructs grown in the perfusion+shear or shear only 
PCC bioreactor.  Data are presented for one experimental run and are presented as 
mean ± SEM (n = 3 constructs) (+ p < 0.05 vs. Perfusion+Shear Day 4).  Confocal 
fluorescence images are constructs grown in the perfusion+shear or shear bioreactor after 
28 days.  Live cells fluoresced green and dead cells or fragments fluoresced red. 
 
 
 
Shear 
Perfusion+Shear 
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4.3.2 Perfusion and Shear versus Shear Cartilage Construct Growth: Mechanical 
Properties  
In Figure 4.14 the aggregate modulus over the course of 28 days were not 
significantly different from Day 4 values for either bioreactor.  In addition, there was no 
difference in stiffness between the perfusion+shear and shear bioreactor.  By Day 28 the 
bioreactors produced TECCs with a compressive modulus of 0.15 ± 0.02 MPa.  In 
comparison, the compressive modulus of native cartilage was significantly greater at 
0.57 ± 0.10 MPa (p < 0.05), while the PLLA scaffold’s compressive modulus (cultured 
for 28 days in media with no cells) was equivalent to the TECCs at 0.10 ± 0.04 MPa. 
 
 
Figure 4.14.  Compressive modulus of TECCs cultured in PCC bioreactor.  Data are 
presented as mean ± SEM (n = 3 constructs). 
 
 
 
 Figure 4.15 shows the variability in permeability over the course of 28 days and 
between the perfusion+shear and shear bioreactor.  There was no significant difference in 
permeability over the course of 28 days for either bioreactor conditions or between the 
two bioreactors.  By Day 28 the bioreactors produced TECCs with a permeability 
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constant of 2.0 ± 0.5 x10-13 m4/(N*s).  In comparison, the permeability constant of native 
cartilage was on the same order of magnitude as the TECCs at 1.2 ± 0.8 x10-13 m4/(N*s).  
However, the permeability constant for PLLA scaffolds after 28 days in culture media 
(0.6 ± 0.2 x10-13 m4/(N*s)) was significantly less permeable than Day 7 and Day 28 
samples from the perfusion+shear bioreactor and Day 14 and Day 21 samples in the shear 
bioreactor (p < 0.05). 
 
 
 
Figure 4.15.  Permeability constant of TECCs over the course of 28 days cultured in the 
PCC bioreactor.  Data are presented as mean ± SEM (n = 3 constructs). 
 
 
No significant difference in the shear and dynamic modulus was detected between 
the perfusion+shear and shear bioreactor.  For either bioreactor, at 28 days the dynamic 
modulus increased as frequency increased from 0.01 Hz to 1 Hz, which indicated 
viscoelastic behavior (Figure 4.16A).  Over the course of the experiment the shear 
modulus at 1 Hz decreased over time from Day 4 values (Figure 4.16B); where the 
perfusion+shear bioreactor decreased from 1.2 ± 0.2 MPa on Day 4 to 0.3 ± 0.1 MPa on 
Day 28 and the shear bioreactor went from 0.9 ± 0.2 MPa on Day 4 to 0.4 ± 0.1 MPa.  By 
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Day 14 there was a significant drop in the perfusion+shear modulus compared to Day 4 
values (p < 0.05).  In comparison, the shear modulus of native cartilage was measured at 
0.7 ± 0.2 MPa at 1 Hz, while PLLA scaffolds after 28 days in culture media (no cells) 
had a shear modulus of 1.8 ± 0.7 MPa. 
    
 
Figure 4.16.  Shear/Dynamic modulus of TECCs cultured in PCC bioreactor for 28 days.  
Data are presented as mean ± SEM (n = 3 constructs). (A) Dynamic modulus between 
0.01-1 Hz; (B) shear modulus at 1 Hz over the course of 28 days. (+ p < 0.05 vs. 
Perfusion+Shear Day 4) 
 
 
 
A 
B 
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Seen in Figure 4.17 for a frequency of 1 Hz, the perfusion+shear bioreactor had a 
significant increase in phase angle from 4.2 ± 0.1 º at Day 4 to 15 ± 1 º at Day 28; as well 
as, the shear bioreactor, which increased from 5.1 ± 0.3 º at Day 4 to 11 ± 1 º at Day 28 
(p < 0.05).  In addition, there was a significant difference between the two bioreactors by 
Day 21 (p < 0.05).  In comparison, the phase angle of native cartilage was greater than 
Day 28 TECCs measured at 29 ± 6 º (p < 0.06), while the phase angle of PLLA was 
significantly lower than Day 28 TECCs measured at 6.2 ± 0.8 º (p < 0.05). 
 
 
Figure 4.17.  Phase angle measured at 1 Hz for TECCs cultured over 28 days.  Data are 
presented as mean ± SEM (n = 3 constructs). (* p < 0.05 vs. Shear, + p < 0.05 vs. 
Perfusion+Shear Day 4, $ p < 0.05 vs. Shear Day 4) 
 
 
4.4 Effect of Mechanical Stimulation on Tissue-Engineered Cartilage Growth In 
Vivo 
After 28 days in bioreactor culture and before implantation, constructs in the 
perfusion+shear bioreactor had 11 ± 1 million cells per construct, which was significantly 
greater than the shear bioreactor at 7.9 ± 0.8 million cells per construct and the static 
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bioreactor at 5.7 ± 1.5 million cells per construct (p < 0.05) (Figure 4.18A).  Seen in 
Figure 4.18B, GAG content per construct between the perfusion+shear and shear 
bioreactor prior to implantation was equivalent, in which the perfusion+shear bioreactor 
produced 0.8 ± 0.2 mg/construct and the shear bioreactor 1.2 ± 0.2 mg/construct.  The 
static bioreactor produced 0.3 ± 0.2 mg of GAG per construct, which was significantly 
less than the shear bioreactor of 1.2 ± 0.2 mg of GAG per construct (p < 0.05).  Total 
collagen production per construct before implantation showed significantly more total 
collagen between the mechanically active bioreactors and the static bioreactor, where the 
perfusion+shear bioreactor produced 0.47 ± 0.03 mg/construct, the shear bioreactor 
0.50 ± 0.04 mg/construct, and the static bioreactor 0.17 ± 0.08 mg/construct (p < 0.05) 
(Figure 4.18C).   
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Figure 4.18.  Cell number and matrix deposition in the perfusion+shear bioreactor, shear 
bioreactor, and static bioreactor prior to implantation.  Data are presented as mean ± SEM 
(n = 5 constructs).  (A) Cells/construct; (B) GAG/construct; (C) total collagen/construct.  
By Day 28 constructs from the perfusion+shear bioreactor had significantly more cells 
and total collagen than the static bioreactor (* p < 0.05) 
 
 
 
 125
The 3 mm in diameter implants were punched out of the 10 mm TECCs harvested 
from the bioreactors.  Assuming an even distribution, the relative concentration of cells, 
GAG, and total collagen for a 3 mm construct implant with a volume of 13.2 mm3 for 
each bioreactor was derived and is summarized in Table 4.4 along with the control 
groups.  The assumption of an even distribution of cells and extracellular matrix was not 
accurate based on histological analysis (see Figure 4.12); however, the derivation allowed 
us to make a relative comparison of the TECCs cultured in the bioreactors to the implants 
in the control groups (Group A, B, and F) 
 
Table 4.4.  Biochemical composition of implants on day of surgery 
 Implant Cells GAG Total collagen 
Group A Xiphoid defect 0 cells 0 mg 0 mg 
Group B PLLA scaffold 0 cells/cm3 0 mg/cm3 0 mg/cm3 
Group C Static bioreactor 0.5 ± 0.1 x10
6 
cells/cm3 
0.03 ± 0.02 
mg/cm3 
0.015 ± 0.007 
mg/cm3 
Group D Perfusion+shear bioreactor 
1.0 ± 0.1 x106 
cells/cm3 
0.07 ± 0.01 
mg/cm3 
0.042 ± 0.003 
mg/cm3 
Group E Shear bioreactor 0.7 ± 0.1 x10
6 
cells/cm3 
0.11 ± 0.02 
mg/cm3 
0.045 ± 0.003 
mg/cm3 
Group F Cells 5x106 cells 0 mg 0 mg 
 
 
 
All of the animals survived the surgery and post-surgical stage.  No complications 
were observed post-implantation and through the course of the experimental run.  After 
28 days post-implantation, the xiphoids and TECCs were excised and imaged.  Samples 
were stained for cells, GAG, collagen type II, and collagen type I.  Figures 4.19 - 4.23 
show the cross-section of the implant surrounded by the xiphoid.   
Except for the empty defect model, all implants supported cell growth and 
extracellular matrix deposition.  Compared to the other five groups, the empty defect had 
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the least amount of healing in terms of cellular and extracellular matrix deposition into 
the defect region.  Even when no cells were present in the implant (Group B: PLLA 
scaffold), cells and extracellular matrix deposition occurred after 28 days in vivo.  
Compared to Figure 4.12 of TECCs prior to implantation, after 28 days in vivo Groups D 
and E (shear bioreactor and perfusion+shear bioreactor, respectively) showed increase 
amounts of cells and extracellular matrix deposition in the implant.  In Figure 4.21, which 
stained for GAG (red stain), only the shear bioreactor, perfusion+shear bioreactor, and 
cells group showed any retention of GAG.  The static bioreactor showed no presence of 
GAG.  This observation indicated increased maturation occurred after implantation for 
TECCs cultured in mechanically active bioreactors, i.e. the shear and perfusion+shear 
bioreactor.  There was no discernable difference between the two mechanically active 
bioreactors in cellular and extracellular matrix deposition.  The greatest intensity of GAG 
occurred in the cells only control group.  This group also had significantly higher 
amounts of cells when implanted compared to any of the other groups, which may have 
increased the maturation of the cartilage implants.  However, seen in Figure 4.19F, at 4x 
magnification, the structural integrity of the xiphoid was compromised in the cells only 
group; whereas, with the implant, the shape of the xiphoid remained more linear 
compared to the cells only group (Figure 4.19).  Finally, all implants stained for both 
collagen type II (Figure 4.22) and collagen type I (Figure 4.23) (brown stain).  Type I 
collagen was mainly located around the edges of the implants or at the interface between 
the implants and xiphoids.  This indicated that the implants maintained cartilage 
phenotype, but that fibroblast-like tissue (scar tissue) was also present, indicative of 
healing mechanisms.      
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Figure 4.19.  Cellular histological analysis at 4x magnification of implants in a xiphoid 
chondral defect model.  (A) Xiphoid defect; (B) PLLA scaffold; (C) static bioreactor; (D) 
perfusion+shear bioreactor; (E) shear bioreactor; (F) cells.  Arrows indicate either 
implant (dashed arrows) or native xiphoid cartilage (solid arrows).  Open unstained areas 
indicated presence of polymer.  The cross-sectional area of the implant and surrounding 
cartilage at 4x was larger than the field of view.  As such, two images across the 
thickness of the implant were imaged and cropped together to give one image 
representative of the cross-sectional area. 
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Figure 4.20.  Cellular histological analysis at 10x magnification of implants in a xiphoid 
chondral defect model.  (A) Xiphoid defect; (B) PLLA scaffold; (C) static bioreactor; (D) 
perfusion+shear bioreactor; (E) shear bioreactor; (F) cells.  Arrows indicate either 
implant (dashed arrows) or native xiphoid cartilage (solid arrows).  Open unstained areas 
indicated presence of polymer. 
 
 
 
Figure 4.21.  GAG (red stain) histological analysis at 10x magnification of implants in a 
xiphoid chondral defect model.  (A) Xiphoid defect; (B) PLLA scaffold; (C) static 
bioreactor; (D) perfusion+shear bioreactor; (E) shear bioreactor; (F) cells.  Arrows 
indicate either implant (dashed arrows) or native xiphoid cartilage (solid arrows).  GAG 
in the implant region is circled for Group D and E.  Open unstained areas indicated 
presence of polymer. 
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Figure 4.22.  Collagen type II (brown stain) histological analysis at 10x magnification of 
implants in a xiphoid chondral defect model.  (A) Xiphoid defect; (B) PLLA scaffold; (C) 
static bioreactor; (D) perfusion+shear bioreactor; (E) shear bioreactor; (F) cells.  Arrows 
indicate either implant (dashed arrows) or native xiphoid cartilage (solid arrows).  Open 
unstained areas indicated presence of polymer. 
 
 
 
Figure 4.23.  Collagen type I (brown stain) histological analysis at 10x magnification of 
implants in a xiphoid chondral defect model.  (A) Xiphoid defect; (B) PLLA scaffold; (C) 
static bioreactor; (D) perfusion+shear bioreactor; (E) shear bioreactor; (F) cells.  Arrows 
indicate either implant (dashed arrows) or native xiphoid cartilage (solid arrows).  Open 
unstained areas indicated presence of polymer. 
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4.5 Cryopreservation of Tissue-Engineered Cartilage Constructs 
 There was considerable variability from experiment to experiment.  For this 
reason, multiple experimental trials on the same cryopreservation study were normalized 
to a control within the trial and then grouped and average together to determine the 
overall result.  Values for each experiment are provided in Appendix B.  This was due to 
the inconsistency in achieving successful vitrification during each experimental trial.  
Further discussion on unsuccessful vitrification is discussed in Chapter 5.  Successful 
vitrification was achieved when the drop in temperature from 4°C to –100°C occurred at 
a rapid rate of approximately -40°C per minute.  However, some trials showed that the 
temperature drop instead occurred at a rate of approximately -10°C per minute, which 
resulted in visible ice formation.  A comparison between successful and unsuccessful 
vitrification showed that the trend between the cryopreservation methods studied 
remained the same.  The differences lie in the relative cell viability levels.  For example, 
in Table 4.5 the cryopreservation method studied was between VS70 in 6/7 steps and 
VS70 in 4/4 steps.  In the fourth trial, successful vitrification occurred when the 
temperature dropped from 4°C to -100°C occurred at -38.5 °C/min minutes and resulted 
in approximately 47% relative cell viability levels for both VS70 in 6/7 steps and VS70 
in 4/4 steps.  In the third trial, unsuccessful vitrification occurred when the temperature 
dropped from 4°C to -100°C occurred at -7.3 °C/min minutes and resulted in 
approximately 9% relative cell viability levels for both VS70 in 6/7 steps and VS70 in 
4/4 steps.  Thus, while there was a noticeable difference in cell viability levels between 
successful and unsuccessful vitrification, there was no noticeable difference between 
VS70 in 6/7 steps and VS70 in 4/4 steps. 
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Table 4.5.  Relative cell viability levels after vitrification 
 
Cell Viability Levels Experimental Trial VS70 in 6/7 steps VS70 in 4/4 steps 
Cooling Rate from 
4°C to -100°C 
1 s 39.6 ± 9.7% 42.1 ± 4.2% -47.6 °C/min 
2 u 11.5 ± 2.2% 20.8 ± 5.4% -5.4 °C/min 
3 u 10.8 ± 1.4% 7.3 ± 1.3% -7.3 °C/min 
4 s 44.5 ± 6.0% 50.0 ± 2.5% -38.5 °C/min 
Data are presented as mean ± SEM (n = 4 constructs).  
s: successful vitrification; u: unsuccessful vitrification 
 
 
 
4.5.1 Cryopreservation of Native Cartilage 
Native articular cartilage was harvested from bovine calves and punched into 
10 mm diameter plugs.  Cell viability levels were normalized to VS55 in 6/7 steps.  For 
the one trial, native cartilage treated with VS70 in 6/7 steps retained a 2.8 ± 0.1 -fold 
increase in cell viability levels over VS55 in 6/7 steps (see Figure 4.24) (p = 0.0005). 
 
 
Figure 4.24.  Cell viability levels for native cartilage treated with VS55 in 6/7 steps and 
VS70 in 6/7 steps.  VS70 retained a 2.8 ± 0.1-fold increase in cell viability levels over 
VS55 in 6/7 steps (p = 0.0005 vs. VS55 in 6/7 steps) (n = 4 cartilage plugs).  This was an 
unsuccessful vitrification experiment; therefore, the highest cell viability levels were 
8.1 ± 0.5% for VS55 in 6/7 steps and 22.0 ± 1.2% for VS70 in 6/7 steps. 
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Confocal images, seen in Figure 4.25, showed the distribution of live and dead 
cells throughout the thickness of cartilage.  Because this experimental trial was an 
example of unsuccessful vitrification, most cells did not survive this cryopreservation 
experiment.  However, cell that did survive were visible along the surface of the native 
cartilage (located along the right-hand side of the images).   
 
 
 
   
Figure 4.25.  Confocal images of live and dead cells throughout the thickness of 
cryopreserved native cartilage.  Live cells (green) were located along the surface (right-
hand side) of the cartilage, while dead cells and fragments (red) were found in the 
interior.  For these sample images, VS70 in 6/7 steps retained more live cells (23.5%) 
than VS55 in 6/7 steps (8.1%). 
   
 
4.5.2 Traditional Freezing versus Vitrification on the Effect of Cell Viability     
TECCs used in this study were cultured for 7 days in the PCC bioreactor and 
contained 1.2 ± 0.1 million cells per construct.  Traditionally frozen samples actually 
fared better in maintaining cell viability levels at 32.8 ± 5.9%, while vitrified samples 
treated with VS55 in 6/7 steps maintained only 18.7 ± 2.9% cell viability levels 
VS55 in 6/7 steps VS70 in 6/7 steps 
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(p = 0.08).  Seen in Figure 4.26, traditionally frozen samples normalized to VS55 in 6/7 
steps had a 1.8 ± 0.3 -fold increase over VS55 in 6/7 steps.  
 
 
Figure 4.26.  Cell viability levels for TECCs treated with VS55 in 6/7 steps and 1 M 
DMSO.  Frozen samples retained a 1.8 ± 0.3 -fold increase in cell viability levels over 
vitrified samples treated with VS55 in 6/7 steps (p = 0.08 vs. VS55 in 6/7 steps) (n = 4 
constructs for VS55 in 6/7 steps and n = 5 constructs for traditionally frozen constructs).  
This was a successful vitrification experiment; therefore, the highest cell viability levels 
were 32.8 ± 5.9% for frozen samples and 18.7 ± 2.9% for VS55 in 6/7 steps. 
 
 
Confocal images, seen in Figure 4.27, showed the distribution of live and dead 
cell over the surface of TECCs.  Though this experimental trial was an example of 
successful vitrification, most cells did not survive this cryopreservation experiment.  
However, cells that did survive were visible and distributed over the surface of the 
TECCs. 
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Figure 4.27.  Confocal images of live and dead cells over the surface (not over the cross-
section) of cryopreserved TECCs.  Live cells (green) and dead cells and fragments (red) 
were distributed over the surface of the TECCs. 
 
 
 
4.5.3 Cytotoxicity of Vitrification Solution 
 Seen in Figure 4.28, non-vitrified samples treated with VS70 in 6/7 steps 
normalized to VS55 in 6/7 steps had a 36.0 ± 11.3% decrease in cell viability levels 
compared to VS55 in 6/7 steps (p = 0.05).  The highest cell viability levels reached for 
non-vitrified samples were 58.8 ± 4.8% for TECCs treated with VS55 in 6/7 steps and 
29.4 ± 3.7% for TECCs treated with VS70 in 6/7 steps (p = 0.003).  
 
VS55 in 6/7 steps Frozen 
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Figure 4.28.  VS55 in 6/7 steps compared to VS70 in 6/7 steps without cryopreservation.  
VS70 in 6/7 steps maintained 36.0 ± 11.3% less viable cells than VS55 in 6/7 steps 
(p = 0.05 vs. VS55 in 6/7 steps) (N = 4 experimental trials).  The highest cell viability 
levels reached were 58.8 ± 4.8% for VS55 in 6/7 steps and 29.4 ± 3.7% for VS70 in 6/7 
steps. 
 
 
The confocal images presented showed no noticeable difference in cells viability 
even though VS55 in 6/7 steps maintained more viable cells than VS70 in 6/7 steps.  
Figure 4.29 shows the cell distribution and viability throughout the thickness of the 
TECCs.  Live cells were noticeably visible along the surface of the constructs. 
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Figure 4.29.  Confocal images of live and dead cells throughout the thickness of non-
vitrified TECCs.  The surface (right-hand side) showed a concentration of densely packed 
cells.  Live cells (green) were located throughout the thickness of the cartilage, while 
dead cells and fragments (red) were sparsely distributed.  For these sample images of 
TECCs containing 6.0 ± 0.4 million cells per construct, VS55 in 6/7 steps retained more 
live cells (40.1%) than VS70 in 6/7 steps (26.2%).  The viability levels of the entire 
construct were measured quantitatively via the alamarBlue assay, while the confocal 
images was a single-plane image at the center of the construct. 
 
 
4.5.4 Effect of Cryopreservation Formulations on Cell Viability Levels 
 Seen in Figure 4.30, VS70 in 6/7 steps normalized to VS55 in 6/7 steps 
maintained a 2.2 ± 0.4 -fold increase in cell viability levels over VS55 in 6/7 steps after 
cryopreserved (p = 0.08).  The highest cell viability levels reached for vitrified TECCs 
with 1.0 ± 0.2 million cells per construct for VS55 in 6/7 steps was 20.9 ± 2.7%, while 
VS70 in 6/7 steps maintained 39.7 ± 9.7% relative cell viability levels (p = 0.15). 
   
VS55 in 6/7 steps VS70 in 6/7 steps 
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Figure 4.30.  VS55 in 6/7 steps compared to VS70 in 6/7 steps.  VS70 in 6/7 steps 
maintained twice as many viable cells than VS55 in 6/7 steps (p = 0.08 vs. VS55 in 
6/7 steps) (N = 3 experimental trials).  TECCs were cultured 6 or 7 days before 
cryopreserved.  The highest cell viability levels reached were 20.9 ± 2.7% for VS55 in 
6/7 steps and 39.7 ± 9.7% for VS70 in 6/7 steps (p = 0.15). 
 
 
 
The TECCs cultured for 14 days contained 8.3 ± 1.2 million cells per construct.  
The TECCs treated with VS70 in 6/7 steps normalized to VS55 in 6/7 steps had a 
2.6 ± 0.3 -fold increase in viable cells over VS55 in 6/7 steps (Figure 4.31A) (p = 0.01).  
In Figure 4.31B, TECCs cultured to 28 days (6.4 ± 0.7 million cells per construct) also 
showed a difference between VS70 in 6/7 steps to VS55 in 6/7 steps, where VS70 in 
6/7 steps maintained a 2.2 ± 0.4 -fold increase in viable cells over VS55 in 6/7 steps after 
cryopreserved (p = 0.04).  Each of these experimental trials was conducted once and was 
an example of unsuccessful vitrification.  This resulted in low cell viability levels overall.  
However, given the similar trend between successful and unsuccessful vitrification (see 
Table 4.5), VS70 in 6/7 steps would likely still maintain significantly greater cell 
viability levels over VS55 in 6/7 steps during successful vitrification.  
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Figure 4.31.  VS55 in 6/7 steps compared to VS70 in 6/7 steps for Day 14 and Day 28 
TECCs.  VS70 in 6/7 steps maintained twice as many viable cells than VS55 in 6/7 steps 
(p < 0.05 vs. VS55 in 6/7 steps) (n = 4 constructs).  TECCs cultured for 14 days before 
cryopreserved maintained 10.9 ± 1.6% viability when treated with VS55 in 6/7 steps, 
while VS70 in 6/7 steps maintained 28.6 ± 1.6% viability.  TECCs cultured for 28 days 
before cryopreserved maintained 9.8 ± 2.7% viability when treated with VS55 in 6/7 
steps, while VS70 in 6/7 steps maintained 21.7 ± 3.5% viability. 
 
 
 
Seen in Figure 4.32, VS83 in 6/7 steps normalized to VS55 in 6/7 steps 
maintained 64.7 ± 1.5% less viable cells over VS55 in 6/7 steps (p = 0.08).  The TECCs 
cultured for 6 days in the PCC bioreactor had 0.7 ± 0.3 million cells per construct when 
vitrified.  This experimental trial was an example of successful vitrification, and thus, cell 
viability levels for vitrified TECCs treated with VS55 in 6/7 steps was 18.5 ± 3.7%, while 
VS83 in 6/7 steps maintained only 6.5 ± 0.3%. 
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Figure 4.32.  VS55 in 6/7 steps compared to VS83 in 6/7 steps.  VS83 in 6/7 steps 
maintained less than half as many viable cells than VS55 in 6/7 steps (p = 0.08 vs. VS55 
in 6/7 steps) (n = 3 constructs).  This was a successful vitrification experiment; therefore, 
the highest cell viability levels were 18.5 ± 3.7% for VS55 in 6/7 steps and 6.5 ± 0.3% 
for VS83 in 6/7 steps. 
 
 
 
Confocal images showed that after vitrification most of the cells died in the 
interior of the constructs.  Seen in Figure 4.33, most cells within the TECCs treated with 
VS83 in 6/7 steps were dead, while those treated with VS55 in 6/7 steps or VS70 in 6/7 
steps showed that cells along the surface of the constructs remained viable after 
vitrification.  Though overall, vitrification in all three solutions resulted in low cell 
viability with the maximum viability levels at 39.6 ± 9.7% with VS70 in 6/7 steps. 
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Figure 4.33.  Live and dead staining across the thickness of the constructs for 
cryopreserved TECCs treated with VS55 in 6/7 steps, VS70 in 6/7 steps, or VS83 in 6/7 
steps.  Live cells fluoresced green and dead cells or fragments fluoresced red. For these 
sample images, the surface of the constructs (right-hand side) showed presence of live 
cells for VS55 (20.8% viable) and VS70 (30.4% viable), while the interior and VS83 
(6.2% viable) showed mostly dead cells and fragments. 
 
 
4.5.5 Reduction of Steps in Introduction/Elution of CPAs 
Compared to VS55 and VS83, VS70 maintained the highest cell viability levels of 
approximately 40%.  Thus, the next study focused on the number of steps the CPAs in 
VS70 were introduced and eluted, which was changed to reduce exposure time and 
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simplify the cryopreservation process.  The six discrete steps of introduction of CPAs that 
gradually increased to the full-strength mixture were reduced to four discrete steps.  
Similarly, the seven steps of elution of CPAs that gradually reduced the strength of the 
CPAs were reduced to four steps.  Total time to introduce the TECCs to 6 or 7 steps took 
90 or 105 minutes, respectively, whereas 4 steps took 60 minutes.  Seen in Figure 4.34, 
VS70 in 4/4 steps normalized to VS70 in 6/7 steps maintained only a 1.2 ± 0.2 -fold 
increase in cell viability levels over VS70 in 6/7 steps after cryopreserved (p = 0.53).  
The highest cell viability levels reached for vitrified TECCs with 2.6 ± 0.2 million cells 
per construct for VS70 in 4/4 steps was 50.0 ± 2.5%, while VS70 in 6/7 steps maintained 
an equivalent of 44.5 ± 6.0% relative cell viability levels. 
 
 
Figure 4.34.  VS70 in 6/7 steps compared to VS70 in 4/4 steps.  VS70 in 4/4 steps 
maintained equivalent amounts of viable cells compared to VS70 in 6/7 steps (p = 0.53) 
(N = 4 experimental trials). The highest cell viability levels reached were 44.5 ± 6.0% for 
VS70 in 6/7 steps and 50.0 ± 2.5% for VS70 in 4/4 steps. 
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Confocal images across the thickness of the constructs showed the distribution of 
live and dead cells, with dead cells found mainly in the interior of the constructs after 
vitrification.  Seen in Figure 4.35, most cells within the TECCs in VS70 in 6/7 steps 
treated constructs were dead.  However, along the surface of the constructs live cells were 
prevalent.  Similar behavior was noticed after vitrification of TECCs treated with VS70 
in 4/4 steps. 
 
 
  
Figure 4.35.  Live and dead staining across the thickness of the constructs for 
cryopreserved TECCs treated with VS70 in 6/7 steps or VS70 in 4/4 steps.  The surface 
(right-hand side) showed prevalence of live (green) cells.  Dead cells or fragments (red) 
were also detected throughout the thickness of the constructs.  For these sample images, 
VS70 in 6/7 steps maintained 30.4% viable cells and VS70 in 4/4 steps maintained 51.7% 
viable cells for constructs with 2.6 ± 0.2 million cells per construct. 
 
 
4.5.6 Introduction of CPAs via the PCC Bioreactor 
 Before utilizing the PCC bioreactor to pump the vitrification solution, the shear 
stress exerted on the TECCs was determined according to Equation 3.3 described in 
Chapter 3: 
VS70 in 6/7 steps VS70 in 4/4 steps 
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d
Vm
w
 8             Equation 3.3 
 
The vitrification solution pumped into the PCC bioreactor at a rate of 10 mL/min.  This 
correlated to a rate of 1.25 mL/min/construct for 8 constructs embedded in the bottom 
row of the PCC bioreactor or 0.07 cm/s/construct.  At 4°C the viscosity of VS55 was 
measured at 2.55 ± 0.01 cP and the viscosity of VS70 was 2.31 ± 0.00 cP (p < 0.05).  
Thus, the shear stress at the wall exerted in the TECCs as the vitrification solution was 
pumped through the constructs was between 0.9 and 1.3 dynes/cm2 for VS55 and 0.8 and 
1.2 dynes/cm2 for VS70.  However, this calculation assumed that the pore density size 
remained the same, between 106 and 150 m.  In actuality, the pore size most likely 
decreased as cellular and extracellular matrix deposition increased over the course of 7 
days in bioreactor culture.   
From the previous studies, VS70 was chosen over VS55 to pump into the PCC 
bioreactor due to higher cell viability results.  In addition, because VS70 in 4/4 steps was 
not detrimental to cell viability compared to VS70 in 6/7 steps, VS70 in 4/4 steps was 
modified to pump into the PCC bioreactor (see Section 3.8 for set-up).  Seen in Figure 
4.36, VS70 in 4/4 steps using the PCC bioreactor normalized to VS70 in 4/4 steps using 
the orbital shaker maintained only 1.0 ± 0.1 -fold increase in cell viability levels over 
VS70 with the orbital shaker after cryopreserved (p = 0.97).  The highest cell viability 
levels reached for successfully vitrified TECCs (cultured for seven days) with 
2.6 ± 0.2 million cells per construct for VS70 with the orbital shaker was 56.0 ± 3.3%, 
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while VS70 in the PCC bioreactor maintained an equivalent amount at 47.8 ± 5.6% 
(p = 0.23). 
. 
 
Figure 4.36.  VS70 in 4/4 steps using the PCC bioreactor method compared to the orbital 
shaker method.  The PCC bioreactor method maintained equivalent amounts of viable 
cells compared to the orbital shaker method (N = 3 experimental trials).  The highest cell 
viability levels reached were 56.0 ± 3.3% for VS70 in 4/4 steps and 47.8 ± 5.6% for 
VS70 in the PCC bioreactor. 
 
 
 
Confocal images of vitrified TECCs treated with either the orbital shaker method 
or the PCC bioreactor method showed a distribution of live and dead cells throughout the 
thickness of the constructs.  Seen in Figure 4.37, TECCs treated with the orbital shaker or 
with the PCC bioreactor had live cells primarily on the surface of the construct.  
However, live cells were also visible in the interior of the constructs, but no discernable 
difference was seen between the two treatments. 
 
 
 
 145
 
  
Figure 4.37.  Live and dead staining across the thickness of the constructs for 
cryopreserved TECCs treated with VS70 in 4/4 steps using the orbital shaker or the PCC 
bioreactor.  The surface (right-hand side) showed prevalence of live (green) cells.  Live 
cells were also found in the interior of the constructs.  Dead cells and fragments 
fluoresced red.  For these sample images, the orbital shaker method maintained 50.1% 
viable cells and the PCC bioreactor method maintained 44.1% viable cells for constructs 
with 2.6 ± 0.2 million cells per construct. 
 
 
4.6 Summary of Cell Viability after Cryopreservation 
 The separate cryopreservation studies taken together showed that overall VS70 
was the best vitrification formulation compared to VS55 and VS83.  VS70 maintained 
almost twice as many viable cells over the standard VS55, while VS83 maintained less 
than half as many viable cells than VS55.  VS70 was introduced and eluted in 6 and 7 
steps, respectively.  By reducing the number of steps to 4 for introduction and 4 for 
elution, the cell viability levels remained unchanged from the baseline of VS70 in 6/7 
steps.  Thus, the reduction of steps had no effect on cell viability while simplifying the 
vitrification process.  Finally, by introducing and eluting VS70 through the TECCs using 
the PCC bioreactor, the cell viability levels remained unchanged from the baseline of 
VS70 in 4/4 steps using the orbital shaker.  The highest cell viability levels reached after 
Orbital Shaker PCC Bioreactor 
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vitrification of the TECCs was approximately 50% when treated with VS70 in 6/7 steps, 
in 4/4 steps, and in the PCC bioreactor.  Table 4.6 summarizes the highest cell viability 
levels reached for each successful vitrification study. 
 
Table 4.6.  Highest cell viability levels reached in each cryopreservation study 
Cryopreservation Study Cell Viability Levels (%) 
Traditional vs. VS55 6/7 32.8 ± 5.9  vs.  18.7 ± 2.9 
VS55 6/7 vs. VS83 6/7 18.5 ± 3.7  vs.  6.5 ± 0.3 
VS55 6/7 vs. VS70 6/7 20.9 ± 2.7  vs.  39.7 ± 9.7 
VS55 6/7 vs. VS70 6/7 no 
vitrification 58.8 ± 4.8  vs.  29.4 ± 3.7 
VS70 6/7 vs. VS70 4/4 44.5 ± 6.0  vs.  50.0 ± 2.5 
VS70 4/4: Orbital Shaker vs. 
PCC Bioreactor 56.0 ± 3.3  vs.  47.8 ± 5.6 
    Data are presented as mean ± SEM for n constructs 
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CHAPTER 5 
DISCUSSION 
 
 These results show for the first time the importance of fluid-induced shear in the 
production of tissue-engineered cartilage constructs in a bioreactor environment.  We 
used two model systems for this study: the concentric cylinder bioreactor, which exposed 
the TECCs to surface shear, and the perfusion concentric cylinder bioreactor, which 
exposed the TECCs to orthogonal shear forces in addition to surface shear via the 
addition of perfusion.  We found that the proliferation and distribution of cells within the 
construct and the quality of their extracellular matrix were impacted by the direction of 
shear and the magnitude of shear that they experienced.  We also showed that the PCC 
bioreactor could be used to introduce and elute cryoprotectant agents, but the variability 
inherent in the system precluded identification of an optimal cryopreservation protocol.  
These experiments are discussed below. 
 
5.1 Effects of Mechanical Stimulation on TECC Development 
The premise that mechanical forces that modulates chondrocytes’ behavior in vivo 
will also influence their behavior in vitro (Saini and Wick 2003; Sharma and Elisseeff 
2004) has led to a number of studies that showed that cell-seeded scaffolds are influenced 
by their environment, stimulating chondrogenesis and matrix synthesis (Freed, Vunjak-
Novakovic et al. 1993; Vunjak-Novakovic, Freed et al. 1996; Davisson, Kunig et al. 
2002; Darling and Athanasiou 2003; Saini and Wick 2003; Xu, Urban et al. 2006).  
Culture of tissue-engineered cartilage under high shear stresses (turbulent flow) in 
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bioreactors created elongated cells and collagen fibrils in regions exposed to shear and 
increased cell content, GAG, and collagen by 70%, 60%, and 125%, respectively, when 
compared to static cultures (Vunjak-Novakovic, Freed et al. 1996).  Davisson et al. 
seeded ovine chondrocytes under perfusion at 0.05 mL/min and then perfused with 
culture media at 0.8 mL/min.  After nine days GAG content increased by 40% along with 
cell content compared to static cultures (Davisson, Sah et al. 2002).  Some of the reasons 
speculated as to why mechanically active bioreactors enhance growth compared to static 
cultures are that they increase nutrient and oxygen transfer due to increased mixing 
patterns, that they distribute cells more uniformly due to the design of the bioreactors, 
and that they stimulate chondrogenesis due to hydrodynamic forces with specified 
magnitude and type (Freed, Hollander et al. 1998; Lee, Grad et al. 2005).  These studies 
led to the motivation for the development of the PCC bioreactor, in which multi-
directional forces were hypothesized to influence cartilage growth.   
 
5.2 Perfusion Concentric Cylinder Bioreactor for the Production of Tissue-
Engineered Cartilage: Effect of Perfusion Coupled with Shear on Construct 
Development  
The PCC bioreactor was designed to incorporate convective flow of fluid through 
the cell-seeded scaffolds while fluid also flowed over the surface of the scaffolds.  This 
bioreactor system was used to understand how mechanical forces enhance the growth and 
structure of tissue-engineered cartilage grown over the course of 28 days.  The inner bob 
of the PCC bioreactor was designed to closely imitate the inner bob of the CC bioreactor, 
however significant changes had to be made for perfusion through the scaffolds to occur. 
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Many of the operating parameters for the PCC bioreactor were based on the 
studies carried out in the CC bioreactor, which determined that 38 rpm and 90% porous 
PLLA were optimum culturing conditions.  Saini determined that at 38 rpm, as opposed 
to 76 rpm, maximum cell growth and significantly more GAG was deposited per 
construct.  In addition, maximum collagen deposition occurred at 38 and 76 rpm 
compared to static and 19 rpm (Saini 2001).  At this rotation, constructs in the CC 
bioreactor experienced a surface shear stress of 1.2 dynes/cm2.  These observations led to 
the final selection of 38 rpm for the rotation speed of the outer cup in the PCC bioreactor.  
In addition, 90% porous PLLA was chosen over PGA (poly glycolic acid) due to higher 
cell number and GAG deposition per construct (Saini 2001).  The perfusion flow rate of 
0.6 mL/min/construct, which started at Day 4 of culture, was chosen by Rangamani, the 
original inventor of the PCC bioreactor.  The addition of perfusion prior to Day 4 may 
have been detrimental to cell viability, and thus was eliminated during the seeding period 
(Rangamani 2005). 
The PCC inner bob did not conform to the shape of a cylindrical bob due to the 
extruding construct arms.  However, at 38 rpm the Reynolds number indicated laminar 
flow, and thus discrete steady path lines from the rotating outer cup to at least the edge of 
the construct arms.  By assuming that flow was not angularly dependent, the velocity 
exerted on the top of the open cavity could be calculated with the simplified model of two 
concentric cylinders, in which the inner central hub minus the construct arms represented 
the inner radius.  The open cavity model for CFD calculations that was used to calculate 
the shear stress profile over the construct indicated that along the surface, the center of 
the construct experienced a relatively uniform shear stress between 0.1 and 0.5 dynes/cm2 
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and an average stress of 3 dynes/cm2 near one edge (Figure 4.1B).  This result was 
markedly different from the homogeneous shear stress (1.2 dynes/cm2) exerted on the 
constructs in the CC bioreactor (Williams, Saini et al. 2002).  Had the constructs not been 
embedded into the arms, but aligned to the edge of the arms (i.e. no open cavities), the 
shear stress experienced on the surface of the construct would have been nearly 
homogeneous.  The shear stress, based on Newton’s law of viscosity, and derived from 
Navier-Stokes equations for the annulus region between two concentric cylinders (Saini 
2001), would have been 0.99 dynes/cm2.  This open cavity design indicated a limitation 
in the PCC bioreactor, where the constructs overall experienced multi-directional flow 
and heterogeneous surface shear stress; however, it is important to note that the first aim 
of this project focused on the comparison of the different types of bioreactors and not 
mechanical forces.   
The CFD model for flow over the constructs in the open cavity was done as a 
two-dimensional cavity over the diameter of the construct.  Recirculation was evident and 
a homogeneous flow and shear stress did not occur for the PCC bioreactor except at the 
center of the construct at 0.4 dyne/cm2.  Other sections on the surface of the construct 
were not evaluated, but CFD modeling would have shown recirculation as well.  The 
shear stress profile could be further evaluated in future studies over the entire surface of 
the construct as discrete cavities of varying lengths.   
The fluid perfusion orthogonal to the surface shear exerted a shear stress between 
0.13 and 0.18 dynes/cm2 on cells in the construct.  Fluid perfusion may also have 
occurred in the CC bioreactor, especially early in culture when the relatively large pores 
(106 – 150 m in diameter) were not filled with cells and extracellular matrix, such that 
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shear stress was exerted in the pores of the scaffolds.  The affixed scaffolds are banked 
along the surface of the inner bob.  Thus, fluid could permeate through the side of the 
porous scaffolds at 38 rpm (10.44 cm/s).  At this speed the shear stress, calculated from 
Equation 3.3, through the porous scaffolds was between 39 and 55 dynes/cm2.  Though 
this is a high shear stress value, fluid also has a tendency to flow in the path of least 
resistance, and flowing around the scaffolds is less work than flowing through the 
scaffolds.  Thus, while some fluid perfusion may have occurred through the side of the 
scaffolds in the CC bioreactor, the shear stress exerted via perfusion may have been less 
than the shear stress that occurred on the surface of the scaffolds.  Fluid perfusion itself 
was not a different mechanical force than from shear stress, but rather, the PCC 
bioreactor exerted shear stresses of different magnitudes on the constructs in directions 
orthogonal to each other.  So while this research refers to perfusion and shear as separate 
mechanical forces, in reality, both forces employed shear stress.  
In the PCC bioreactor, cells seeded, proliferated, and deposited extracellular 
matrix on PLLA scaffolds.  The choice of PLLA scaffolds was decided because of the 
ease in synthesis and inexpensiveness of the material.  Other scaffolds such as poly-
glycolic acid (PGA), which would have produced more uniform tissue (Saini 2001), 
would not have been an ideal choice because of the poor material properties.  That is, the 
addition of perfusion adds an additional load that would force the PGA scaffolds out of 
the construct arms, while PLLA has the stiffness to withstand perfusion.  Hybrid polymer 
scaffolds, such as poly-lactic-co-glycolic acid (PLGA), may have the stiffness needed 
while producing uniform tissues.  The ideal scaffold for the culture of TECCs would fully 
maximize the potential for the PCC bioreactor.   
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Diffusion flux was eliminated when perfusion occurred (i.e. when convective flux 
dominated), which led to a linear dependence for the transport of oxygen across the 
thickness of the construct (Equation 4.4).  When this assumption was not made, the 
oxygen concentration profile from the species continuity equation followed an 
exponential and linear profile (see Appendix A for derivation): 
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However, when plotted, the oxygen profile showed that the linear dependence of oxygen 
across the thickness of the construct still dominated and that there was less than a 0.13% 
difference between the profiles plotted from Equation 4.4 (Figure 4.2) and Equation 5.1. 
To rely on diffusion alone, the oxygen concentration within the constructs would 
have reached zero by Day 28.  Thus, perfusion dramatically increased oxygen transport 
within the constructs.  This result had the potential to improve cell growth within the 
center of the constructs by preventing oxygen depletion.  Cells propagated towards the 
interior of the constructs from the surface shear face because cells were initially seeded 
under shear forces only, without the aid of perfusion.  This observation was made evident 
in the histological images.  Over time, however, cells and extracellular matrix did deposit 
on the perfusion face of the constructs.  Though histological images showed lack of cells 
within the central-interior of the constructs, this could be explained by the low initial 
seeding of the scaffolds and thus, low overall cell number in the constructs.  Higher cell 
density would further penetrate the constructs and the nutrient transport calculations have 
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shown that the cell growth would not have been limited by oxygen availability for 
constructs cultured in the PCC bioreactor.  
The initial low seeding of the constructs was due to the low cell density in media 
prior to seeding.  150 million cells were suspended in 350 mL of media 
(0.4 million cells/mL) for the PCC bioreactor.  In comparison, the CC bioreactor had a 
cell density of 2.4 million cells/mL prior to seeding.  The high volume requirements in 
the PCC bioreactor (400 mL) compared to the CC bioreactor (62 mL) also were a factor 
in the low seeding efficiency.  The geometric design of the PCC bioreactor left regions of 
“dead space” near the central hub and between the construct arms.  These empty regions 
never came into contact with scaffolds; and thus, cells located in those regions aggregated 
together lowering the overall seeding efficiency of the PCC bioreactor.  Cells also 
permeated through the scaffolds without attaching to the matrix and settled at the bottom 
of the central hub.  Though the cells did not attach to the bottom surface because of the 
silicone coating, after 28 days a thin biofilm layer of cartilage was found inside the 
central hub.  This tissue-engineered cartilage (without a scaffold matrix) adopted the 
central hub’s dimensions (5.08 cm diameter) to form a thin circular piece of cartilage.  
The lack of disturbance in the central hub made the environment ideal for growth of 
tissue-engineered cartilage and lowered the overall seeding efficiency of the PCC 
bioreactor.  Another reason for the low seeding efficiency was that the scaffolds were 
embedded inside the arms, whereas, in the CC bioreactor the scaffolds were not.  The 
decreased surface area of the scaffolds in the PCC bioreactor provided less cell-
attachment sites, lowering overall seeding efficiency. 
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The low seeding efficiency of the PCC bioreactor was determined by cell content 
from Day 4 samples.  However, chondrocytes remained viable, proliferated, and 
synthesized GAG and collagen in the PLLA scaffolds over the course of 28 days, which 
demonstrated that the bioreactor was conducive to cartilage growth.  No statistics could 
be performed between the constructs harvested from the top row and bottom row because 
three constructs were harvested at each time point (two from one row and one from the 
other).  Yet, the general observation in construct composition showed no noticeable 
difference between those harvested from the top or bottom row, which indicated that 
variance between the perfusion flow rate (69%) between the top and bottom row of the 
PCC bioreactor had little effect on cartilage composition.  In fact, the variances were 
similar between constructs harvested from the PCC bioreactor and from the CC 
bioreactor.  This observation led more credibility to use the average flow rate of 
0.6 mL/min/construct to calculate the shear stress  (0.13 - 0.18 dynes/cm2) through the 
construct regardless of its position. 
While the PCC bioreactor was conducive to cartilage growth, the bioreactor was 
compared to the previously characterized CC bioreactor to gauge its effectiveness.  
Constructs from the CC bioreactor had about twice as much ECM than the PCC 
bioreactor, yet did not proliferate as fast as the PCC bioreactor (Figure 4.7).  The multi-
directional stresses in the PCC bioreactor may have affected the proliferation rate as 
opposed to the CC bioreactor, which experienced only surface shear stress.  Initial cell 
density is also an important variable in tissue-engineered cartilage production and can 
influence cellular proliferation, phenotypic stability, structure, and matrix deposition.  
Cell seeding studies showed that scaffolds seeded at high densities 
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(e.g. 30 - 40 x106 cells/cm3) maintained their differentiated phenotype and secreted more 
ECM, while those at low densities produced less ECM (Bruckner, Horler et al. 1989; 
Vunjak-Novakovic, Obradovic et al. 1998; Mauck, Wang et al. 2003; Saini and Wick 
2003).  In another study by Puelacher et al., constructs seeded with less than 
20x106 cells/cm3 created more fibrous and inferior cartilage (Puelacher, Kim et al. 1994).  
Mandl et al. showed that seeding at low cell density increased the proliferation rate due to 
lack of cell-to-cell contact inhibition (Mandl, van der Veen et al. 2004).  Therefore, a 
high seeding density would have maintained important cell-to-cell interaction influencing 
proliferation, matrix synthesis, and differentiation (Watt 1988) in the bioreactors.  That 
the constructs from the CC bioreactor produced more ECM could have been due to the 
higher initial cell density, 12 ± 4 million cells/cm3, compared to the PCC bioreactor, at 
5 ± 1 million cells/cm3, which enhanced cell-to-cell contact.  However, the difference 
between the initial cell densities was not significant.  As such, the most likely reason for 
the higher ECM content was because of the higher shear stress in the CC bioreactor.  
That both bioreactors expressed collagen type I was also indicative of possible 
dedifferentiation of some chondrocytes to more fibroblastic structure and attributed to the 
low cell seeding of the scaffolds, in agreement to previous studies (Puelacher, Kim et al. 
1994).  From histological images in Figure 4.9, constructs from the PCC bioreactor 
showed a more even distribution of cells and extracellular matrix than the CC bioreactor.  
This could be attributed to the orthogonal fluid regime in the PCC bioreactor, which 
distributed cells to both sides of the constructs surfaces more than the one-directional CC 
bioreactor fluid regime, which had constructs affixed to a non-permeable inner bob. 
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Derived from Freed et al., the growth curve of tissue-engineered cartilage 
constructs to describe proliferation could be modeled after a polynomial equation that 
accounted for initial cell density,  (cells/construct), the initial cell growth rate, 
 (cells/construct/day), and the decrease in growth rate over time, 
- (cells/construct/day2).  The proliferation of cells, X (cells/construct), in the PCC and 
CC bioreactor was fitted to the quadratic equation as a function of time, t (days) (Freed, 
Vunjak-Novakovic et al. 1993): 
 
2)( tttX                         Equation 5.2 
 
Table 5.1 lists the coefficients and R2 value extrapolated from fitting the experimental 
data to the growth curve for the bioreactors.  The extrapolated negative initial cell density 
coefficient was due to the low seeding density for the PCC bioreactor.  The PCC 
bioreactor had a higher initial growth rate () and a decrease in growth () compared to 
the CC bioreactor.  The growth curve predicted that the PCC bioreactor would culture 
cells to a maximum of 11 million cells per construct by Day 23, while the maximum 
growth occurred in the CC bioreactor at Day 2 with 2.2 million cells per construct.  
However, this was due to the observation cell in the CC bioreactor had not yet entered 
log phase and that in the cells in the PCC bioreactor for this experimental run had entered 
death phase by Day 28.  Repeat of this experimental run, however, showed that the PCC 
bioreactor extended cell growth up to 37 days, while CC bioreactor only reached 
maximum cell growth by Day 23.  These calculations showed that the addition of 
perfusion extended the growth time in the PCC bioreactor over the CC bioreactor.   
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Table 5.1.  Cell growth kinetics as a function of time in the PCC and CC bioreactor 
 
Bioreactor  (cells/construct) 

(cells/construct/day) 
 
(cells/construct/day2) R
2 
PCC -5.19x106 1.40x106 3.00x104 0.910 
CC 2.27x106 -4.71x104 -1.53x104 0.989 
 
 
In terms of ECM growth, new GAG synthesis leveled off by Day 14 for the PCC 
bioreactor and by Day 7 for the CC bioreactor.  Continuous production of GAG could not 
be maintained for prolong periods.  This may have occurred because cells became 
accustomed to the steady shear environment signaling them to a more quiescent state, 
which inhibited GAG synthesis.  The PCC bioreactor, however, appeared to prolong new 
GAG synthesis a week longer than the CC bioreactor.  This observation was seen again 
when the experimental trial was repeated.  That GAG production leveled off or decreased 
as a result of steady mechanical loading over a prolong growth period has been shown in 
literature (Saini and Wick 2003; Seidel, Pei et al. 2004; Gemmiti and Guldberg 2006).  
However, by introducing a new mechanical stimulation after Day 4, it was possible that 
the cells responded to the more dynamic loading environment in the PCC bioreactor, 
which prolonged GAG synthesis.  The CC bioreactor, which had greater shear stress 
values, continued to produce more total collagen than the PCC bioreactor after 28 days, 
which indicated that collagen was dependent on the magnitude of the mechanical loading.  
The primary focus of this experiment was to compare the growth in two different 
bioreactors.  By Day 28, samples in both bioreactors had roughly the same amount of 
cells.  However, by Day 28 the CC bioreactor produced 1.4 ± 0.17 x10-4 g of GAG per 
cell and 0.69 ± 0.08 x10-4 g of total collagen per cell, which was significantly greater 
than the PCC bioreactor, which produced 0.70 ± 0.07 x10-4 g of GAG per cell and 
 158
0.40 ± 0.02 x10-4 g of total collagen per cell, respectively (p < 0.05).  This observation 
indicated that the incorporation of perfusion through the constructs in the PCC bioreactor 
had little role in ECM growth and was most likely governed by the higher surface shear 
forces in the CC bioreactor.  This was more clearly seen in histological images where 
ECM deposition was primarily regulated to the surface shear face in the CC bioreactor 
(Figure 4.9). 
Articular cartilage is an avascular tissue, with low oxygen tension (1 - 3%).  Cells 
have adapted to this low oxygen tension by undergoing glycolysis for their energy needs 
(Brighton and Heppenstall 1971; Rajpurohit, Koch et al. 1996; Archer and Francis-West 
2003).  In literature, studies have shown that chondrocytes respond favorably to low 
physiologic oxygen tension (less than 5% compared to 20% oxygen), with increased 
ECM expression, specifically up-regulation of aggrecan and collagen type II, and down-
regulation of collagen type I (Murphy and Athanassios 2001; Saini and Wick 2004; 
Wernike, Li et al. 2008), but no significant difference in cellular proliferation (Malda, 
van den Brink et al. 2004).  However, Lewis et al. were able to model oxygen availability 
to cell density and speculated that chondrocytes increased their proliferative behavior in 
scaffolds during the first 14 days in regions where there were no oxygen limitations 
(Malda, van den Brink et al. 2004; Lewis, Macarthur et al. 2005).  The PCC bioreactor 
incorporated convective flow, which increased oxygen transport across the thickness of 
the constructs, while the CC bioreactor relied on diffusion of oxygen through the 
constructs (Williams, Saini et al. 2002).  The increase in oxygen availability may have 
been responsible for the increase in cellular proliferation in constructs cultured in the 
PCC bioreactor.  In turn, the decrease in oxygen availability in constructs cultured in the 
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CC bioreactor may have been responsible for the overall increase in ECM synthesis per 
cell compared to the PCC bioreactor.  Indeed, the limited oxygen availability in the CC 
bioreactor may have been more ideal for chondrocytes to behave as they would in vivo, 
while the increased availability of oxygen may have triggered cellular proliferation in the 
PCC bioreactor. 
Tissue development was non-uniform for both bioreactors and showed 
preferential growth on the surface shear face.  This was partially due to the seeding 
period, which was governed by surface shear forces only and low seeding efficiency.  
Some growth was seen in the constructs on the face affixed to the inner bob of the CC 
bioreactor, however more intense staining of cells and ECM was detected on the 
perfusion face of constructs from the PCC bioreactor.  Tissue development from the CC 
bioreactor has stagnant regions with no stimulation while the PCC bioreactor had multi-
directional mechanical loading on both faces, which contributed to the distribution of 
cells and ECM.  No GAG was seen on the direct surface of the constructs, but detected 
towards the interior away from the high shear stresses.  The lack of GAG on the surface 
indicated that small molecular weight glycosaminoglycans were unable to adhere to the 
constructs and were likely sheared off due to the high shear stresses.  Detection of soluble 
GAG in the media supported this hypothesis, where up to 58% of the GAG produced was 
released in the CC bioreactor and up to 91% of the GAG produced was released in the 
PCC bioreactor.  The addition of perfusion in the PCC bioreactor may have forced small 
molecular weight glycosaminoglycans from the interior of the constructs into the media, 
hence more GAG was detected in the media of the PCC bioreactor than the CC 
bioreactor.  Other studies have supported this observation; in particular, Seidel et al. 
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showed that tissue-engineered cartilage lacked GAG along the edges of the constructs 
exposed to fluid, but retained GAG in the interior of the constructs away from direct 
exposure (Seidel, Pei et al. 2004).   
The cell viability of TECCs was viewed under the confocal using live/dead 
analysis.  Quantification of live and dead cells visualized under the confocal was not 
accurate due to the inhomogeneity of the cells throughout the constructs and the fact that 
only a small sample size at the center of the construct was imaged.  These images also 
amounted to only 1% of the total construct area and thus, were not representative of the 
entire construct.  Time constraints limited confocal visualization of the entire construct.  
Thus, the measurements stating that the cell viability of the constructs was approximately 
52% by Day 28 for constructs from the CC or PCC bioreactor (and 51% for constructs 
from the perfusion+shear and shear bioreactor) were not accurate.  If more images were 
taken of each construct, cell viability levels would most likely have been higher and more 
accurate, and any differences in cell viability between the two bioreactors would have 
been noticeable.   
The PCC versus CC study (and perfusion+shear versus shear study) were each 
evaluated for one experimental trial.  Statistics using the Student’s t-test assumed that the 
samples harvested were independent of each other.  However, constructs within the 
bioreactor could have influenced the growth of other constructs within the same 
bioreactor, and thus be dependent upon each other.  This would have affected the 
significance of our results.  Therefore, the entire experimental run was repeated and 
evaluated once more for each study.  The same trend was observed as the first trial and 
can be seen in Appendix B.  However, major differences in cellular and ECM content 
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existed between the first and second independent runs due to variations in the animal 
source.  As such, the two runs could not be grouped and statistically evaluated together 
for each bioreactor’s effect on cellular growth and ECM deposition because the variations 
between the two runs were greater than the variations between constructs. 
One of the main goals in tissue engineering is the development of bioreactor 
technology, which can be used to promote the growth of functional tissues for human 
implantation.  This study demonstrated the growth of tissue-engineered cartilage cultured 
in a perfusion concentric cylinder bioreactor that incorporated orthogonal fluid regimes 
with a quantifiable hydrodynamic environment to mechanically stimulate cell-seeded 
scaffolds.  One of the advantages of the PCC bioreactor over the CC bioreactor was the 
opportunity for implantation of constructs into cartilage defects.  The CC bioreactor 
constructs required silicone and plastic adhesives that when removed damaged the 
constructs.  This level of destruction made them unusable for implantation.  Whereas, the 
PCC bioreactor constructs were affixed via tension into the construct arms and were 
easily removed without damage.  Our results indicated that the PCC bioreactor greatly 
affected cellular proliferation and prolonged new extracellular matrix synthesis, but 
produced less ECM than the previously characterized CC bioreactor.  This bioreactor was 
useful to study construct development and the role of hydrodynamic loading.  These 
results have important applications in tailoring the growth of tissue-engineered cartilage.  
By allowing focus on cellular proliferation as opposed to ECM deposition, we address 
issues related to the optimization of cartilage development in cartilage bioprocess 
engineering.  Thus far, cartilage constructs cultured in bioreactors have lower ECM 
composition than native cartilage (containing 60 - 70% collagen and 15 - 20% GAG) 
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(Mansour 2004), which suggests improvements in strategies to increase matrix 
production are necessary.  The biomechanical environment controls cellular proliferation 
and ECM development, addressing the need for research into an optimal bioreactor 
design for cartilage tissue engineering.  
 
5.3 Mechanical Stimulation for Improved Properties of Tissue-Engineered 
Cartilage: Effect of Perfusion and Shear Cartilage Growth 
 Native articular cartilage experiences a number of mechanical forces, perfusion of 
fluid through the permeable cartilage, compression due to motion of the joint, hydrostatic 
pressure, and fluid-induced shear over the surface of the cartilage.  Two of these 
mechanical forces, perfusion and shear, were adapted to the bioreactor environment and 
applied to constructs cultured in the PCC bioreactor.  The first aim of this project focused 
on the characterization of the PCC bioreactor and compared the new bioreactor to the 
previously characterized CC bioreactor.  Because the two bioreactors had different 
culture environments and geometric designs, which resulted in different surface shear 
stresses, a comparison between the effect mechanical forces had on construct growth 
could not be determined.  This led to the motivation of the second aim of this project, 
where mechanical forces, perfusion and shear, were applied to constructs cultured in the 
PCC bioreactor.  Perfusion and shear were applied to one PCC bioreactor, while only 
shear was applied to another.  A perfusion only application in the PCC bioreactor would 
have completed this study; however, the aim of this study focused instead on the effect 
multi-directional fluid flow had on construct growth.  In addition, the risk of 
contamination increased when more than two PCC bioreactors were in use in each 
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experimental run because of the increased handling of the bioreactors.  A perfusion only 
application in the PCC bioreactor would also have been detrimental to growth, simulating 
a static culture due to the low shear stress from fluid perfusion (0.14 dynes/cm2).  The 
focus of this aim was to understand the effect mechanical forces had on construct 
cartilage growth both in vitro and in vivo. 
 From nutrient transport calculations for oxygen, a shear only application in the 
PCC bioreactor relied on diffusion alone for oxygen transport through the thickness of 
the constructs.  This resulted in a severe drop in oxygen levels (to 0 mol/m3) from 
equilibrium values by Day 28 in the PCC bioreactor in the interior of the constructs, 
which contained approximately 4 million cells per construct.  In contrast, the 
perfusion+shear bioreactor had only a 13.9% drop in oxygen levels across the thickness 
of the constructs, which contained approximately 10 million cells per construct.  Though 
oxygen depletion was more pronounced in the shear bioreactor and may have had limited 
transport of cells to the interior of the TECCs, the live/dead staining showed no 
discernable pattern of dead cells (see Figure 4.13).  Most cells on the surface of the 
TECCs were alive and proliferating.  Improved oxygen transport, however, may have 
been one of the reasons for the increase in cellular and ECM deposition in the 
perfusion+shear bioreactor over the shear bioreactor. 
 Sikavitsas et al. demonstrated that though mass transfer of nutrients and waste 
removal increased as perfusion rate increased, the response to increased shear stress was 
the primary factor in improving mineralization of osteoblasts.  Their study demonstrated 
that by varying viscosity (hence shear stress) of the perfusing culture media with dextran, 
without increasing mass transfer, that mineralized matrix deposition increased as shear 
 164
stress increased from 0.1 to 0.3 dynes/cm2 (Sikavitsas, Bancroft et al. 2003).  This 
reasoning, if applied to the PCC bioreactor with chondrocytes, which had a magnitude 
shear stress of approximately 0.42 dynes/cm2 (assuming 0.4 dynes/cm2 from the surface 
shear calculations), would also explain the increase in ECM deposition in the 
perfusion+shear bioreactor, which had more mechanical forces than the shear bioreactor.  
The multi-directional flow in the perfusion+shear bioreactor increased the shear stress 
exerted on the constructs both in magnitude and direction.  Collagen, in particular, 
showed a definite increase in the perfusion+shear bioreactor compared to the shear 
bioreactor. 
Collagen production may have also increased, in response, as a protective 
measure to the increase in mechanical loading over the shear bioreactor.  The collagen 
matrix provided a barrier to direct interaction between cells and mechanical loading.  In 
turn, the collagen matrix deformation, as a result of mechanical loading, relayed signals 
to chondrocytes in a variety of mechanotransduction pathways to affect chondrogenesis.  
In contrast, by Day 28, GAG deposition per construct showed no significant difference 
between the perfusion+shear bioreactor (1.2 ± 0.1 mg/construct) and shear bioreactor 
(1.2 ± 0.3 mg/construct).  GAG production rate in the perfusion+shear bioreactor peaked 
a week later the shear bioreactor.  This observation could be explained by the addition of 
perfusion as a new mechanical force, whereas, the shear bioreactor experienced a 
constant mechanical environment.  Other studies have shown that a dynamic culture 
environment was needed to maintain GAG synthesis.  Saini showed that a dynamic 
culture environment that oscillated from 19 rpm (0.6 dynes/cm2) to 38 rpm 
(1.2 dynes/cm2) was needed for continuous production of glycosaminoglycan, while still 
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maintaining collagen synthesis.  Otherwise, GAG synthesis rate entered a quiescent state 
(Saini 2001).  This would explain why the GAG production rate slowed and leveled out 
after 21 days in culture for the perfusion+shear bioreactor (after 14 days for the shear 
bioreactor) and why no significant difference between the two bioreactors existed after 28 
days in GAG content.  Thus, a constant fluid-induced shear may not be able to stimulate 
GAG synthesis for long-term culture.  Both bioreactors released a large percentage of 
GAG into the culture media, where small glycosaminoglycan chains were sheared off of 
the PLLA scaffolds. 
The effects of continuous and dynamic loading on matrix synthesis seen in our 
studies have been observed in a number of other bioreactor studies in literature (Kisiday, 
Jin et al. 2004; Seidel, Pei et al. 2004; Gemmiti and Guldberg 2006; Xie, Han et al. 
2007).  In a parallel plate flow chamber bioreactor developed by Gemmiti et al., 
chondrocytes were subjected to fluid-induced shear (1 dynes/cm2) for three days after two 
weeks under static culture.  The results showed that after three days of shear, collagen 
content increased significantly, but not GAG or cell number, when compared to static 
culture.  This suggested that collagen, responsible for tensile properties, responded to 
shear, while GAG, responsible for compressive properties, did not (Gemmiti and 
Guldberg 2006).  Kisiday et al. compared proteoglycan and collagen synthesis in tissue-
engineered cartilage cultured either under continuous compression (2.5% strain 
superimposed on a 5% static compression offset at 1 Hz) for 45 minutes every six hours 
or intermittent compression (where continuous compression was applied every other 
day).  Their study determined that while short-term culture (less than 48 hours) of 
compression increased proteoglycan and collagen synthesis, long-term culture (greater 
 166
than 14 days) of intermittent compression, as opposed to continuous compression, 
increased proteoglycan synthesis, but had no effect on collagen synthesis.  The 
speculation was that cells responded to the intermittent dynamic environment by 
synthesizing macromolecules to resist compressive forces (i.e. proteoglycan) (Kisiday, 
Jin et al. 2004).  In a similar study carried out by Xie et al., continuous compression 
(10% strain at 0.1 Hz) on tissue-engineered cartilage constructs also resulted in a 
decreased expression of both aggrecan and collagen type II expression over intermittent 
loading (where continuous compression was applied every other day) after three days in 
culture (Xie, Han et al. 2007). 
When cartilage growth was normalized to cell content for Day 28 samples, the 
perfusion+shear bioreactor produced 0.9 ± 0.1 x10-4 g of GAG per cell and 
2.1 ± 0.2 x10-4 g of total collagen per cell, which was not significantly different from 
the shear bioreactor at 4.3 ± 1.6 x10-4 g of GAG per cell and 6.2 ± 3.9 x10-4 g of total 
collagen per cell, respectively.  This observation showed that increase in ECM production 
was due more to the increase in mechanical loading in the perfusion+shear bioreactor 
than to the increase in cell number or decrease in oxygen availability in the shear 
bioreactor.  Table 5.2 shows the ratio of ECM content per cell for both bioreactors as well 
as the ratio of collagen to GAG per construct.  When compared to native cartilage, the 
percentage of GAG and collagen produced per cell in the bioreactor was less than 0.01%.  
However, the ratio of collagen to GAG in the perfusion+shear bioreactor (2.42 ± 0.15) 
was greater than native cartilage (1.5), while the shear bioreactor had a ratio of 
1.19 ± 0.32.  This observation suggested that improvement was needed in GAG synthesis 
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in the perfusion+shear bioreactor and collagen synthesis in the shear bioreactor to match 
native cartilage composition and produce functionally relevant articular cartilage.   
 
 
Table 5.2.  Effect of mechanical stimulation on extracellular matrix production on Day 28 
samples 
 
 Perfusion+Shear Shear Native Cartilage a 
GAG (g/cell) 0.9 ± 0.1 x10-4 4.3 ± 1.6 x10-4 1.4  
Total Collagen (g/cell) 2.1 ± 0.2 x10-4 6.2 ± 3.9 x10-4 2.1 
Collagen/GAG 2.4 ± 0.2* 1.2 ± 0.3* 1.5 
* p < 0.05 between perfusion+shear and shear bioreactor 
a. (Saini and Wick 2003) 
 
 
The significant increase in cell proliferation in the perfusion+shear bioreactor 
indicated chondrocytes dependence on mechanical stimulation.  The effect of shear stress 
on the up-regulation of cell proliferation has been discussed in literature (Bancroft, 
Sikavitsas et al. 2002; Malaviya and Nerem 2002; Raimondi, Moretti et al. 2006).  
Raimondi et al. showed a dose-dependent response, where increasing the shear stress 
through the scaffold from 0.05 to 0.6 dynes/cm2, caused an increase in cell number by 
1.7 fold compared to static controls (Raimondi, Moretti et al. 2006).  When constructs in 
the PCC bioreactor were exposed to both perfusion and shear, cell growth was 
significantly affected by the multi-directional flow than when compared to constructs 
exposed to only shear.  Both et al. showed that low cell seeding density influenced the 
proliferation rate of mesenchymal stems cells cultured in monolayer.  Cells seeded at 
100 cells/cm2 reached 200x106 cells 4.1 days earlier than those seeded with 
5000 cells/cm2 (Both, van der Muijsenberg et al. 2007).  This indicated higher 
proliferation rates when cells were seeded at lower densities.  Despite that the PCC 
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bioreactor had low initial cell density, both bioreactors were seeded with approximately 
the same number of cells at Day 4 and demonstrated that the increase in cellular 
proliferation was likely due to the addition of perfusion in the perfusion+shear bioreactor.  
This increase in proliferation behavior matched the results obtained when the PCC 
bioreactor was compared to the CC bioreactor, which only employed surface shear over 
the constructs.  Even though the CC bioreactor had higher shear stress than the PCC 
bioreactor and few nutrient limitations (Williams, Saini et al. 2002), the PCC bioreactor 
still caused higher proliferation rates.   
Derived from Freed et al., the growth curve of tissue-engineered cartilage 
constructs to describe proliferation could be modeled after a polynomial equation that 
accounted for initial cell density,  (cells/construct), the initial cell growth rate, 
 (cells/construct/day), and the decrease in growth rate over time, 
- (cells/construct/day2).  The proliferation of cells, X (cells/construct), in the PCC 
bioreactor was fitted to the quadratic equation as a function of time, t (days) (Freed, 
Vunjak-Novakovic et al. 1993): 
 
2)( tttX                         Equation 5.2 
 
Table 5.3 lists the coefficients and R2 value extrapolated from fitting the experimental 
data to the growth curve for the perfusion+shear bioreactor and shear bioreactor.  The 
extrapolated negative initial cell density coefficient was due to the low seeding density 
for both bioreactors.  The perfusion+shear bioreactor had a higher initial growth rate () 
and slower decrease in growth () over the shear bioreactor.  The growth curve predicted 
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that the perfusion+shear bioreactor would culture cells to a maximum of 14 million cells 
per construct by Day 38, while the shear bioreactor already reached a maximum by 
Day 22 at 4.7 million cells per construct.  Repeat of this experimental run showed the 
same trend where perfusion+shear extended cell growth up to 37 days, while shear only 
reached maximum cell growth by Day 17.  These calculations further showed that the 
addition of perfusion extended the growth time in the PCC bioreactor.   
 
Table 5.3.  Cell growth kinetics as a function of time in the perfusion+shear and shear 
bioreactor 
 
Bioreactor  (cells/construct) 

(cells/construct/day) 
 
(cells/construct/day2) R
2 
Perfusion 
+Shear -3.55x10
6 9.45x105 1.26x104 0.970 
Shear -2.74x106 6.63x105 1.47x104 0.914 
 
 
Bovine cartilage was chosen because large amounts of cells can be extracted from 
a single source.  Variations exist, however, between animal sources, and affect the goal to 
develop consistent results in cartilage growth in the PCC bioreactor.  Mesenchymal stem 
cells (MSC) as a primary source would alleviate this problem.  Ideally, this type of 
system could be used to implant TECCs into human cartilage defects.  The source and 
amount of cells would be of concern, where MSC and human chondrocytes would have 
to be expanded first to a high cell density (greater than 20x106/cm3) before seeded into 
the bioreactor.  More studies on the examination of the growth curve of the PCC 
bioreactor with human chondrocytes or MSC would elucidate the minimum number of 
cells needed to seed the bioreactors, shortening the wait time for patients.        
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That proliferation was affected by directional shear stress may be attributed to the 
mechanotransduction pathways.  This result highlighted that mechanoreceptors in the 
cells may be sensitive to not only the magnitude of the stresses, but also the direction of 
the stress vectors.  The exact mechanism for translating shear stress due to perfusion to 
pathways that induce proliferation is not well understood.  Though not a directional study 
of stress vectors, Malaviya and Nerem were able to demonstrate that chondrocytes 
cultured in a parallel plate flow chamber and exposed to 35 dynes/cm2 proliferated and 
increased by 6 fold compared to 4 fold in static culture.  They were also able to show that 
the effect of shear stress on proliferation was partially mediated by transforming growth 
factor beta 1 (TGF-1), a known mitogen for chondrocytes, which was up-regulated 
3.5 fold compared to static culture (Malaviya and Nerem 2002).  
Histological images showed tissue development with cellular and extracellular 
matrix deposition across the thickness of the constructs (see Figure 4.12).  Despite the 
addition of perfusion in the perfusion+shear bioreactor, the shear bioreactor also showed 
cartilage development on the backside of the constructs.  This was the result of “static 
culture” on the backside of the constructs in the shear bioreactor (where perfusion 
occurred in the perfusion+shear bioreactor).  Diffusion of culture media from the 
backside through the constructs aided cartilage development in the shear bioreactor.  In 
fact, the addition of perfusion on the backside of the constructs had no visible role in the 
distribution of cells and extracellular matrix throughout the constructs.  Seen in 
Figure 4.12, GAG staining in the shear bioreactor was more intense than the 
pefusion+shear bioreactor.  GAG deposition was also seen near the backside of the 
constructs in the shear bioreactor, whereas, the addition of perfusion in the 
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perfusion+shear bioreactor possibly decreased GAG attachment to the scaffolds. Thus, 
the addition of perfusion resulted in less intense staining for GAG at the center.  Both 
bioreactors stained equally for collagen type II and type I.  The presence of collagen type 
I was not surprising due to the presence of collagen type I gene expression in the 
perfusion+shear bioreactor (see Figure 4.10).  The presence of collagen type I was due to 
possible dedifferentiation of chondrocytes and the result of the formation of fibrous tissue 
to protect cells from direct mechanical loading.  
The compressive modulus measured the bulk stiffness of the TECCs.  Primarily, 
GAG chains provided resistance to compressive forces by drawing in water to resist 
loading and providing stiffness (Mansour 2004).  In this study, there was no significant 
difference in the modulus over the course of the experimental run, nor between the two 
bioreactors.  After 28 days the modulus measured 0.15 MPa, which was only 25% of 
native cartilage.  Based on biochemical composition, the relatively low GAG content in 
the constructs cultured in the perfusion+shear and shear bioreactor may have accounted 
for the low modulus.  In addition, the negatively charged PLLA scaffolds may have 
provided the main resistance to compressive forces. 
The permeability constants describe the ease of fluid permeation through TECCs.  
Generally, native cartilage has permeability constants between 10-14 and 10-16 m4/(N*s) 
(Cohen, Chorney et al. 1994; Heneghan and Riches 2008).  The permeability constant 
measured for native cartilage using the confined compression testing apparatus seen in 
Figure 3.10A was 1.16 ± 0.78 x10-13 m4/(N*s).  This measurement was at least one order 
of magnitude greater than found in literature (Holmes and Mow 1990; Soltz and Ateshian 
1998; Chen, Bae et al. 2001).  The discrepancy may be due to the age of the cartilage 
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tested, where samples measured in literature were from mature bovines.  Our samples 
were from newborn calves.  Immature cartilage has less cross-linkages in the 
extracellular matrix, and thus possibly more permeable than adult samples.  In this study, 
the permeability constants measured from the dynamic portions of the confined 
compression test showed no significant difference over the course of 28 days, nor 
between the two bioreactors.  After 28 days the permeability constant measured 
2.0x10-13 m4/(N*s) and was equivalent to native juvenile cartilage, but 220% more 
permeable than PLLA scaffolds (0.61 ± 0.23 x10-13) (p < 0.05).  This observation may be 
explained by the breakdown of the PLLA polymer, which increased the negative charge 
of the PLLA scaffold.  This increase in negative charge retarded fluid flow, and thus 
decreased permeability in the confined chamber.  Overall, the permeability constants 
were higher than those found in literature.  The nonlinear biphasic theoretical equation, 
Equation 3.13, was used to calculate the permeability constants.  The permeability 
calculations assumed that the fluid velocity through the constructs was the same as the set 
ramp rate of 0.0005 mm/s.  In actuality, fluid flow may have been lower if resistance to 
flow was considered (as in the PLLA scaffolds), which would have decreased the 
permeability constants.  This was not assumed because the compression apparatus did not 
have the means to measure interstitial fluid flow rates.  Instead, we assumed that fluid 
flow was based on forced convection from the non-permeable indenter.  The biphasic 
theory also assumed a homogenous tissue; however, based on histological analysis, the 
TECCs were not homogeneous and had regions where PLLA dominated.  Taken together, 
these major assumptions may have contributed to the higher than normal permeability 
constants for native juvenile cartilage and TECCs. 
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The permeability constant could also have been calculated from a permeability-
strain relationship equation based on the linear biphasic theory which was derived from 
mass and momentum balances (Mow, Kuei et al. 1980): 
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 where, 
V0 is the strain rate, 
t is time 
 
 
This equation did not require the knowledge of the fluid rate and could have been used to 
fit the dynamic portion of the experimental data to calculate the permeability constant.  
The simplicity of the non-linear biphasic equation was chosen over the linear biphasic 
equation to calculate the permeability constant.  However, Heneghan and Riches 
compared the two theories and showed that the permeability constants calculated had the 
same order of magnitude (between 10-14 and 10-16 m4/(N*s)) regardless of the 
permeability-strain equation used, and were also within the same order of magnitude of 
the permeability constants measured from direct permeation experiments (Heneghan and 
Riches 2008). 
The shear modulus measured resistance due to deformation parallel to the load 
and took in account the amount and interaction of the ECM network.  This in turn, 
provided a more accurate assessment of the mechanical properties of TECCs.  The 
collagen fibrils provided the main resistance to tensile (stretching) loading (Mansour 
2004), which was applicable to shear deformation.  However, the orientation of the fibrils 
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and the degree of cross-linking in the matrix between the collagen and GAG also 
determined the shear properties of the cartilage (Stading and Langer 1999; Silver, 
Christiansen et al. 2001).  In this study, the shear modulus for both bioreactors decreased 
over the course of 28 days, which was surprising due to the increase in ECM deposition 
in the TECCs.  However, the phase angle increased over the course of 28 days, and the 
perfusion+shear bioreactor had a significantly higher phase angle than the shear 
bioreactor.  The complex shear modulus is a combination of the elastic modulus (storage) 
and viscous modulus (loss) and the phase angle measures the ratio of the viscous 
behavior to the elastic behavior.  Based on the biochemical composition, the total 
collagen in the perfusion+shear bioreactor was significantly greater than the shear 
bioreactor.  Because collagen is the primary component responsible for viscous behavior, 
this would explain why the phase angle was greater as well.  Yet, the decrease in the 
shear modulus indicated that the interaction between the collagen and GAG was lacking, 
i.e. low amounts of cross-linking (immature cartilage) that provide the resistance to 
loading, which allowed the viscous sliding of uninhibited collagen fibrils.  The high shear 
modulus (1.83 MPa) and low phase angle (6.15°) of the PLLA scaffolds supported this 
observation, in which the stiff scaffold had no collagen to contribute to the viscous 
behavior.  Stading and Langer have demonstrated that over time the ECM composition 
and structure influence the shear modulus of the TECCs and that mature cartilage with 
high collagen and GAG (and high levels of cross-linking) showed an increase in stiffness 
over time (Stading and Langer 1999).  However, Raimondi et al. were able to show that 
collagen scaffolds seeded with chondrocytes, decreased in their storage modulus and 
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increased in phase angle over time, which is in agreement with our results (Raimondi, 
Colombo et al. 2003). 
We created a xiphoid chondral defect in a nude rat model to observe cartilage 
healing.  The purpose of this study was to evaluate this new technique and the role of 
mechanically stimulated tissue-engineered cartilage to heal cartilage defects.  This was 
the next logical step in the bioprocess scheme: to evaluate the necessity of bioreactors 
that employ mechanical forces in order to heal cartilage defects.  Though not articular 
cartilage, the xiphoid had similar composition as hyaline cartilage and served as a model 
for these cartilage studies.  One problem with the nude rat model had to do with the 
thickness of the xiphoid.  The 5-week old rats had thin xiphoids (less than 2 mm in 
thickness), while the TECCs had an average thickness of 1.87 mm.  This resulted in an 
uneven fit and healing between the implant and defect, which is easily seen in 
Figure 4.19.  Nevertheless, the implant was lined up on one side of the cartilage defect 
and sealed with SepraFilm during the surgery.  Prior to implantation, constructs from the 
perfusion+shear and shear bioreactor had twice as many cells and ECM compared to 
those in the static bioreactor.  The implants, however, had significantly less cells than the 
cells only implants (Group F).  The results from the histology showed more 
differentiation and mature cartilage in the TECCs cultured in either the perfusion+shear 
or shear bioreactor, which was evidenced by the presence of GAG in the implants.  
TECCs cultured in the static bioreactor and the PLLA scaffolds showed only cells.  No 
detection of GAG was seen throughout the implants.  These results highlighted the 
importance and necessity of mechanically active environments to culture TECCs before 
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implantation in order to prolong maturation and extend cartilage growth after 
implantation.   
Group F contained implants that had only cells, but no scaffold or ECM.  This 
control group also had significantly higher amounts of cells than any other implant group 
(5x106 cells).  Group F showed the most maturation than any of the other implant groups, 
with intense staining for cells and GAG.  This observation showed the necessity to 
consider cell density in implants, in which the higher the cell density, the greater the 
maturation and healing.  This was further verified when constructs from the 
perfusion+shear and shear bioreactor showed more maturation than the static bioreactor 
and PLLA scaffold group, which had a significantly lower cell density or none in the case 
of the PLLA scaffold.  Even though Group F showed the most positive result compared 
to the implants from the bioreactors, the structural integrity was compromised in this cells 
only group.  The xiphoid cartilage was unable to maintain its original shape without the 
aid of the scaffolds as seen in Figure 4.19.  Therefore, both cell density and structural 
support has to be considered for tissue-engineering cartilage for the purpose of healing 
cartilage defects.  Collagen type I was detected in all implant groups.  Collagen type I is a 
marker for scar tissue and indicated that while articular cartilage was detected by the 
presence of type II collagen, the detection of type I collagen at the interfaces and edges of 
the implants indicated that the xiphoid was attempting to heal the defect with fibrous scar 
tissue.  The empty defect model indicated that without the aid of an implant, poor healing 
occurred and little to no cells or ECM was present in the defect region.  The results from 
this animal study indicated that cell density as oppose to ECM content was the primary 
factor in the success of engineered cartilage maturation.  Mechanically active bioreactors 
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could still play a role in tissue engineering by expanding cell number in a scaffold to a 
critical cell density (in this case 5x106) to promote maturation. 
Some studies have been carried out on the implantation of TECCs into cartilage 
defects.  The animal models most commonly used were subcutaneous implants into nude 
rats or mice (Jin, Park et al. 2007; Jung, Kim et al. 2008).  Jung et al. implanted 
mechanically stimulated cartilage constructs (cultured for either 10 days or 24 days) 
subcutaneously into nude mice models.  Their results showed that these mechanically 
stimulated constructs increased in maturity and formed well-developed cartilage over 
those cultured under static conditions.  This was in agreement with our results.  They also 
noted, however, that TECCs stimulated for 24 days became more hypertropic compared 
to the 10 day old implanted constructs (Jung, Kim et al. 2008).  This study suggested that 
while mechanically stimulated constructs were beneficial to growth upon implantation 
and enhanced chondrogenesis, the age of the cells also had to be considered in optimizing 
growth after implantation.     
The improved maturation of implanted tissue-engineered cartilage cultured in the 
PCC bioreactor necessitated the role for mechanically active bioreactors to heal cartilage 
defects.  The perfusion+shear bioreactor may play an important role in the future of tissue 
engineering, given that the biochemical composition showed that the addition of 
perfusion greatly improved cellular proliferation from a low cell-seeding density.  The 
perfusion+shear bioreactor could provide the mechanical environment to expand a small 
amount of cells extracted from patients in a relatively short culture period compared to a 
shear only bioreactor.  The mechanical properties indicated that the TECCs grown in 
either bioreactor provided less than ideal behavior to native cartilage.  The increase in 
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phase angle in the perfusion+shear bioreactor and decrease in shear modulus indicated 
that high collagen content over GAG was not enough to improve the stiffness of the 
TECCs.  More improvement in the culture conditions to increase GAG content and 
maturation to increase cross-linking would improve the compressive and shear modulus 
of the TECCs.  This study created a better understanding of hydrodynamic forces on the 
growth of cells and extracellular matrix deposition.  A proposed new model extrapolated 
from these results would be to use directional perfusion to increase proliferation rates, 
surface shear to increase collagen synthesis, and intermittent dynamic compression or 
dynamic fluid-induced shear to increase GAG synthesis.  Taken together, the growth of 
tissue-engineered cartilage could be tailored by these mechanical forces to produce 
constructs with the desired composition and properties prior to implantation into cartilage 
defects.  
 
5.4 Cryopreservation of Tissue-Engineered Cartilage 
 The long-term success of implanted tissue-engineered cartilage constructs for 
osteoarthritis and other cartilage-damaged injuries depends on suitable storage methods.  
Long-term storage that maintains cartilage viability and function can provide an “off-the-
shelf” availability for patients without the need to wait for cells to grow and make 
TECCs.  To date most research in cryopreservation has been on native tissues and cells.  
The interaction between newly formed tissue and the scaffold matrix during vitrification 
is not well understood and as such, few studies have been carried out on preservation of 
tissue-engineered constructs.  The focus of this study was to investigate the factors that 
regulate the preservation of tissue-engineered cartilage by studying cell viability levels as 
 179
a result of vitrification methods that have previously been effective for native articular 
cartilage.  The use of different vitrification formulations and introduction and elution 
methods provides insight into the cytotoxicity of cryoprotectant agents as well as their 
mass transfer properties through TECCs. 
The method to quantify cell viability was assessed by the measurement of the 
metabolic activity of cells.  Similar to the cytotoxic MTT (3-[4,5-dimethylthiazol-2-yl]-
2,5-diphenyl tetrazolium bromide) assay, the non-cytotoxic alamarBlue assay measured 
the color change as the dye is reduced by mitochondrial and cytosolic enzymes 
characteristic of metabolic activity.  In addition, cells are quantified (DNA assay) to give 
a perspective of the viability levels detected.  For example, TECCs that had 
contamination or less than 0.5x106 cells per construct had unusually high cell viability 
levels (between 80% and 110% viability).  This demonstrated not only a lower limit to 
the effectiveness of the viability assay, but also allowed us to discount the data gathered 
from these experimental runs.  Cell viability was re-tested four hours after the 
cryopreservation studies.  However, cells have been shown to undergo apoptosis 24 hours 
after thawing from traditional freezing methods even when cell viability levels were high 
immediately after thawing.  Milosevic et al. has shown that even after a week, cell 
viability levels decreased 50 - 60% after thawing from traditional freezing (Milosevic, 
Storch et al. 2005).  These observations show that the viability assessments may not be 
entirely accurate and that viability at least 24 hours after preservation or apoptosis assays 
needs to be assessed to fully gauge the effectiveness of different preservation methods.  
Live/dead confocal images supplemented the alamarBlue assay in order to view the 
orientation of live and dead cells throughout the thickness of the constructs.  
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Quantification of live and dead cells visualized under the confocal was not accurate, as 
they did not match viability levels measured from the alamarBlue assay (data not shown).  
The inaccuracy stemmed from the single images taken at one plane along the z-axis at the 
center of the construct and due to the inhomogeneity of the cells throughout the 
constructs.  These images also amounted to only 1% of the total construct area and thus, 
were not representative of the entire construct.  Time constraints also limited confocal 
visualization of the entire construct.   
The largest hindrance to the viability studies was the risk of ice formation as the 
temperature of the TECCs dropped from 4°C to -100°C.  Vitrification is defined as fast 
cooling of approximately -40°C per minute for tissues.  Glass formation was critical 
because ice crystals damaged delicate cell membranes.  In many of the experimental 
trials, unsuccessful vitrification occurred, which is defined as slow cooling and 
visualization of ice crystals and resulted in low cell viability levels in the TECCs.  The 
temperature gradient played a large role in the success of vitrification.  The mechanical 
freezer was maintained at -150°C and the initial temperature of the TECCs was 4°C.  The 
temperature change initiated from a pre-cooled isopentane bath located in the mechanical 
freezer or the small-scale bench-top system to the aluminum mesh vitrification canister 
(that held the vials), which then proceeded through the borosilicate glass, the vitrification 
solution, and finally to the TECCs.  Table 5.4 lists the estimated thermal conductivity, the 
density multiplied by the heat capacity value, and the thermal diffusivity found in 
literature, for the materials mentioned. 
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Table 5.4.  Thermal properties of the materials used in vitrification 
Material 
Thermal 
Conductivity 
(W/(m*K)) 
Heat Capacity x 
Density 
(J/(m3*K) 
Thermal 
Diffusivity 
(m2/s) 
Isopentane a 0.17 1.07x106 1.57x10-7 
Aluminum b 236.09 2.39x106 9.86x10-5 
Glass c 1.11 2.10x106 5.29x10-7 
Vitrification Solution d 0.36 2.98x106 1.21x10-7 
TECCs e 0.48 3.73x106 1.28x10-7 
a. Linearly extrapolated to –150°C (Schumann, Aston et al. 1942; U.S.CoastGuard 1999) 
b. Measured at 4°C (Giauque and Meads 1941; Steele and Pinsky 2008) 
c. Measured at 4°C (Carwile and Hoge 1966; Yamashita, Tojo et al. 2001) 
d. Fitted to the energy equation for temperature change (Mukherjee 2008) 
e. Measured at 27°C for native cartilage (Youn, Telenkov et al. 2000) 
 
 
 
Aluminum had the largest conductivity and diffusivity; however, given its wire 
mesh configuration, most of the glass vials came in contact with liquid isopentane.  Based 
on Fourier’s law of heat conduction, the largest heat flux occurred through the aluminum 
and glass materials.  The vitrification solution (VS55) had the smallest diffusivity and 
could be seen as the limiting factor to temperature change for the system.  VS70 had a 
higher concentration of CPAs than VS55, which may have resulted in a smaller thermal 
diffusivity and thus longer temperature change than VS55.  However, except for the 
aluminum canister, the diffusivities were on the same order of magnitude, and thus would 
have had roughly equal thermal transport times.  The mass properties and path length of 
the aluminum, glass, and vitrification solutions was constant.  This left the isopentane 
bath as a possible reason for unsuccessful vitrification.  Based on Newton’s law of 
cooling, increasing the contact surface area of the isopentane bath to the glass vials would 
increase the heat flow.  Khirabadi et al. found that the cooling rate of the VS55 occurred 
faster if vials were immersed deeper into an isopentane bath.  For example, an immersion 
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of vials 3 cm into the pre-cooled isopentane bath had a cooling rate of -43°C per minute, 
while 6 cm resulted in -71°C per minute (Khirabadi, Song et al. 2001).  In our 
experiments, vials were immersed anywhere between 2 to 6 cm in the pre-cooled bath, in 
which the isopentane level was always above the level of the vitrification solution inside 
the vials.  Successful vitrification, however, would still occur sporadically in vials 
immersed in 2 cm or 6 cm of isopentane.  Nevertheless, isopentane served as a better 
conduit for cooling than cooled air at –150°C, which had a thermal conductivity of 
approximately 0.01 W/(m*K) (Bird, Stewart et al. 2002).  
The ability to maintain a stable pre-cooled isopentane bath varied as well, 
especially in regards to the small-scale bench-top method, which affected the success of 
vitrification.  The closed insulated system maintained a stable temperature in the vapor 
phase of the liquid nitrogen.  When opened to room temperature, temperature fluctuations 
inside the system occurred, which affected the temperature of the isopentane and thus the 
heat transfer rate.  The temperature of liquid nitrogen is -196°C, while the melting 
temperature of isopentane is -160°C.  The isopentane would begin to solidify in the 
small-scale bench-top system after a prolong period in liquid nitrogen, which affected its 
thermal diffusivity.  In our experimental trials, the isopentane was allowed to equilibrate 
with the vapor phase of the liquid nitrogen inside the bench-top system for at least 30 
minutes before used for vitrification.  When the mechanical freezer (set at -150°C) was 
available the isopentane bath remained stable.  The mechanical freezer had a larger 
volume compared to the small-scale bench-top system, which created a stable 
temperature environment.  Samples could be stored overnight in the freezer and 
maintained at -150°C.  Whereas, liquid nitrogen in the small-scale bench-top system 
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would evaporate overtime, raising the temperature of the system.  When vitrification 
occurred in the small-scale bench-top system, we assumed that most cell damage was 
caused by ice crystal formation, which only occurred during the cooling and re-warming 
stage from the glass transition temperature (-135°C).  Thus, eliminating storage of the 
samples overnight when we used the small-scale bench-top system should not have 
affected the resulting cell viability levels. 
Ideally, the storage of the TECCs at -196°C in liquid nitrogen would have been 
more preferable and easier than storage at -150°C.  Yet, the storage of the samples were 
kept at -150°C instead of -196°C to prevent thermal cracking.  The further the samples 
were in temperature from their glass transition temperature, the higher the risk was for 
thermal cracking and ice formation. 
In this study, VS70 was determined as the optimum vitrification solution over 
VS55 and VS83.  VS83 proved to be highly cytotoxic under conditions of exposure, due 
to its high concentration of cryoprotectant agents.  VS55, in contrast, could not 
adequately maintain cell viability levels equivalent to VS70.  VS70, which was more 
cytotoxic than VS55, preserved twice as many cells as VS55.  This pattern of cell 
viability was constant even when cell number in the TECCs increased (as in Day 14 and 
Day 28 samples), which determined that using a short-term culture period may 
adequately represent results for TECCs cultured for longer periods.  The toxicity of the 
vitrification solution was evident when TECCs exposed to VS70 for approximately 30 
minutes at 4ºC, had a third less viable cells than VS55.  But then, the protective effect of 
VS70 was observed when twice as many cells survived over VS55 after vitrification.  
The highest viability level measured with VS70 without vitrification was 29.4%, while 
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the highest viability level measured with VS70 with vitrification was 39.7%.  The 
discrepancy was due to the prolonged exposure of VS70 at 4ºC when samples were not 
vitrified.  When samples were vitrified, metabolic activity ceased; and thus, the toxic 
behavior of VS70 could not affect the cell viability levels, which occurred at 4ºC.  
However, a parallel study directly comparing cytotoxicity and vitrification would better 
elucidate the full effect of VS70 on cell viability levels. 
The more concentrated VS70 solution (compared to VS55) provided the best 
balance of CPAs to protect cells from ice damage without becoming too cytotoxic.  Fahy 
et al. hypothesized that solutions with higher hydrogen bonding energy could vitrify 
solutions with high water concentration, but were also more toxic than solutions with low 
hydrogen bonding energy between water and the hydrogen bonding groups in 
cryoprotectant agents.  The suggestion was that there existed a threshold concentration, 
CT, in which CPAs below the CT was not cytotoxic.  As such, the toxicity could be 
reduced more severely than the ability of the CPAs to prevent ice formation, which may 
explain VS70’s performance over VS55 (Fahy, Wowk et al. 2004).  Only three 
formulations of DMSO, formamide, and 1,2-propanediol were tested.  Further variations 
in formulation or conditions of exposure could further increase cell viability by reducing 
CPAs toxicity while preventing ice formation during vitrification. 
The maximum cell viability in TECCs retained for VS70 in 6/7 steps was 39.7%.  
In native bovine cartilage tissues, VS70 in 6/7 steps still retained more viable cells than 
VS55 in 6/7 steps.  In comparison, Song et al. were able to preserve up to 80% viability 
of vitrified rabbit articular cartilage with VS55 in 6/7 steps (Song, Lightfoot et al. 2003).  
Pegg et al. preserved ovine cartilage with 10% DMSO in 5/4 steps to –196°C, but only 
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recovered 11% of functional [35S]sulfate incorporation into GAG (Pegg, Wusteman et al. 
2006).  The difference in viability levels highlighted that separate protocols are needed 
between native animal tissues and for tissue-engineered constructs, in which the 
interaction between cells and scaffolds have to be considered. 
In one study, VS55 in 6/7 steps was compared to traditionally frozen samples.  
Traditionally frozen samples maintained 32.8% viability compared to 18.7% of VS55 in 
6/7 steps.  Although VS70 could maintain 40 - 50% viability, it was not directly 
compared to frozen samples.  Traditionally frozen samples in 1 M of DMSO was less 
cytotoxic than the vitrification solutions.  DMSO, which blocks ice formation, was the 
main contributor to successful cryopreservation.  The low cytotoxicity and the prevalence 
of cells along the surface of the constructs may have resulted in the higher viability levels 
over the fast vitrification.  Though clearly more studies on traditional freezing treatments 
are needed, this particular study primarily focused the effect of vitrification solutions on 
cell viability in TECCs.  As such, optimization of the slow cooling method with 
1 M DMSO was not investigated further.     
The next study focused on the number of steps used to gradually introduce and 
elute the full-strength mixture of VS70.  The highest cell viability levels reached for 
VS70 in 4/4 steps was 50.0%, and 45.5% for VS70 in 6/7 steps.  Initially 6 steps 
introduction and 7 steps elution was used and full exposure time was 90 and 105 minutes, 
respectively.  Reduction of steps (4 introduction and 4 elution) reduced exposure time to 
60 minutes each.  This simplified and shortened the CPAs exposure process.  Pegg et al, 
found that chondrocytes were particularly resistant to and were more able to withstand 
osmotic imbalances than other cells (Pegg, Wang et al. 2006).  Though reduction of steps 
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increased the concentration gradient and thus osmotic imbalances, our results showed that 
reduction of steps had no detrimental effects on cell viability levels.  The higher 
concentration gradients in the 4/4 steps method, however, may have under-exposed the 
TECCs to the CPAs because only 15 minutes was given for diffusion of the CPAs, in 
each step, which would have reduced cell viability levels.  The 6/7 steps method, in turn, 
may have over-exposed the TECCs to the CPAs because of the additional steps required, 
which also would have reduced cell viability levels.   
The final study utilized the result that 4/4 steps method was not detrimental to cell 
viability and modified the method to the PCC bioreactor.  The hypothesis was that 
increasing mass transport of the CPAs through the TECCs would improve cell viability 
levels.  The highest cell viability levels reached for VS70 in the PCC bioreactor was 
47.8%, while VS70 in 4/4 steps using the orbital shaker to introduce and elute the CPAs 
maintained 56.0%.  This was surprising when mass transfer estimations were made.  The 
step-wise introduction and elution methods were carried out on an orbital shaker at 4°C at 
approximately 100 rpm.  Diffusion of DMSO, formamide, and 1,2-propanediol were the 
main limitation to mass transfer.  Measured by Mukherjee et al. the diffusivity for 
DMSO, formamide, and 1,2-propanediol into cartilage tissue at room temperature were 
4.63x10-10 m2/s, 3.47x10-10 m2/s, and 6.67x10-10 m2/s, respectively.  Based on Fick’s 
second law of diffusion, the time for VS55 to permeate native cartilage and equilibrate 
with the surrounding bulk VS55 solution took approximately 2 - 3 hours (Mukherjee, Li 
et al. 2008).  If these diffusivity constants were applied to TECCs, then the 15-minute 
exposures to vitrification solutions using the orbital shaker method were not adequate for 
complete permeation of CPAs.  However, this assumption did not account for convection 
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due to the orbital shaker and increased porosity of the TECCs over native cartilage 
(65 - 85% porous), which would have shortened the equilibrium time.  Also, this 
assumption did not take in account that our system was at 4°C, which would have 
extended equilibrium time.  During introduction and elution of the vitrification solution, 
media remained inside the constructs (observed by a red coloring in the white constructs), 
but was not quantified.  This observation, however, confirmed that CPAs did not 
permeate completely into the constructs.  Therefore, we hypothesized that using 
convective flow in the PCC bioreactor as the main transport of the CPAs through the 
TECCs, would have overcome these transport limitations and improved cell viability.   
The Peclet number (Equation 3.7), which was estimated from the diffusivity of 
the CPAs and a path length of 1.87 mm, exceeded 1800, which indicated that convective 
transport dominated when CPAs perfused through the constructs inside the PCC 
bioreactor.  The shear stress exerted on the constructs due to perfusion fell within 
physiological range.  Thus, the stresses were not detrimental to cell viability, and any 
protective or detrimental effects of the vitrification solution were due to permeation of 
the cryoprotectants.  During the introduction and elution of the CPAs using the PCC 
bioreactor, media was removed from the constructs (observed by no red coloring in the 
white constructs).  This observation indicated that CPAs did permeate completely into the 
constructs.  Mass transfer estimations indicated that there were limitations to the 
penetration of CPAs in the orbital shaker method.  However, the quantitative cell 
viability analysis of constructs preserved indicated that possible mass transfer limitations 
due to the orbital shaker method or that increased permeation due to the PCC bioreactor 
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method had no effect on cell viability, given that there were no noticeable differences in 
viability levels between the two treatments.   
All the vitrification studies were supplemented with confocal images that showed 
the distribution of live and dead cells across the thickness of the constructs after 
preservation.  The confocal images of live and dead cells seemed to indicate that there 
were some limitations to reach the interior of the TECCs.  Most live cells were limited to 
the surface of the constructs within easy access of the CPAs.  There also may have been 
an unavoidable bias because most cells cultured on the TECCs after 7 days were also 
primarily located on the constructs’ surface.  Even though Day 14 and Day 28 samples 
for VS55 and VS70 comparison did not show differences to Day 6 and Day 7 samples, 
extended growth studies for the orbital shaker method and the PCC bioreactor method 
comparison may show differences.  This was reasoned because confocal images showed 
some cells in the interior (not quantified) preserved in the PCC bioreactor method (see 
Figure 4.37).  Another explanation for the lack of difference between the orbital shaker 
and PCC bioreactor method was that convective flow may have over-exposed TECCs to 
CPAs, lowing cell viability levels.  The reduction of exposure time may increase cell 
viability while still fully exposing TECCs to CPAs.  Nevertheless, the introduction of the 
PCC bioreactor was not detrimental to cell viability in comparison to the orbital shaker 
method.  This result could be further utilized and taken advantage of by streamlining the 
bioprocess scheme from cell culture to preservation in one-step. 
The PCC bioreactor method was not detrimental to cell viability when used to 
perfuse vitrification solution through TECCs.  This advantage allows for future studies 
where cells can be cultured in the PCC bioreactor and preserved in the same system.  In 
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turn, this reduces handling and possible contamination risks, as well as, providing a one-
step process from culture to preservation, streamlining the bioprocess scheme from 
culture to market.  One disadvantage, thus far, was that the TECCs had to be removed for 
the vitrification process (4°C to –100°C) and re-warming process (-150°C to 4°C).  
Currently, the design of the PCC bioreactor prevents removal of the construct arms from 
the central hub, nor can the polycarbonate PCC bioreactor be exposed to –150°C without 
warping or cracking the material.  (Polycarbonate is stable between -40°C and 95°C.)  If 
the PCC bioreactor had easily removable arms that held the TECCs or was made out of a 
durable material (i.e. borosilicate glass or polypropylene) that withstood low storage 
temperatures, then the vitrification process could be further simplified by simply 
lowering the bioreactor system into the mechanical freezer for vitrification.  However, the 
thickness of the material would affect the rate of cooling and re-warming of the TECCs, 
and thus, more research into this method would have to be explored. 
In conclusion, VS70 affected cell viability levels after vitrification, more so than 
VS55 or VS83.  The protective effect of this formulation showed that cells were sensitive 
to the concentration of DMSO, 1,2-propanediol, and formamide.  DMSO probably played 
an important role in protecting cells during vitrification, given that traditionally frozen 
samples in 1 M DMSO also fared well.  The reduction of steps did not affect cell viability 
levels because even though osmotic stress increased, chondrocytes, which are fairly 
resistant to osmotic stress, were better able to handle larger concentration gradients in 
shorter steps.  However, the reduction of exposure time due to reduction of steps may 
have also under-exposed the TECCs to the CPAs, reducing overall cell viability levels.  
The addition of convective flow did not alter cell viability levels and offered the 
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opportunity to streamline the bioprocess scheme from culture to preservation in one-step.  
The PCC bioreactor method was not detrimental to cell viability when used to perfuse the 
CPAs, but may also have over-exposed TECCs to the CPAs, reducing cell viability 
levels.  These results and the variability in cell viability levels due to the success rate of 
vitrification showed that vitrification protocols and temperature exposure has a critical 
role in maintaining high cell viability levels.  The use of the PCC bioreactor method 
allows for future studies where cells can be cultured in the PCC bioreactor and preserved 
in the same system.  In turn, this reduces handling of samples and possible contamination 
risks and provides a one-step process from culture to preservation.  The difference in cell 
viability levels reached for TECCs and rabbit native cartilage and other tissues indicate 
that TECCs require different protocols than those for native tissues.  The interaction 
between engineered tissue and the scaffold matrix may play an as yet unknown role in the 
success of vitrification.  The highest cell viability levels reached were 50%, which 
indicated that more research into the vitrification method need to be investigated for 
improvement in the cell viability levels of TECCs. 
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CHAPTER 6 
CONCLUSIONS AND FUTURE DIRECTIONS 
 
The main goal of tissue engineering is to develop replacement tissues and organs.  
The challenge is to find the right combination of cells, scaffolds, and environment that 
improves the growth of tissue to produce functionally relevant constructs suitable for 
implantation into defects, as well as finding long-term storage solutions for “off-the-
shelf” availability.  In this work, the perfusion concentric cylinder bioreactor was 
characterized and evaluated for its ability to grow tissue-engineered cartilage.  Key 
mechanical forces were evaluated, perfusion and shear, to determine their effect on 
chondrogenesis.  The final aspect of this work evaluated construct preservation methods 
in order to meet market demands for tissue-engineered cartilage.  This research gave 
insight into factors that may be important for the culture and preservation of tissue-
engineered cartilage.  From our observations, we found that the addition of perfusion 
orthogonal to surface shear increased the proliferation rate of cells, while the magnitude 
of shear stress controlled collagen deposition in constructs cultured in the PCC 
bioreactor.  We also observed that the PCC bioreactor could be used to permeate CPAs 
through TECCs cultured in the bioreactor without affecting cell viability, thus 
streamlining the bioprocess scheme from culture to preservation.   
The comparison of the PCC bioreactor to the CC bioreactor showed that overall 
the original bioreactor produced more ECM over the course of 28 days.  What was 
interesting to note was the high rate of proliferation that occurred in the PCC bioreactor, 
despite that cells were seeded at approximately the same concentration in both the CC 
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and PCC bioreactor.  The high ECM deposition was attributed to the higher shear stress 
in the CC bioreactor over the PCC bioreactor.  Though this study alone could not confirm 
that perfusion was partially responsible for cell growth and not a function of low seeding 
density (which increases the proliferation rate of cells due to limited cell-to-cell contact 
(Mandl, van der Veen et al. 2004)), the second aim of this research project did, which 
investigated the role of mechanical forces on chondrogenesis. 
The second aim of this study was to investigate the role of mechanical forces in 
vitro by utilizing the PCC bioreactor as a bench-top model.  From the perfusion+shear 
versus shear studies, the proliferation rate and total collagen deposition in the 
perfusion+shear bioreactor was significantly higher than the shear bioreactor, while GAG 
deposition remained the same in either bioreactor.  Because the proliferation rate was 
greater in the PCC bioreactor when compared to the CC bioreactor, despite the higher 
shear stress in the CC bioreactor, the results from the perfusion+shear versus shear 
studies indicated that perfusion was the main contributor to the increase in cell growth for 
TECCs.  This observation thus indicated that directional shear stress was mainly 
responsible for cellular proliferation while the magnitude of shear was responsible for 
total collagen production.  Another possible reason was that perfusion increased oxygen 
transport through the constructs, thus increasing the proliferation rate of cells.  The 
prolonged GAG synthesis in the perfusion+shear bioreactor over the shear bioreactor, i.e. 
with the addition of a new mechanical force, was responsible for prolonged GAG 
deposition.  Based on literature, intermittent perfusion flow or compression would 
prolong GAG synthesis (Kisiday, Jin et al. 2004; Gemmiti and Guldberg 2006).  Taken 
together, these observations lead to a proposed model to consider for the growth of 
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TECCs: perfusion to increase cellular proliferation, surface shear to increase collagen 
production, and intermittent compression or fluid flow to increase GAG production.  This 
information can be applied to tailor the growth of TECCs for patients by first expanding 
the small amount of cells extracted from them with perfusion, and then focusing on the 
growth and deposition of ECM with shear and intermittent perfusion or compression.  
The end result could maximize cartilage growth in a time-efficient manner to meet 
market demands.  
 One advantage of this PCC bioreactor bench-top model is that 
mechanotransduction pathways can be further investigated.  Because directional shear 
may be responsible for proliferation, studies inhibiting membrane receptors, integrins, or 
ion channels may suppress proliferation despite the addition of perfusion.  Studies 
focused on the blocking of G-proteins, growth factors, calcium channels, or kinases with 
inhibitors in the culture media would elucidate possible pathways activated by the 
mechanical loads. 
The animal study involved one trial with TECCs cultured either with mechanical 
forces or under static forces for 28 days prior to implantation.  The histological results 
showed that the mechanically stimulated samples prolonged cartilage growth and induced 
maturation in vivo, which was observed via the presence of GAG over the static samples.  
The mechanically stimulated samples also had more cells and ECM than the static culture 
samples before implantation.  This demonstrated the necessity to consider mechanical 
loads and cell density in the culture of TECCs before implantation to heal cartilage 
defects.  Combined with the results from the perfusion+shear versus shear studies, a 
proposed model to tailor the growth of TECCs prior to implantation would be to use 
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perfusion and shear in the PCC bioreactor to not only stimulate chondrogenesis, but to 
expand cells to a desired density suitable for implantation.  
A weakness in this study was that there was no direct relation of perfusion to 
cellular proliferation without the addition of shear to the bioreactor.  The ideal 
experiment would have been to run four PCC bioreactors in parallel: perfusion, shear, 
perfusion+shear, and static.  The low perfusion rate (0.6 mL/min/construct) indicated that 
there might not have been any significant difference between the perfusion bioreactor and 
static bioreactor, and that the combination of the two forces, perfusion and shear, had to 
act together to affect proliferation and collagen synthesis.  The risk of contamination 
would have increased as well because three or more bioreactors in use at the same time 
increases handling and exposure to a non-sterile environment.  Future studies of this ideal 
experiment though, would be able to confirm the direct effect of perfusion on the 
proliferation rate of cells.  
The final aim of this study was to assess the effect different cryopreservation 
protocols had on TECCs.  The most noticeable result was that an increase in the 
concentration of cryoprotectant agents in VS70 from the baseline VS55 preserved twice 
as many cells.  However, also noticeable was that the reduction of steps to introduce and 
elute vitrification solutions did not affect the viability, nor did the perfusion of the 
solution through the constructs using the PCC bioreactor.  The conclusions that could be 
drawn from these observations was that chondrocytes in TECCs were neither affected by 
the increase in osmotic stresses due to the higher concentration changes in the shorten 
steps method nor by the increase in permeation of CPAs in the PCC bioreactor method.  
The cryopreservation studies showed that even with successful vitrification (fast cooling), 
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the highest cell viability levels reached were 50%.  Clearly, further methods should be 
explored to increase and maximize cell viability levels.  The orbital shaker method and 
PCC bioreactor method did not affect cell viability levels, but did reduce total 
introduction and eluting time, as well as, simplified the process from culture to 
vitrification.  The role of DMSO, 1,2-propanediol, and formamide should be investigated 
further.  DMSO plays a large part in the success of vitrification, while formamide is 
cytotoxic.  Increasing DMSO concentration and reducing formamide in VS70 could be 
investigated in future studies.  Other variables beside CPA formulations could be 
investigated on their role in cell viability levels, such as temperature storage and 
temperature exposure during introduction and elution of CPAs.  The storage of samples at 
–196°C (liquid nitrogen) would ease transport cost, but may be detrimental to cell 
viability due to the risk of devitrification.  TECCs were exposed to the vitrification 
solution at 4°C, where metabolic activity had slowed.  Exposing TECCs to the full-
strength vitrification solution (last addition step and first removal step) at approximately 
-15°C, where metabolic activity has halted and ice has not formed yet, may decrease the 
cytotoxic effect of the vitrification solution.  Maintaining consistent fast cooling and re-
warming rates would also increase cell viability levels.  Another aspect to investigate is 
not only cell viability levels, but also cartilage functionality.  There is a need to determine 
that cells could continue to proliferate and produce ECM after vitrification.  One way to 
do this is to measure [35S]sulfate incorporation or [3H]proline incorporation after 
preservation to determine if cells are synthesizing GAG or collagen, respectively.  The 
result from the cryopreservation studies demonstrates that vitrification protocols can be 
manipulated to affect cell viability levels.  The interaction of scaffolds and cells need to 
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be considered, as successful vitrification of native cartilage cannot always be applied to 
achieve successful vitrification of TECCs.    
In summary, the perfusion concentric cylinder bioreactor is conducive to cartilage 
growth and identifies possible regions where perfusion and shear affects cartilage growth.  
In addition, storage protocols for the preservation of TECCs show that cell viability 
levels are dependent on cryoprotectant formulations, cooling and re-warming rates, and 
not affected by the method of introduction and elution of CPAs investigated in this study.  
This allows for streamlining the bioprocess scheme for tissue engineering from culture to 
preservation.  Despite these results, there are opportunities to improve cartilage growth 
and vitrification, mainly surrounding the geometry and design of the inner bob of the 
PCC bioreactor.   
 
6.1 Recommendations for the Improvement of the Design of the PCC Bioreactor 
 The current design of the PCC bioreactor demonstrates possible methods to 
increase seeding efficiency, reduce nutrient requirements, and simplify the vitrification 
process, without losing the ability to perfuse fluid through the constructs.  Currently, the 
bioreactor is seeded with 150x106 cells per 350 mL, which translates to 
0.43x106 cells/mL.  In comparison, the CC bioreactor is seeded with 2.4x106 cells/mL.  
Reduction of the culture media in the PCC bioreactor would increase the seeding density 
and efficiency.  This can be achieved by reducing the amount of “dead space” between 
the central hub and outer cup region.  Starting from an inner bob of the CC bioreactor, a 
cylindrical hole could be drilled axially though the bob to represent the central hub of the 
inner bob of the PCC bioreactor.  The dimensions would be 5.08 cm in diameter and 
 197
11.8 cm long for an inner bob 12.8 cm in length.  From the radial position, two rows of 8 
construct arms would be drilled 45 degrees apart.  The two rows would be separated by 
2.54 cm in height, the same as the PCC bioreactor.  The length of the arms would be less 
than the PCC bioreactor construct arms (2.4 cm) at 2.2 cm, but still have a large entrance 
length for a full parabolic flow to develop.  The reduction in culture media is estimated to 
be approximately 50% (about 150 mL may still be required to completely cover the 
construct arms).  The cell-seeding density would increase to approximately 
1.0x106 cells/mL.  The media requirements also would reduce drastically without 
impeding nutrient limitations, saving cost for the month-long experimental runs. 
 Another redesign element to consider is the height of the open cavity.  The 
construct was set into the construct arm, which resulted in a 2.13 mm in height open 
region, and which ensured that the construct was tightly embedded into the arm forcing 
fluid through the construct.  However, this height also resulted in considerable 
recirculation of fluid flow and heterogeneous shear stress over the surface of the 
construct.  Reduction of height would limit recirculation, but limit the tight fit needed for 
perfusion.  CFD modeling could be performed to see what the minimum height of the 
open cavity would have to be to increase homogeneity of shear stress, while still 
maintaining perfusion through the constructs. 
 The PCC bioreactor has the advantage of simple scale-up to increase the number 
of constructs cultured in one system.  Scale up of the system would occur by increasing 
the amount of rows of construct arms.  However, the pressure gradient would be 
considerably less in the top rows as oppose to the bottom rows.  Having individual 
perfusion tubing to pump fluid into each of construct arms would alleviate pressure 
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gradients.  This would require engineering a system designed to connect tubing to each of 
the construct arms from the central hub to a single reservoir.  Not only would this method 
ensure equal perfusion flow rates to all of the construct arms regardless of their position, 
but also eliminate fluid in the central hub.  This would eliminate cartilage formation away 
from the scaffolds, increase seeding efficiency, and decrease nutrient depletion of culture 
media. 
 The next recommended change on the design of the PCC bioreactor is the choice 
of material for the inner bob.  Polycarbonate is a clear material, which allows ease of 
checking on the perfusion aspect of the PCC bioreactor; however, it is not easily steam 
sterilized, nor can it handle extremely low temperatures used for vitrification.  Steam 
sterilization provides a simple, fast, and inexpensive method of sterilization, while 
ethylene oxide sterilization is costly and has a lengthy sterilization time.  Polypropylene 
or borosilicate glass could be manufactured as the inner bob of the PCC bioreactor to 
ease sterilization methods.  Though polypropylene would reduce the visibility of the 
interior of the central hub, individual perfusion tubing to each of the construct arms 
would negate the need to do so.  Polypropylene or glass materials could also withstand 
low temperatures used in vitrification.  The system, after perfused with the vitrification 
solution would be immersed into an isopentane bath and cooled to –100°C.  This would 
also eliminate the need for individual glass vials in tube racks.  A thermocouple could be 
inserted in the gap region to monitor the temperature change.  One consideration though, 
is determining if the thickness of the outer glass cup affects the cooling and re-warming 
rates of the system, but given that glass has a low thermal conductivity of 1.1 W/(m*K) at 
4°C (Carwile and Hoge 1966), the rates should not be affected greatly. 
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 Contamination within the PCC bioreactor was a major delay in the experimental 
runs.  The most common contaminant was yeast, which thrived in humid warm 
environments, like the incubator.  This high risk of contamination also limited the 
number of experimental runs and studies that could be performed at one time.  The inner 
bob of the PCC bioreactor was most likely the source of contamination because of its 
alternative sterilization method.  Ethanol rinse and UV sterilization was the initial 
sterilization method, but was then switched to ethylene oxide sterilization, which was less 
abrasive to the polycarbonate material.  Over time however, the polycarbonate material 
has degraded and is currently showing signs of cracking and warping.  This is due to the 
fact that the material is not durable or suited for repetitive long-term cell culture.  The 
suggestions made in this section lead to possible paths for improvements in the design of 
the PCC bioreactor that can be made if future studies assessing the role of perfusion and 
shear on chondrogenesis are carried out. 
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APPENDIX A 
DEVELOPMENT OF BIOREACTOR THEORY AND MECHANICAL 
PROPERTIES 
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The PCC bioreactor consisted of an immobile inner cylindrical bob and a rotating 
outer cup.  Scaffolds were embedded into protruding construct arms that radiated from 
the inner bob.  The following section describes the derivation for the calculation of the 
velocity profile between the two cylinders of the PCC bioreactor and the fluid velocity 
over the construct arms.  The solution was based on the derivation shown by Saini and 
Bird et al. (Saini 2001; Bird, Stewart et al. 2002).  Figure A.1 shows a schematic of the 
PCC bioreactor (top view) listing coordinates used in the calculation of velocity in the 
PCC bioreactor. 
 
 
Figure A.1.  Schematic of the perfusion concentric cylinder region in the bioreactor (Top 
View). 
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Navier-Stokes equation for motion: 
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Assuming no slip at the walls, the boundary conditions are: 
 
B.C.1.  KRratv  0  
B.C.2.   RratRv   
 
Equation A.3 can be integrated to obtain: 
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The boundary condition solutions are: 
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When boundary conditions are substituted into Equation A.5: 
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where, 
iRKR             Equation A.9 
 
The following section calculates the diffusivity of oxygen and the equilibrium 
concentration of oxygen in media.  The Wilke-Change equation (Equation A.10) was 
used to calculate the diffusivity of oxygen in water.  Culture media were composed of 
mainly water, and thus the Wilke-Change correlation was an adequate estimate for 
diffusivity into liquids.  The equation assumed that oxygen was dilute in water at 37°C 
(Bird, Stewart et al. 2002).  Henry’s Law (Equation A.11) was used to calculate the 
equilibrium concentration of oxygen into water as water was in equilibrium with the gas 
phase in the incubator (Hines and Maddox 1985). 
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where, 
H20 = 2.6 
MH20 = 18 g/gmol 
T = 310.15 K 
 = 0.695 cP 
VO2 = 25.6 cm3/gmol  
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where, 
PO2 = 0.2 atm 
HA (37°C) = 5.17x104 atm (Hines and Maddox 1985) 
H2O = 0.99 g/cm3 
 
The following section calculates the equilibrium time for oxygen in media to 
reach the saturated oxygen level of 0.212 mol/m3.  The derivation started from the species 
continuity equation and assumed that no perfusion occurred.  The total volume in the 
PCC bioreactor was 350 mL, which correlated to approximately 5 cm in height from the 
liquid-to-air interface.  The solution assumed that oxygen diffusion occurred in the axial 
direction only from the liquid-to-air interface, that diffusivity of oxygen in media was 
constant at 3.23x10-9 m2/s, and that there was no metabolic consumption of oxygen in the 
media.  At the liquid-to-air interface the concentration of oxygen in the gas phase was 
 205
derived from the ideal gas law for oxygen in the incubator (20% O2/5% CO2) at 37°C.  
Thus, the solution to the species continuity equation for non-steady state diffusion of 
oxygen in media was calculated as follows: 
 
Species continuity equation for oxygen: 
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The boundary and initial conditions are: 
 
B.C.1.  00/859.7 31 22  tforzatmmolCC OO  
B.C.2.  tallforzatmmolCO  32 /0  
I.C.1.  00/0 32  zfortatmmolCO  
 
Substituting the boundary and initial conditions, the solution to Equation A.13 is: 
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The equilibrium time for media to reach saturated oxygen levels of 0.212 mol/m3 at 
z = 5 cm was calculated by solving the error function in Equation A.14.  Thus, the time to 
reach equilibrium was 21.9 hours.  If the assumption that fresh media were already 
saturated with oxygen when prepared, and that perfusion after four days in the PCC 
bioreactor increased oxygen transport within the bioreactor, then the time to reach 
oxygen saturation levels in media would be less than the estimated 21.9 hours.  Thus, the 
concentration of oxygen in media before transport through the constructs was held steady 
at 0.212 mol/m3.  
 The following section derives the nutrient transport profile across the thickness of 
the constructs when both diffusivity and convective transport were considered.  The 
equation originated from the species continuity equation, Equation A.12, for steady-state 
oxygen transport in one direction, where the x component is as follows: 
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Equation A.15 can be integrated to obtain: 
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The boundary conditions are: 
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Substituting the boundary conditions, the solution to Equation A.16 is: 
 
0
2
2/
/
2
2 )1()1(
2
2 O
m
ODxV
DLV
m
O
O CV
xR
e
eV
LR
C Om
Om
     Equation A.17 
 
The following section is an example of the calculation of the compressive 
modulus and permeability constant from a confined compression test.  Four compression 
tests were carried out on each sample at 5, 10, 15, and 20 % strain seen in Figure A.2.  
The applied strain and subsequent equilibrium stress were plotted in Figure A.3 to 
calculate the compressive modulus, HA.  
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Figure A.2.  Confined compression curve for a Day 28 perfusion+shear sample.  Test 
represents stress-strain relationship during dynamic and relaxation times, as indicated. 
(A) One of the four dynamic strains tested; (B) one of the four dynamic stresses 
measured, which corresponded to the dynamic strain indicated by A; (C) one of the four 
relaxation strains held for 15 minutes; (D) one of the four relaxation stresses measured, 
which corresponded to the relaxation strain indicated by C; (E) one of the four peak 
stresses measured at the end of the dynamic portion of the compression test 
 208
 
Compressive Modulus
 = 0.15 - 0.0028
R2 = 0.9759
0
0.01
0.02
0.03
0 0.05 0.1 0.15 0.2 0.25
Equilibrium Strain
Eq
ui
lib
riu
m
 S
tr
es
s 
(M
Pa
)
 
 
Figure A.3.  Equilibrium modulus for a Day 28 perfusion+shear sample.  Data from the 
relaxation portion of the compression test were plotted to calculate the compressive 
modulus of tissue-engineered cartilage samples.  The last ten seconds of the compressive 
strain values for each relaxation curve (four curves total) were plotted against the 
corresponding measured relaxation stress.  The linear fit revealed the slope, which 
corresponded to the equilibrium modulus of the sample tested, 0.15 MPa.   
 
 
 
Data from the dynamic portion of the compression test were plotted to calculate 
the permeability constant of tissue-engineered cartilage samples.  The negative of the 
compressive strain values for each dynamic curve (four curves total) were plotted against 
the corresponding measured permeability, k, which was inversely related to the dynamic 
stress (see Equation 3.15).  The data was fitted to an exponential curve 
(k = k0e-M, Equation 3.13) to give the permeability parameters, k0 and M.  Table A.1 
shows an example measurement for a Day 28 sample harvested from a perfusion+shear 
bioreactor along with the R2 value.  The poor fit at 5% strain resulted in its elimination 
for the calculated average permeability constant. 
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Table A.1.  Permeability constant for Day 28 perfusion+shear sample 
 
Equilibrium Strain k0 (m4/(N*s)) M R2 
0.05 2.52E-13 8.54 0.86 
0.1 2.72E-13 16.11 0.97 
0.15 2.69E-13 14.26 0.96 
0.2 2.59E-13 12.89 0.97 
Average 2.67E-13 14.42 0.97 
SEM 3.66E-15 0.93 0.00 
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APPENDIX B 
EXPERIMENTAL DATA 
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Table B.1.  PCC experiment 1 
PCC Bioreactor Day 4 Day 7 Day 14 Day 21 Day 28 
351815 2950180 4966285 4084615 8146154
266497 2204096 6854539 8518434 7096310Cells/construct 
0 1511076 5379266 7157040 6152428
Average 194425 2221784 5733363 6586696 7131631
SEM 117345 415528 573124 1311317 575810
      
0 265.09 230.79 351.87 350.45 
0 151.11 375.59 110.91 334.77 g GAG/construct
83.29 233.01 315.07 419.57 242.37 
Average 15.45 216.40 307.15 294.11 309.20 
SEM 33.93 33.94 41.99 93.66 33.72 
      
0 67.65 424.76 1026.16 1091.61
0 113.42 644.27 513.53 1608.03g collagen/construct
0 83.69 508.43 1088.69 1344.35
Average 0 88.25 525.82 876.13 1348.00
SEM 1.89 13.41 63.96 182.20 149.09 
 
 
 
 
 
 
 
 
 
 
 
 
 212
Table B.2.  PCC versus CC experiment 1 
CC Bioreactor Day 4 Day 7 Day 14 Day 21 Day 28 
1374495 3801195 4804106 8266564 10703962
1231109 3822770 5424496 7733852 10057694Cells/construct 
2894366 2500213 3642563 6923547 14505837
     17169141
Average 1833323 3374726 4623722 7641321 13109158
SEM 532134 437301 522247 390446 1201698
      
360.97 1522.76 1395.98 1571.00 1695.54
382.85 1514.35 1595.13 1215.34 1862.15g GAG/construct
676.80 1008.90 923.63 1536.78 1652.91
     1997.91
Average 473.54 1348.67 1304.91 1441.04 1802.13
SEM 101.83 169.90 199.12 113.28 55.29 
      
102.05 291.32 360.08 1025.93 1356.21
67.60 252.13 502.34 667.76 1246.72g collagen/construct
71.65 140.69 477.10 907.66 2306.50
     2407.06
Average 80.43 228.04 446.51 867.12 1829.12
SEM 10.87 45.12 43.82 105.36 291.42 
      
PCC Bioreactor Day 4 Day 7 Day 14 Day 21 Day 28 
783044 2011494 7645405 13975599 9756454
988517 2885104 5331812 15288776 11846357Cells/construct 
489554 2525130 7645405 10028712 9897311
     6628736
Average 753705 2473910 6874208 13097696 9532214
SEM 144783 253486 771198 1580623 584035 
      
311.60 242.60 857.03 895.02 541.60 
378.92 111.89 492.80 887.17 975.80 g GAG/construct
102.92 298.70 857.03 973.00 820.41 
     389.58 
Average 264.48 217.73 735.62 918.40 681.85 
SEM 83.09 55.34 121.41 27.40 110.00 
      
      
      
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Table B.2.  PCC versus CC experiment 1 (continued) 
      
47.24 54.07 231.07 968.75 804.73 
15.86 92.01 395.32 1272.52 997.48 g collagen/construct
38.17 67.74 395.32 849.64 755.49 
     536.38 
Average 33.75 71.27 340.57 1030.30 773.52 
SEM 9.32 11.09 54.75 125.90 63.95 
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Table B.3.  PCC versus CC experiment 2 
CC Bioreactor Day 4 Day 7 Day 14 Day 21 Day 28 
2653207 2706348 7148326 5868303 7683035
2260020 2783195 6917533 9232877 7243046Cells/construct 
2182906 3658691 7170459 6037568 6788227
Average 2365378 3049412 7078772 7046249 7238103
SEM 145626 305447 80872.7 1094405 258321 
      
286.79 942.11 1317.18 1150.68 1139.42 
487.06 511.35 1079.58 1698.77 1517.45 g GAG/construct 
330.63 423.66 741.84 1142.98 1326.66 
Average 368.16 625.71 1046.20 1330.81 1327.85 
SEM 60.78 160.22 166.92 183.99 109.13 
      
67.92 144.86 736.38 1157.98 1834.53 
55.19 171.25 750.88 1584.68 1932.22 g collagen/construct
85.98 233.29 918.63 1195.33 1641.78 
Average 69.70 183.13 801.96 1312.67 1802.84 
SEM 8.93 26.21 58.48 136.44 85.32 
      
PCC Bioreactor Day 4 Day 7 Day 14 Day 21 Day 28 
185132b 2257928b 5493323b 8744076b 10814064b
405509b 2846642t 8630492t 4169375t 9562322tCells/construct 
70703t 1473802t 3035327b 6896536t 7097164t
Average 220448 2192791 5719714 6603329 9157850
SEM 98250 397641 1619147 1328715 1091869
      
309.06 289.79 448.74 854.89 796.45 
232.62 293.30 1070.53 360.50 790.03 g GAG/construct 
282.10 472.12 487.31 442.32 435.89 
Average 274.59 351.74 668.86 552.57 674.12 
SEM 22.38 60.20 201.14 153.00 119.13 
      
42.77 132.90 450.64 1712.92 1639.49 
30.89 86.84 1117.26 819.94 1484.39 g collagen/construct
28.50 175.47 526.67 800.10 1484.68 
Average 34.05 131.74 698.19 1110.99 1536.19 
SEM 4.41 25.59 210.68 301.02 51.65 
b: bottom row, t: top row 
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Table B.4.  Perfusion+shear versus shear experiment 1 
Perfusion+Shear Day 4 Day 7 Day 14 Day 21 Day 28 
467758t 1919472b 8085956t 10336068b 13846829b
469595b 2174417t 9596421b 10181725t 12816990tCells/construct 
269569b 423743t 7748173b 8785463t 13391430t
Average 402307 1505877 8476850 9767752 13351750
SEM 66371 546050 568215 493161 297950 
      
150.00 116.93 704.50 925.68 1355.18 
122.31 184.94 668.35 771.29 942.23 g GAG/construct 
57.22 4.20 468.00 529.27 1194.66 
Average 109.84 102.02 613.62 742.08 1164.02 
SEM 27.50 52.71 73.55 115.36 120.19 
      
39.62 120.10 648.58 1440.63 2875.62 
47.64 50.44 556.09 1137.18 2363.53 g collagen/construct
69.81 24.46 484.94 921.25 3151.11 
Average 52.36 65.00 563.20 1166.35 2796.76 
SEM 9.03 28.55 47.37 150.64 230.75 
      
Shear Day 4 Day 7 Day 14 Day 21 Day 28 
590222t 220746b 4227764t 4694056b 4890157b
266165b 181176t 3879711b 3995503t 6404423t Cells/construct 
280084b 206897t 2897795b 6830726t 768382t 
Average 378824 202940 3668423 5173428 4020987
SEM 105775 11593 398199 852833 1684026
      
68.53 477.19 749.84 1173.21 1304.33 
64.85 440.43 726.56 1396.23 1714.22 g GAG/construct 
56.89 134.09 804.37 1350.28 583.19 
Average 63.42 350.57 760.26 1306.57 1200.58 
SEM 3.44 108.76 23.06 67.99 330.59 
      
80.07 138.30 541.36 860.70 1196.58 
52.27 164.61 432.82 1017.22 1429.05 g collagen/construct
32.09 86.68 524.15 900.57 1067.35 
Average 54.81 129.86 499.44 926.16 1230.99 
SEM 13.91 22.89 33.68 46.96 105.82 
 b: bottom row, t: top row 
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Table B.5.  Perfusion+shear versus shear experiment 2 
Perfusion+Shear Day 4 Day 7 Day 14 Day 21 Day 28 
185132t 2257928b 5493323b 8744076b 10814064b
405509b 2846642t 8630492t 4169375t 9562322t Cells/construct 
70703b 1473802t 3035327b 6896536t 7097164t 
Average 220448 2192791 5719714 6603329 9157850 
SEM 98250 397641 1619147 1328715 1091869 
      
309.06 289.79 448.74 854.89 796.45 
232.62 293.30 1070.53 360.50 790.03 g GAG/construct 
282.10 472.12 487.31 442.32 435.89 
Average 274.59 351.74 668.86 552.57 674.12 
SEM 22.38 60.20 201.14 153.00 119.13 
      
42.77 132.90 450.64 1712.92 1639.49 
30.89 86.84 1117.26 819.94 1484.39 g collagen/construct
28.50 175.47 526.67 800.10 1484.68 
Average 34.05 131.74 698.19 1110.99 1536.19 
SEM 4.41 25.59 210.68 301.02 51.65 
      
Shear Day 4 Day 7 Day 14 Day 21 Day 28 
380993t 1803698t 743317t 1959938b 4553622t 
53069b 1233404t 3960861b 5348497t 3472623t Cells/construct 
51100b 2282927b 3532472b 4946374t 3387697b 
Average 161721 1773343 2745550 4084936 3804647 
SEM 109638 303351 1008726 1068822 375289 
      
267.16 261.16 632.24 1020.86 463.94 
272.08 181.09 700.61 983.46 521.21 g GAG/construct 
271.43 472.70 878.27 578.48 382.71 
Average 270.23 304.98 737.04 860.93 455.95 
SEM 1.54 86.99 73.32 141.64 40.18 
      
42.54 87.86 443.98 767.08 831.96 
37.06 68.74 402.56 780.40 871.64 g collagen/construct
49.10 116.39 322.18 641.66 667.01 
Average 42.90 90.99 389.57 729.71 790.20 
SEM 3.48 13.84 35.75 44.19 62.65 
            b: bottom row, t: top row 
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Table B.6.  Perfusion+shear versus shear experiment 3: mechanical properties 
Perfusion+Shear Day 4 Day 7 Day 14 Day 21 Day 28 
0.08 0.11 0.12 0.09 0.15 
0.12 0.17 0.05 0.06 0.10 
0.12 0.10 0.07 0.04 0.13 
Compressive 
Modulus      
(MPa) 
    0.23 
Average 0.11 0.13 0.08 0.06 0.15 
SEM 0.01 0.02 0.02 0.02 0.03 
      
1.66E-13 1.31E-13 9.84E-14 1.75E-13 2.67E-13
1.29E-13 2.00E-13 5.30E-13 7.21E-13 3.39E-13
5.67E-14 1.32E-13 3.71E-13 9.03E-13 1.27E-13
Permeability 
Constant 
(m4/(N*s)) 
    1.58E-13
Average 1.17E-13 1.54E-13 3.33E-13 6.00E-13 2.23E-13
SEM 3.21E-14 2.27E-14 1.26E-13 2.19E-13 4.90E-14
      
830540 632130 470550 72610 366130 
722020 897380 34144 115460 325290 
1548500  252320 159490 21183 
1255100 1418800 542150 112690 306980 
1208000 721790 611690 75712 93680 
1677400 1309000 803190 170900 103720 
    539900 
Shear Modulus 
at 1Hz (Pa) 
    485900 
Average 1206927 995820 452341 117810 280348 
SEM 154611 157170 111323 16736 67204 
      
4.4 6.5 8.0 13.3 14.2 
4.4 7.7 15.0 12.8 18.7 
4.0  13.0 14.9 13.8 
3.9 4.6 11.5 14.8 15.1 
4.5 6.6 8.0 15.1 14.3 
4.2 5.7 6.7 16.0 15.5 
    13.0 
Phase Angle at 
1 Hz (degree) 
    12.1 
Average 4.23 6.22 10.37 14.48 14.59 
SEM 0.10 0.52 1.35 0.49 0.70 
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Table B.6.  Perfusion+shear versus shear experiment 3: mechanical 
properties (continued) 
 
Shear Day 4 Day 7 Day 14 Day 21 Day 28 
0.14 0.09 0.06 0.11 0.12 
0.22 0.21 0.11 0.08 0.20 
0.03 0.06 0.10 0.11 0.11 
Compressive 
Modulus      
(MPa) 
0.07     
Average 0.12 0.12 0.09 0.10 0.14 
SEM 0.04 0.05 0.02 0.01 0.03 
      
1.22E-13 4.85E-14 5.01E-13 1.93E-13 3.76E-13
6.86E-14 5.80E-13 4.94E-13 3.24E-13 5.01E-14
1.39E-14 1.33E-14 2.02E-13 1.57E-13 8.46E-14
Permeability 
Constant 
(m4/(N*s)) 
1.17E-12     
Average 3.45E-13 2.14E-13 3.99E-13 2.25E-13 1.70E-13
SEM 2.77E-13 1.83E-13 9.84E-14 5.08E-14 1.03E-13
      
494630 617380 70577 436420 778950 
378500 2000800 903270 1507000  
1023200 641090 413180 432120 221830 
764020 796150 562330 368900 243480 
1379500 590990 958660 196600 431280 
560430 849740 783500 1007200 207100 
1902000     
Shear Modulus 
at 1 Hz (Pa) 
309930     
Average 851526 916025 615253 658040 376528 
SEM 195876 221053 137779 203251 108462 
      
5.3 6.0 8.1 6.1 9.9 
6.2 5.3 6.1 4.5  
4.8 5.3 6.1 7.5 10.6 
4.7 5.4 5.9 6.7 12.8 
4.1 5.4 5.0 6.5 8.1 
5.2 5.2 5.0 5.8 12.9 
4.4     
Phase Angle at 
1 Hz (degree) 
6.0     
Average 5.1 5.4 6.0 6.2 10.9 
SEM 0.3 0.1 0.5 0.4 0.9 
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Table B.7.  VS55 6/7 steps versus VS70 6/7 steps on native cartilage 
 VS55 6/7 steps VS70 6/7 steps 
8.12 22.49 
9.09 20.04 
7.13 23.40 
Viability (%) 
8.94 26.01 
Average 8.32 22.99 
SEM 0.45 1.23 
p-value 0.0005 
Time (s) 4ºC  -100ºC 678 
 
 
 
Table B.8.  Traditional freezing versus VS55 6/7 steps 
 VS55 6/7 steps Frozen 
12.47 38.51 
26.53 23.45 
17.08 20.77 
18.63 52.95 
Viability (%) 
 28.26 
Average 18.68 32.79 
SEM 2.93 5.88 
p-value 0.077 
Time (s) 4ºC  -100ºC 124 
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Table B.9.  VS55 6/7 steps versus VS70 6/7 steps – no cryopreservation 
 VS55 6/7 steps VS70 6/7 steps 
34.27 34.68 
40.12 19.95 
48.60 26.28 
Viability (%) 
42.84 23.83 
Average 41.46 26.19 
SEM 2.98 3.12 
p-value 0.0122 
Time (s) at 4ºC 1416 
   
53.32 49.46 
55.47 45.24 
42.41 39.60 
Viability (%) 
52.58 61.57 
Average 50.94 48.97 
SEM 2.91 4.66 
p-value 0.7336 
Time (s) at 4ºC 1530 
   
51.14 12.97 
41.89 14.38 
27.88 17.54 
Viability (%) 
10.41 16.72 
Average 32.83 15.40 
SEM 8.87 1.05 
p-value 0.1437 
Time (s) at 4ºC 1757 
   
56.30 35.67 
46.35 35.70 
67.54 22.48 
Viability (%) 
64.89 23.64 
Average 58.77 29.37 
SEM 4.78 3.65 
p-value 0.0033 
Time (s) at 4ºC 1739 
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Table B.10.  VS55 6/7 steps versus VS70 6/7 steps 
Day 6 or 7 samples VS55 6/7 steps VS70 6/7 steps 
26.76 21.23 
13.92 38.21 
19.92 66.67 
Viability (%) 
22.93 32.48 
Average 20.88 39.65 
SEM 2.71 9.67 
p-value 0.1460 
Time (s) 4ºC  -100ºC 131 
   
16.01 17.07 
9.00 14.04 
11.92 25.62 
Viability (%) 
6.72 22.54 
Average 10.91 19.82 
SEM 2.00 2.61 
p-value 0.0378 
Time (s) 4ºC  -100ºC 437 
   
8.34 30.51 
11.49 22.82 
8.85 29.75 
Viability (%) 
6.76 20.37 
Average 8.86 25.86 
SEM 0.98 2.52 
p-value 0.0036 
Time (s) 4ºC  -100ºC 372 
   
Day 14 samples VS55 6/7 steps VS70 6/7 steps 
8.29 18.37 
14.79 27.78 
8.12 33.03 
Viability (%) 
12.31 35.26 
Average 10.88 28.61 
SEM 1.63 3.76 
p-value 0.0118 
Time (s) 4ºC  -100ºC 687 
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Table B.10.  VS55 6/7 steps versus VS70 6/7 steps (continued) 
Day 28 samples VS55 6/7 steps VS70 6/7 steps 
17.70 13.95 
6.37 18.54 
7.21 24.20 
Viability (%) 
7.76 29.98 
Average 9.76 21.67 
SEM 2.66 3.48 
p-value 0.0370 
Time (s) 4ºC  -100ºC 198 
 
 
 
Table. B.11.  VS55 6/7 steps versus VS83 6/7 steps 
 VS55 6/7 steps VS83 6/7 steps 
20.79 7.06 
11.30 6.15 Viability (%) 
23.50 6.39 
Average 18.53 6.53 
SEM 3.70 0.27 
p-value 0.08 
Time (s) 4ºC  -100ºC 225 
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Table B.12.  VS70 6/7 steps versus VS70 4/4 steps 
 VS70 6/7 steps VS70 4/4 steps 
21.23 39.66 
38.21 52.34 
66.67 44.48 
Viability (%) 
32.48 32.11 
Average 39.65 42.15 
SEM 9.67 4.25 
p-value 0.82 
Time (s) 4ºC  -100ºC 131 
   
5.54 13.17 
11.16 23.76 
15.46 11.46 
Viability (%) 
14.04 34.90 
Average 11.55 20.82 
SEM 2.19 5.42 
p-value 0.16 
Time (s) 4ºC  -100ºC 1145 
   
12.44 10.80 
7.08 6.41 
13.38 7.44 
Viability (%) 
10.43 4.60 
Average 10.83 7.31 
SEM 1.39 1.30 
p-value 0.11 
Time (s) 4ºC  -100ºC 849 
   
30.38 51.74 
57.15 46.87 
38.92 45.20 
Viability (%) 
51.43 56.26 
Average 44.47 50.02 
SEM 6.05 2.50 
p-value 0.43 
Time (s) 4ºC  -100ºC 160 
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Table B.13.  Orbital Shaker versus PCC bioreactor (BR)  
 PCC BR Orbital Shaker 
21.92 6.31 
9.31 6.28 
6.25 7.78 
7.44 9.32 
5.52  
8.80  
8.32  
Viability (%) 
6.93  
Average 9.31 7.42 
SEM 1.86 0.72 
p-value 0.37 
Time (s) 4ºC  -100ºC 374 
   
21.99 54.08 
44.07 50.12 
46.14 54.44 
71.45 65.31 
63.36  
32.82  
54.54  
Viability (%) 
47.84  
Average 47.78 55.99 
SEM 5.60 3.26 
p-value 0.23 
Time (s) 4ºC  -100ºC 213 
 
 
 
 
 
 
 
 225
Table B.13.  Orbital Shaker versus PCC bioreactor (BR) (continued) 
 PCC BR Orbital Shaker 
2.32 10.38 
14.73 6.68 
1.61 4.49 
2.66 6.54 
10.02  
5.50  
8.83  
Viability (%) 
3.53  
Average 6.15 7.02 
SEM 1.64 1.23 
p-value 0.68 
Time (s) 4ºC  -100ºC 723 
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